Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 714 cited sources checked · 0 supported · 0 flagged
- Findingcitation
An updated meta-analysis of empiric antifungal therapy versus no antifungal therapy in adult critically ill patients found no difference in short-term mortality.
“In an updated meta-analysis of empiric antifungal therapy versus no antifungal therapy in adult critically ill patients, no difference in short-term mortality was observed.”
Quote in the paperSubstantial claim - Findingown data
In our meta-analysis of 13 studies (1968 patients), de-escalation was associated with improved short-term mortality (RR 0.72; 95% CI 0.57-0.91).
“We identified direct evidence from 13 studies (1968 patients) [277], including 1 RCT [278]. In our meta-analysis, we observed improved short-term mortality in patients who were de-escalated (RR 0.72; 95% CI 0.57–0.91) (Supplementary Appendix 2).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [277] Tabah A, Bassetti M, Kollef MH et al (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46(2):245–265 source
Not checked in the free run.
- cites [278] Leone M, Bechis C, Baumstarck K et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40(10):1399–1408 source
Not checked in the free run.
- Findingnone given
No cost-effectiveness studies have compared balanced and unbalanced crystalloid solutions.
“No cost-effectiveness studies compared balanced and unbalanced crystalloid solutions.”
Quote in the paperSubstantial claim - Findingreasoning
Limited data preclude a cutoff value for crystalloid infusion above which albumin might be considered.
“Limited data precludes a cutoff value for crystalloid infusion above which albumin might be considered as part of resuscitation.”
Quote in the paperSubstantial claim - Findingreasoning
There is a lack of powered well-designed studies supporting gelatin administration in sepsis and septic shock.
“Gelatin is a synthetic colloid used as a resuscitation fluid; there is a lack of powered well-designed studies supporting its administration in sepsis and septic shock.”
Quote in the paperSubstantial claim
- Findingnone given
Large randomized trials comparing arterial blood pressure monitoring with non-invasive methods are still lacking.
“Large, randomised trials that compare arterial blood pressure monitoring versus non-invasive methods are still lacking.”
Quote in the paperSubstantial claim - Findingnone given
No new relevant evidence on invasive versus non-invasive arterial blood pressure monitoring became available since the previous guidelines.
“Since then, no new relevant evidence became available.”
Quote in the paperSubstantial claim - Findingnone given
None of the trials directly compared dobutamine combined with norepinephrine to norepinephrine alone.
“None of the trials directly compared dobutamine combined with norepinephrine to norepinephrine alone.”
Quote in the paperSubstantial claim - Findingcitation
No evidence supports superiority of dobutamine over epinephrine.
“No evidence supports the superiority of dobutamine over epinephrine.”
Quote in the paperSubstantial claim - Findingnone given
No RCTs compared dobutamine to placebo in this population.
“No RCTs compared dobutamine to placebo in this population.”
Quote in the paperSubstantial claim - Findingcitation
Traditional recruitment maneuvers appear to improve 28-day mortality (RR 0.79; 95% CI 0.64-0.96) in patients with ARDS.
“Traditional recruitment maneuvers appear to improve 28-day mortality (RR 0.79; 95% CI 0.64–0.96) in patients with ARDS (Supplementary Appendix 4).”
Quote in the paperSubstantial claim - Findingcitation
Updated meta-analyses demonstrated reduced mortality with IVIGM (RR 0.69; 95% CI 0.55-0.85).
“and IVIGM (RR 0.69; 95% CI 0.55–0.85)”
Quote in the paperSubstantial claim - Findingcitation
On the other hand, continuous NMBA infusion reduced mortality when compared to deep sedation with as needed NMBA boluses (RR 0.71; 95% CI 0.57-0.89).
“On the other hand, continuous NMBA infusion reduced mortality when compared to deep sedation with as needed NMBA boluses (RR 0.71; 95% CI 0.57–0.89).”
Quote in the paperSubstantial claim - Findingreasoning
After excluding high risk of bias studies, the significant reduction in mortality with IVIG/IVIGM is no longer apparent.
“Furthermore, after excluding high risk of bias studies, the significant reduction in mortality is no longer apparent.”
Quote in the paperSubstantial claim - Findingown data
No increase in Clostridoides difficile colitis or pneumonia was observed with stress ulcer prophylaxis.
“No increase in Clostridoides difficile colitis or pneumonia was observed.”
Quote in the paperSubstantial claim - Findingcitation
Updated meta-analyses demonstrated reduced mortality with IVIG (RR 0.73; 95% CI 0.51-0.91).
“The updated meta-analyses demonstrated reduced mortality with IVIG (RR 0.73; 95% CI 0.51–0.91)”
Quote in the paperSubstantial claim - Findingown data
The updated meta-analysis demonstrated a reduction in GI haemorrhage with stress ulcer prophylaxis (RR 0.52; 95% CI 0.45-0.61).
“and a reduction in GI haemorrhage (RR 0.52 95% CI 0.45–0.61).”
Quote in the paperSubstantial claim - Findingown data
The 2021 guideline literature search found no new evidence on haemofiltration, combined haemoperfusion and haemofiltration, or plasma exchange.
“We did not identify new evidence on other modalities such as haemofiltration, combined haemoperfusion and haemofiltration or plasma exchange.”
Quote in the paperSubstantial claim - Findingnone given
There are no high-quality studies examining the effect of intravenous immunoglobulins on outcomes in patients with sepsis or septic shock.
“There are no high-quality studies examining the effect of intravenous (IV) immunoglobulins on the outcomes of patients with sepsis or septic shock.”
Quote in the paperSubstantial claim - Findingcitation
A continuous NMBA infusion did not improve mortality when compared to a light sedation strategy with as needed NMBA boluses but no continuous infusion (RR 0.99; 95% CI 0.86-1.15).
“A continuous NMBA infusion did not improve mortality when compared to a light sedation strategy with as needed NMBA boluses but no continuous infusion (RR 0.99; 95% CI 0.86–1.15).”
Quote in the paperSubstantial claim - Findingreasoning
The updated meta-analysis showed no difference in 28-day mortality (OR 0.99; 95% CI 0.67-1.46; moderate quality).
“Our update of the meta-analysis showed no difference in 28-day mortality (OR 0.99 95% CI 0.67–1.46, moderate quality).”
Quote in the paperSubstantial claim - Findingown data
The updated meta-analysis demonstrated no effect of stress ulcer prophylaxis on mortality (RR 1.01; 95% CI 0.93-1.10).
“This demonstrated no effect on mortality (RR 1.01 95% CI 0.93–1.10)”
Quote in the paperSubstantial claim - Findingnone given
No data exist for patients with contraindications to pharmacologic VTE prophylaxis.
“No data for this population exist.”
Quote in the paperSubstantial claim - Findingcitation
The prior meta-analysis demonstrated significantly lower rates of DVT following LMWH compared to UFH (RR 0.84; 95% CI 0.71-0.98).
“The prior meta-analysis demonstrated significantly lower rates of DVT following the administration of LMWH compared to UFH (RR 0.84 95% CI 0.71–0.98).”
Quote in the paperSubstantial claim - Findingcitation
No significant difference in the risk of hospital mortality was observed between the four blood glucose ranges (< 110, 110-144, 144-180, and > 180 mg/dL).
“No significant difference in the risk of hospital mortality was observed between the four blood glucose ranges.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [519] Yatabe T, Inoue S, Sakaguchi M et al (2017) The optimal target for acute glycemic control in critically ill patients: a network meta-analysis. Intensive Care Med 43(1):16–28 source
Not checked in the free run.
- Findingown data
The use of vitamin C did not reduce mortality compared to usual care (RR 0.79; 95% CI 0.57-1.1; low quality).
“The use of vitamin C did not reduce mortality compared to usual care (RR 0.79; 95% CI 0.57–1.1, low quality).”
Quote in the paperSubstantial claim - Findingcitation
The effect of mechanical ventilation on clinically important bleeding was unclear (RE 1.93, 0.57-6.50, very low certainty).
“The effect of mechanical ventilation on clinically important bleeding was unclear (RE 1.93, 0.57–6.50, very low certainty).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [496] Granholm A, Zeng L, Dionne JC et al (2019) Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 45(10):1347–1359 source
Not checked in the free run.
- Findingcitation
One study reported reduced vasopressor use at 168 h with vitamin C.
“One study reported reduced vasopressor use at 168 h [523].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [523] Fowler AA 3rd, Truwit JD, Hite RD et al (2019) Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI Randomized Clinical Trial. JAMA 322(13):1261–1270 source
Not checked in the free run.
- Findingcitation
Target concentrations of < 110 and 110-144 mg/dL were associated with a four to nine-fold increase in the risk of hypoglycemia compared with 144-180 and > 180 mg/dL.
“Target concentrations of < 110 and 110–144 mg/dL were associated with a four to nine-fold increase in the risk of hypoglycemia compared with 144–180 and > 180 mg/dL.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [519] Yatabe T, Inoue S, Sakaguchi M et al (2017) The optimal target for acute glycemic control in critically ill patients: a network meta-analysis. Intensive Care Med 43(1):16–28 source
Not checked in the free run.
- Findingown data
The literature review found no new RCT evidence comparing LMWH to UFH.
“Our literature review found no new RCT evidence comparing the administration of low molecular weight heparin (LMWH) to unfractionated heparin (UFH).”
Quote in the paperSubstantial claim - Findingcitation
No significant difference in the risk of hypoglycemia was demonstrated comparing a target of 144-180 and > 180 mg/dL (OR 1.72; 95% CI 0.79-3.7).
“No significant difference in the risk of hypoglycemia comparing a target of 144–180 and > 180 mg/dL was demonstrated (OR 1.72; 95% CI 0.79–3.7).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [519] Yatabe T, Inoue S, Sakaguchi M et al (2017) The optimal target for acute glycemic control in critically ill patients: a network meta-analysis. Intensive Care Med 43(1):16–28 source
Not checked in the free run.
- Findingcitation
The updated meta-analysis showed no effect of timing of initiation of renal replacement therapy on mortality and renal recovery.
“No effect of the timing of initiation of renal replacement therapy on mortality and renal recovery was observed.”
Quote in the paperSubstantial claim - Findingown data
No new RCT evidence was identified for VTE prophylaxis.
“No new RCT evidence was identified.”
Quote in the paperSubstantial claim - Findingown data
No significant effect favouring early enteral nutrition was observed for all outcomes evaluated in the meta-analysis.
“No significant effect favouring early enteral nutrition was observed for all outcomes evaluated.”
Quote in the paperSubstantial claim - Findingown data
When these data are added to the meta-analysis, the point estimate for mortality becomes RR 0.9 (95% CI 0.69-1.18; low quality).
“When these data are added to our meta-analysis, the point estimate for mortality becomes RR 0.9 (95% CI 0.69–1.18: low quality).”
Quote in the paperSubstantial claim - Findingnone given
No studies were identified that compared discussions of goals of care and prognosis versus no such discussion in critically ill or septic patients.
“No studies were identified that compared discussions of goals of care and prognosis versus no such discussion in critically ill or septic patients.”
Quote in the paperSubstantial claim - Findingcitation
Carson et al. found increased PTSD symptoms in family surrogate decision makers who received palliative care consultation.
“In contrast, Carson et al. found an increase in PTSD symptoms in family surrogate decision makers with palliative care consultation [543].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [543] Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62 source
Not checked in the free run.
- Findingcitation
Ethics consultation did not affect overall mortality in any study.
“Ethics consultation did not affect overall mortality in any study.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [539] Schneiderman LJ, Gilmer T, Teetzel HD (2000) Impact of ethics consultations in the intensive care setting: a randomized, controlled trial. Crit Care Med 28(12):3920–3924 source
Not checked in the free run.
- cites [540] Schneiderman LJ, Gilmer T, Teetzel HD et al (2003) Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA 290(9):1166–1172 source
Not checked in the free run.
- cites [541] Chen C, Michaels J, Meeker MA (2019) Family outcomes and perceptions of end-of-life care in the intensive care unit: a mixed-methods review. J Palliat Care 35(3):143–153. https://doi.org/10.1177/0825859719874767 source
Not checked in the free run.
- Findingcitation
Neither study demonstrated an effect of interventions on mortality.
“Neither study demonstrated an effect of interventions on mortality.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [542] Andereck WS, McGaughey JW, Schneiderman LJ et al (2014) Seeking to reduce nonbeneficial treatment in the ICU: an exploratory trial of proactive ethics intervention. Crit Care Med 42(4):824–830 source
Not checked in the free run.
- cites [543] Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62 source
Not checked in the free run.
- Findingreasoning
The inclusion criteria and interventions in the reviewed palliative care studies show substantial heterogeneity.
“Criteria for patient inclusion and the interventions in these studies demonstrate significant heterogeneity.”
Quote in the paperSubstantial claim - Findingcitation
The timing of discussions of goals of care and prognosis in the ICU was addressed in one study where 26% of patients had infection or sepsis as a primary diagnosis.
“The timing of discussions of goals of care and prognosis in the ICU was addressed in one study where 26% of patients had infection or sepsis as a primary diagnosis [538].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [538] White DB, Angus DC, Shields AM et al (2018) A randomized trial of a family-support intervention in intensive care units. N Engl J Med 378(25):2365–2375 source
Not checked in the free run.
- Findingcitation
One structured palliative care intervention study found lower prevalence of anxiety, depression, and PTSD symptoms in family members 90 days after the patient's death.
“Only one study with a structured palliative care intervention [547] demonstrated a beneficial effect of lower prevalence of anxiety and depression symptoms and PTSD symptoms in family members 90 days after the patient’s death.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [547] Lautrette A, Darmon M, Megarbane B et al (2007) A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med 356(5):469–478 source
Not checked in the free run.
- Findingreasoning
None of the palliative care studies evaluated critical patient-centered outcomes such as quality of life, physical or cognitive recovery, psychological outcomes, or symptoms.
“Various outcome measures are reported but none of the studies evaluated critical patient-centered outcomes such as QoL, physical or cognitive recovery, psychological outcomes, or symptoms.”
Quote in the paperSubstantial claim - Findingown data
No studies described costs associated with support groups.
“No studies described costs associated with support groups, which will vary given the model and resource availability.”
Quote in the paperNot a substantial claim - Findingcitation
Sepsis education is regarded as low cost and feasible even in low-resource settings because online and published resources exist.
“Sepsis education is regarded as a low cost intervention and feasible, even in low-resource settings, as a number of online and published sepsis education resources exist [589].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [589] Oermann MH, McInerney SM (2007) An evaluation of sepsis Web sites for patient and family education. Plast Surg Nurs 27(4):192–196 source
Not checked in the free run.
- Findingcitation
A small study of ICU relatives found lower anxiety and depression rates in those who preferred an active or shared decision-making role compared to a passive role.
“A small study of ICU relatives found that anxiety and depression rates were lower in those who preferred an active role or shared responsibility in decision-making compared to those who preferred a passive role [591].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [591] Anderson WG, Arnold RM, Angus DC et al (2009) Passive decision-making preference is associated with anxiety and depression in relatives of patients in the intensive care unit. J Crit Care 24(2):249–254 source
Not checked in the free run.
- Findingnone given
Structured handoff interventions for critically ill patients have been evaluated at many transitions of patient care.
“Structured handoff interventions for critically ill patients have been evaluated at many transitions of patient care (ED/ICU, OR/ICU, ICU/ward, and hospital/home).”
Quote in the paperSubstantial claim - Findingcitation
Three qualitative studies identified two common themes of peer support: benefit of knowing others shared similar experiences and benefit of shared coping.
“Three qualitative studies identified two common themes of peer support, (1) benefit of knowing that others shared similar experiences and (2) benefit of shared coping with others [564].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [564] Haines KJ, Beesley SJ, Hopkins RO et al (2018) Peer support in critical care: a systematic review. Crit Care Med 46(9):1522–1531 source
Not checked in the free run.
- Findingnone given
Overall quality of evidence for structured handoff was judged very low.
“Overall quality of evidence was judged to be very low.”
Quote in the paperSubstantial claim - Findingcitation
Six RCTs evaluated educational interventions for critically ill patients and their families.
“We identified six RCTs that evaluated educational interventions for critically ill patients and their families [583–588].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [583] Azoulay E, Pochard F, Chevret S et al (2002) Impact of a family information leaflet on effectiveness of information provided to family members of intensive care unit patients: a multicenter, prospective, randomized, controlled trial. Am J Respir Crit Care Med 165(4):438–442 source
Not checked in the free run.
- cites [584] Bench S, Day T, Heelas K et al (2015) Evaluating the feasibility and effectiveness of a critical care discharge information pack for patients and their families: a pilot cluster randomised controlled trial. BMJ Open 5(11):e006852 source
Not checked in the free run.
- cites [585] Demircelik MB, Cakmak M, Nazli Y et al (2016) Effects of multimedia nursing education on disease-related depression and anxiety in patients staying in a coronary intensive care unit. Appl Nurs Res 29:5–8 source
Not checked in the free run.
- cites [586] Fleischer S, Berg A, Behrens J et al (2014) Does an additional structured information program during the intensive care unit stay reduce anxiety in ICU patients?: a multicenter randomized controlled trial. BMC Anesthesiol 14:48 source
Not checked in the free run.
- cites [587] Gehrke-Beck S, Bänfer M, Schilling N et al (2017) The specific needs of patients following sepsis: a nested qualitative interview study. BJGP Open. 1(1):bjgpopen17X100725 source
Not checked in the free run.
- cites [588] Schmidt K, Worrack S, Von Korff M et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315(24):2703–2711 source
Not checked in the free run.
- Findingcitation
In several qualitative studies, ICU survivors described peer support as a helpful aid to recovery.
“In several qualitative studies, ICU survivors described peer support as a helpful aid to recovery [559–563].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [559] Damianakis T, Tough A, Marziali E et al (2016) Therapy online: A web-based video support group for family caregivers of survivors with traumatic brain injury. J Head Trauma Rehabil 31(4):E12-20 source
Not checked in the free run.
- cites [560] Harvey C, Dixon M, Padberg N (1995) Support group for families of trauma patients: a unique approach. Crit Care Nurse 15(4):59–63 source
Not checked in the free run.
- cites [561] Jones C, Macmillan RR, Griffiths RD (1994) Providing psychological support for patients after critical illness. Clin Intensive Care 5(4):176–179
Not checked in the free run.
- cites [562] Peskett M, Gibb P (2009) Developing and setting up a patient and relatives intensive care support group. Nurs Crit Care 14(1):4–10 source
Not checked in the free run.
- cites [563] Sacco TL, Stapleton MF, Ingersoll GL (2009) Support groups facilitated by families of former patients: creating family-inclusive critical care units. Crit Care Nurse 29(3):36–45 source
Not checked in the free run.
- Findingcitation
Observational studies of structured handoff process have shown mixed effects on clinical events, ICU readmission, length of stay, mortality, and hospital readmission.
“Observational studies of structured handoff process have demonstrated mixed effects, with some finding reductions in unexpected clinical events [569], or ICU readmission [570, 571] and others without impact upon length of stay [572], mortality [572, 573] or hospital readmission [572, 573].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [569] Nanchal R, Aebly B, Graves G et al (2017) Controlled trial to improve resident sign-out in a medical intensive care unit. BMJ Qual Saf 26(12):987–992 source
Not checked in the free run.
- cites [570] Hess DR, Tokarczyk A, O’Malley M et al (2010) The value of adding a verbal report to written handoffs on early readmission following prolonged respiratory failure. Chest 138(6):1475–1479 source
Not checked in the free run.
- cites [571] Hoffman RL, Saucier J, Dasani S et al (2017) Development and implementation of a risk identification tool to facilitate critical care transitions for high-risk surgical patients. Int J Qual Health Care 29(3):412–419 source
Not checked in the free run.
- cites [572] Chaboyer W, Lin F, Foster M et al (2012) Redesigning the ICU nursing discharge process: a quality improvement study. Worldviews Evid Based Nurs 9(1):40–48 source
Not checked in the free run.
- cites [573] Medlock S, Eslami S, Askari M et al (2011) Improved communication in post-ICU care by improving writing of ICU discharge letters: a longitudinal before-after study. BMJ Qual Saf 20(11):967–973 source
Not checked in the free run.
- Findingcitation
Critically ill patients have a decline in socio-economic status after their illness.
“Notably, critically ill patients have a decline in socio-economic status (SES) after their illness [574].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [574] Griffiths J, Hatch RA, Bishop J et al (2013) An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study. Crit Care 17(3):R100 source
Not checked in the free run.
- Findingreasoning
There were insufficient data to allow meta-analysis of handoff studies.
“There were insufficient data to allow for meta-analysis.”
Quote in the paperSubstantial claim - Findingreasoning
Structured handoff processes appear to result in more complete and accurate transfer of information without undesirable effects.
“Structured handoff processes appear to result in more complete and accurate transfer of information, without any undesirable effects.”
Quote in the paperSubstantial claim - Findingown data
The review did not identify any studies specifically evaluating patients with sepsis for handoff.
“We did not identify any studies specifically evaluating patients with sepsis.”
Quote in the paperSubstantial claim - Findingreasoning
Overall quality of evidence for the impact of peer support groups on outcomes was judged very low.
“Overall quality of evidence was judged to be very low for the impact of peer support groups on outcomes.”
Quote in the paperSubstantial claim - Findingnone given
These education studies provided limited data for review.
“These studies provided limited data for review.”
Quote in the paperSubstantial claim - Findingnone given
No studies were identified comparing screening versus no screening for economic and social support.
“No studies were identified comparing screening versus no screening for economic and social support.”
Quote in the paperSubstantial claim - Findingcitation
A single RCT in 8 ICUs found no effect of a standardised handoff process on duration of mechanical ventilation, ICU length of stay, or duration of handover.
“A single RCT using a stepped-wedge design in 8 ICUs evaluated the impact of a standardised handoff process, finding no effect upon duration of mechanical ventilation, ICU length of stay or duration of handover [568].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [568] Parent B, LaGrone LN, Albirair MT et al (2018) Effect of standardized handoff curriculum on improved clinician preparedness in the intensive care unit: a stepped-wedge cluster randomized clinical trial. JAMA Surg 153(5):464–470 source
Not checked in the free run.
- Findingcitation
Studies of tools to promote shared decision making in patients with other serious illnesses show improved patient knowledge and awareness of treatment options.
“Studies of tools employed to promote SDM in patients with other serious illnesses show improved patient knowledge and awareness of treatment options [595].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [595] Austin CA, Mohottige D, Sudore RL et al (2015) Tools to promote shared decision making in serious illness: a systematic review. JAMA Intern Med 175(7):1213–1221 source
Not checked in the free run.
- Findingnone given
No studies were identified comparing shared decision making with other types of ICU or hospital discharge planning.
“No studies were identified that compared SDM with other types of ICU or hospital discharge planning.”
Quote in the paperSubstantial claim - Findingnone given
None of the structured handover tools studied specifically applies to sepsis.
“Of the structured handover tools studied, none specifically applies to sepsis.”
Quote in the paperSubstantial claim - Findingown data
The review did not identify sufficient studies to allow meta-analysis of peer support groups.
“We did not identify sufficient studies to allow for meta-analysis.”
Quote in the paperSubstantial claim - Findingcitation
Racial disparities in sepsis are at least partially explained by living in medically underserved neighborhoods.
“Racial disparities in sepsis [578] are at least partially explained by living in medically underserved neighborhoods [579].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [578] Ogundipe F, Kodadhala V, Ogundipe T et al (2019) Disparities in sepsis mortality by region, urbanization, and race in the USA: a Multiple Cause of Death Analysis. J Racial Ethn Health Dispar 6(3):546–551 source
Not checked in the free run.
- cites [579] Goodwin AJ, Nadig NR, McElligott JT et al (2016) Where you live matters: the impact of place of residence on severe sepsis incidence and mortality. Chest 150(4):829–836 source
Not checked in the free run.
- Findingreasoning
The panel judged there to be insufficient evidence to make a recommendation on early cognitive therapy.
“In view of these findings, the panel judged there to be insufficient evidence to make a recommendation.”
Quote in the paperSubstantial claim - Findingcitation
These outcomes were consistent with a 2019 qualitative analysis of health related quality of life domains identified by sepsis survivors.
“These outcomes were consistent with a 2019 qualitative analysis of health related QoL domains identified by sepsis survivors [621].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [621] Konig C, Matt B, Kortgen A et al (2019) What matters most to sepsis survivors: a qualitative analysis to identify specific health-related quality of life domains. Qual Life Res 28(3):637–647 source
Not checked in the free run.
- Findingcitation
In an analysis of older adults with severe sepsis, one study found that early home health care combined with a medical provider visit was associated with reduced readmission risk.
“In an analysis of older adults with severe sepsis, one study found that the combination of early home health care and a visit with a medical provider was associated with a reduced readmission risk [631].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [631] Deb P, Murtaugh CM, Bowles KH et al (2019) Does early follow-up improve the outcomes of sepsis survivors discharged to home health care? Med Care 57(8):633–640 source
Not checked in the free run.
- Findingcitation
Several studies, mostly before-and-after design, have examined critical care transition programmes on reducing ICU readmission or death among patients transferred from ICU to ward.
“Several studies, mostly before-and-after design, have examined the impact of critical care transition programmes on reducing ICU readmission or death among patients transferred from ICU to the ward [597, 601, 603–611].”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [597] Fabes J, Seligman W, Barrett C et al (2017) Does the implementation of a novel intensive care discharge risk score and nurse-led inpatient review tool improve outcome? A prospective cohort study in two intensive care units in the UK. BMJ Open 7(12):e018322 source
Not checked in the free run.
- cites [601] Stelfox HT, Bastos J, Niven DJ et al (2016) Critical care transition programs and the risk of readmission or death after discharge from ICU. Intensive Care Med 42(3):401–410 source
Not checked in the free run.
- cites [603] Ball C, Kirkby M, Williams S (2003) Effect of the critical care outreach team on patient survival to discharge from hospital and readmission to critical care: non-randomised population based study. BMJ 327(7422):1014 source
Not checked in the free run.
- cites [604] Baxter AD, Cardinal P, Hooper J et al (2008) Medical emergency teams at The Ottawa Hospital: the first two years. Can J Anaesth 55(4):223–231 source
Not checked in the free run.
- cites [605] Choi S, Lee J, Shin Y et al (2016) Effects of a medical emergency team follow-up programme on patients discharged from the medical intensive care unit to the general ward: a single-centre experience. J Eval Clin Pract 22(3):356–362 source
Not checked in the free run.
- cites [606] Elliott D, McKinley S, Alison J et al (2011) Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program. Crit Care 15:R142 source
Not checked in the free run.
- cites [607] Garcea G, Thomasset S, McClelland L et al (2004) Impact of a critical care outreach team on critical care readmissions and mortality. Acta Anaesthesiol Scand 48(9):1096–1100 source
Not checked in the free run.
- cites [608] Green A, Edmonds L (2004) Bridging the gap between the intensive care unit and general wards-the ICU Liaison Nurse. Intensive Crit Care Nurs 20(3):133–143 source
Not checked in the free run.
- cites [609] Leary T, Ridley S (2003) Impact of an outreach team on re-admissions to a critical care unit. Anaesthesia 58(4):328–332 source
Not checked in the free run.
- cites [610] Pittard AJ (2003) Out of our reach? Assessing the impact of introducing a critical care outreach service. Anaesthesia 58(9):882–885 source
Not checked in the free run.
- Findingcitation
Many sepsis survivors experience short and/or long-term sequelae such as cognitive and/or physical disability, with ongoing recovery persisting for months to years.
“Many sepsis survivors experience short and/or long-term sequela such as cognitive and/or physical disability, with ongoing recovery persisting for months to years [620].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [620] Iwashyna TJ, Ely EW, Smith DM et al (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787–1794 source
Not checked in the free run.
- Findingcitation
Information on post-intensive care syndrome may be provided to only one in three ICU survivors.
“Information on post-intensive care syndrome (PICS) may be provided to only one in three ICU survivors [550, 618], mechanical ventilation, dialysis), and common impairments after sepsis.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [550] Govindan S, Iwashyna TJ, Watson SR et al (2014) Issues of survivorship are rarely addressed during intensive care unit stays. Baseline results from a statewide quality improvement collaborative. Ann Am Thorac Soc 11(4):587–591 source
Not checked in the free run.
- cites [618] Weissman GE, Harhay MO, Lugo RM et al (2016) Natural language processing to assess documentation of features of critical illness in discharge documents of acute respiratory distress syndrome survivors. Ann Am Thorac Soc 13(9):1538–1545 source
Not checked in the free run.
- Findingcitation
Several randomised studies have assessed physical rehabilitation programmes for survivors of critical illness.
“Several randomised studies have assessed physical rehabilitation programmes for survivors of critical illness [581, 606, 644–651].”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [581] Gruther W, Pieber K, Steiner I et al (2017) Can early rehabilitation on the general ward after an intensive care unit stay reduce hospital length of stay in survivors of critical illness?: A randomized controlled trial. Am J Phys Med Rehabil 96(9):607–615 source
Not checked in the free run.
- cites [606] Elliott D, McKinley S, Alison J et al (2011) Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program. Crit Care 15:R142 source
Not checked in the free run.
- cites [644] Batterham AM, Bonner S, Wright J et al (2014) Effect of supervised aerobic exercise rehabilitation on physical fitness and quality-of-life in survivors of critical illness: an exploratory minimized controlled trial (PIX study). Br J Anaesth 113:130–137 source
Not checked in the free run.
- cites [645] Battle C, James K, Temblett P et al (2019) Supervised exercise rehabilitation in survivors of critical illness: a randomised controlled trial. J Intensive Care Soc 20(1):18–26 source
Not checked in the free run.
- cites [646] Connolly B, Thompson A, Douiri A et al (2015) Exercise-based rehabilitation after hospital discharge for survivors of critical illness with intensive care unit-acquired weakness: a pilot feasibility trial. J Crit Care 30(3):589–598 source
Not checked in the free run.
- cites [647] Jones C, Skirrow P, Griffiths RD et al (2003) Rehabilitation after critical illness: a randomized, controlled trial. Crit Care Med 31:2456–2461 source
Not checked in the free run.
- cites [648] Jones TK, Fuchs BD, Small DS et al (2015) Post-acute care use and hospital readmission after sepsis. Ann Am Thorac Soc 12(6):904–913 source
Not checked in the free run.
- cites [649] McDowell K, O’Neill B, Blackwood B et al (2017) Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness: a randomised controlled trial (the REVIVE trial). Thorax 72(7):594–595 source
Not checked in the free run.
- cites [650] McWilliams DJ, Benington S, Atkinson D (2016) Outpatient-based physical rehabilitation for survivors of prolonged critical illness: a randomized controlled trial. Physiother Theory Pract 32(3):179–190 source
Not checked in the free run.
- cites [651] Walsh TS, Salisbury LG, Merriweather JL et al (2015) Increased hospital-based physical rehabilitation and information provision after intensive care unit discharge: The RECOVER randomized clinical trial. JAMA Intern Med 175:901–910 source
Not checked in the free run.
- Findingcitation
A feasibility pilot RCT in general medical/surgical ICU survivors found improved executive functioning at 3 months with combined in-home cognitive, physical, and functional rehabilitation after discharge.
“A feasibility, pilot, randomised trial in general medical/surgical ICU survivors comparing usual care to an intervention of combined in-home cognitive, physical, and functional rehabilitation following discharge showed improved executive functioning at 3 months [633].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [633] Jackson JC, Ely EW, Morey MC et al (2012) Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med 40(4):1088–1097 source
Not checked in the free run.
- Findingcitation
Three studies (one RCT and two observational) evaluated early post-hospital follow-up in patients with critical illness.
“Three studies, one RCT [628] and two observational studies [629, 630] evaluated early post-hospital follow-up in patients with critical illness.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [628] Douglas SL, Daly BJ, Kelley CG et al (2007) Chronically critically ill patients: health-related quality of life and resource use after a disease management intervention. Am J Crit Care 16(5):447–457 source
Not checked in the free run.
- cites [629] Jónasdóttir RJ, Jónsdóttir H, Gudmundsdottir B et al (2018) Psychological recovery after intensive care: Outcomes of a long-term quasi-experimental study of structured nurse-led follow-up. Intensive Crit Care Nurs 44:59–66 source
Not checked in the free run.
- cites [630] Kansagara D, Ramsay RS, Labby D et al (2012) Post-discharge intervention in vulnerable, chronically ill patients. J Hosp Med 7(2):124–130 source
Not checked in the free run.
- Findingcitation
Sepsis is associated with newly acquired cognitive impairment and functional disability amongst survivors.
“Sepsis is associated with newly acquired cognitive impairment and functional disability amongst survivors [620].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [620] Iwashyna TJ, Ely EW, Smith DM et al (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787–1794 source
Not checked in the free run.
- Findingcitation
Some small single centre studies tested specific early cognitive therapies to enhance cognitive and overall functional recovery after critical illness.
“Some small single centre studies tested specific early cognitive therapies to enhance cognitive and overall functional recovery after critical illness [634, 635].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [634] Brummel NE, Girard TD, Ely EW et al (2014) Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the Activity and Cognitive Therapy in ICU (ACT-ICU) trial. Intensive Care Med 40(3):370–379 source
Not checked in the free run.
- cites [635] Zhao J, Yao L, Li M et al (2019) Effects of early intervention training on cognitive impairment in critical patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 31(3):298–302
Not checked in the free run.
- Findingcitation
Among older adults, early post-discharge follow-up (within 7 days) with a primary care physician was associated with lower risk of 30-day readmission.
“Among older adults, early post discharge follow-up (within 7 days) with a primary care physician was associated with lower risk of 30-day readmission [626, 627].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [626] Field TS, Ogarek J, Garber L et al (2015) Association of early post-discharge follow-up by a primary care physician and 30-day rehospitalization among older adults. J Gen Intern Med 30(5):565–571 source
Not checked in the free run.
- cites [627] Shen E, Koyama SY, Huynh DN et al (2017) Association of a dedicated post-hospital discharge follow-up visit and 30-Day readmission risk in a Medicare Advantage population. JAMA Intern Med 177(1):132–135 source
Not checked in the free run.
- Findingcitation
Key information from hospitalisation is often missing on hospital discharge documentation.
“Key information from hospitalisation is often missing on hospital discharge documentation [615–618].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [615] Etesse B, Jaber S, Mura T et al (2010) How the relationships between general practitioners and intensivists can be improved: the general practitioners’ point of view. Crit Care 14(3):R112 source
Not checked in the free run.
- cites [616] Kripalani S, LeFevre F, Phillips CO et al (2007) Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 297:831–841 source
Not checked in the free run.
- cites [617] Robelia PM, Kashiwagi DT, Jenkins SM et al (2017) Information transfer and the hospital discharge summary: National primary care provider perspectives of challenges and opportunities. J Am Board Fam Med 30(6):758–765 source
Not checked in the free run.
- cites [618] Weissman GE, Harhay MO, Lugo RM et al (2016) Natural language processing to assess documentation of features of critical illness in discharge documents of acute respiratory distress syndrome survivors. Ann Am Thorac Soc 13(9):1538–1545 source
Not checked in the free run.
- Findingcitation
Observational studies in congestive heart failure have associated early (within 7-14 days) post-discharge follow-up with reduced hospital readmissions.
“Observational studies in patients with congestive heart failure have associated early (within 7–14 days) post-discharge follow-up with reduced hospital readmissions [625].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [625] Hernandez AF, Greiner MA, Fonarow GC et al (2010) Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 303(17):1716–1722 source
Not checked in the free run.
- Findingnone given
Effects of critical care transition programmes on ICU workload and workflow have not been systematically examined.
“Effects on ICU workload and workflow have not been systematically examined.”
Quote in the paperNot a substantial claim - Premisecitation
A meta-analysis of 2 RCTs in Sub-Saharan Africa found higher mortality with standard operating procedures compared with usual care (RR 1.26; 95% CI 1.00-1.58).
“A meta-analysis of 2 RCTs in Sub-Saharan Africa found higher mortality (RR 1.26; 95% CI 1.00–1.58) with standard operating procedures compared with usual care”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Morton B, Stolbrink M, Kagima W et al (2018) The early recognition and management of sepsis in Sub-Saharan African adults: a systematic review and meta-analysis. Int J Environ Res Public Health 15(9):2017 source
Not checked in the free run.
- Premisecitation
One observational study in Sub-Saharan Africa found decreased mortality with standard operating procedures (adjusted HR; 95% CI 0.55-0.98).
“while it was decreased in one observational study (adjusted hazard ratio [HR]; 95% CI 0.55–0.98) [39].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Morton B, Stolbrink M, Kagima W et al (2018) The early recognition and management of sepsis in Sub-Saharan African adults: a systematic review and meta-analysis. Int J Environ Res Public Health 15(9):2017 source
Not checked in the free run.
- Interpretationreasoning
Despite variation in sensitivity and specificity, sepsis screening tools are an important component of early sepsis identification for timely intervention.
“However, while there is wide variation in sensitivity and specificity of sepsis screening tools, they are an important component of identifying sepsis early for timely intervention.”
Quote in the paperSubstantial claim- Rests on an assumption: Early identification and appropriate management in the initial hours after sepsis onset improve outcomes.
- Premisecitation
A pooled analysis of three RCTs did not show a mortality benefit of active sepsis screening (RR 0.90; 95% CI 0.51-1.58).
“A pooled analysis of three RCTs did not demonstrate a mortality benefit of active screening (RR 0.90; 95% CI 0.51–1.58) [33–35].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [33] Downing NL, Rolnick J, Poole SF et al (2019) Electronic health record-based clinical decision support alert for severe sepsis: a randomised evaluation. BMJ Qual Saf 28(9):762–768 source
Not checked in the free run.
- cites [34] Hooper MH, Weavind L, Wheeler AP et al (2012) Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. Crit Care Med 40(7):2096–2101 source
Not checked in the free run.
- cites [35] Shimabukuro DW, Barton CW, Feldman MD et al (2017) Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir Res 4(1):e000234 source
Not checked in the free run.
- Interpretationcitation
The specific components of sepsis performance improvement appear less important than the presence of a programme that includes sepsis screening and metrics.
“The specific components of performance improvement did not appear to be as important as the presence of a programme that included sepsis screening and metrics.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Damiani E, Donati A, Serafini G et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One 10(5):e0125827 source
Not checked in the free run.
- Premisecitation
Studies investigating qSOFA as a sepsis screening tool have produced contradictory results.
“Since that time numerous studies have investigated the potential use of the qSOFA as a screening tool for sepsis [40–42]. The results have been contradictory as to its usefulness.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [40] Fernando SM, Tran A, Taljaard M et al (2018) Prognostic accuracy of the quick sequential organ failure assessment for mortality in patients with suspected infection: a systematic review and meta-analysis. Ann Intern Med 168(4):266–275 source
Not checked in the free run.
- cites [41] Herwanto V, Shetty A, Nalos M et al (2019) Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis. Crit Care Explor. 1(9):e0043 source
Not checked in the free run.
- cites [42] Serafim R, Gomes JA, Salluh J et al (2018) A comparison of the Quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest 153(3):646–655 source
Not checked in the free run.
- Premisecitation
In a retrospective cohort of 1,012,410 sepsis admissions to 509 US hospitals, mortality was lower in hospitals with higher compliance with achieving sepsis bundles after implementation of New York state sepsis regulations.
“A retrospective cohort study of 1,012,410 sepsis admissions to 509 hospitals in the United States in a retrospective cohort examined mortality before (27 months) and after (30 months) implementation of New York state sepsis regulations, with a concurrent control population from 4 other states [38]. In this comparative interrupted time series, mortality was lower in hospitals with higher compliance”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Kahn JM, Davis BS, Yabes JG et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240–250 source
Not checked in the free run.
- Premisecitation
Machine learning screening for hospital-acquired sepsis has higher pooled AUROC, sensitivity, and specificity than traditional tools such as SIRS, MEWS, and SOFA.
“in a meta-analysis of 42,623 patients from seven studies for predicting hospital-acquired sepsis the pooled area under the receiving-operating curve (SAUROC) (0.89; 95% CI 0.86–0.92); sensitivity (81%; 95% CI 80–81), and specificity (72%; 95% CI 72–72) was higher for machine learning than the SAUROC for traditional screening tools such as SIRS (0.70), MEWS (0.50), and SOFA (0.78) [32].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Islam MM, Nasrin T, Walther BA et al (2019) Prediction of sepsis patients using machine learning approach: a meta-analysis. Comput Methods Programs Biomed 170:1–9 source
Not checked in the free run.
- Premisecitation
Ninety-day mortality in the permissive hypotension and usual care groups was similar (41.0% vs 43.8%).
“Ninety-day mortality in the permissive hypotension and usual care groups was similar (41.0% vs 43.8%).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [82] Lamontagne F, Meade MO, Hebert PC et al (2016) Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42(4):542–550 source
Not checked in the free run.
- cites [83] Lamontagne F, Richards-Belle A, Thomas K et al (2020) Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323(10):938–949 source
Not checked in the free run.
- Premisecitation
Pooled positive and negative likelihood ratios from three studies for lactate in suspected sepsis are 4.75 and 0.29, respectively.
“Pooled positive and negative likelihood ratios from the three studies are 4.75 and 0.29, respectively.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [50] Contenti J, Corraze H, Lemoel F et al (2015) Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 33(2):167–172 source
Not checked in the free run.
- cites [51] Karon BS, Tolan NV, Wockenfus AM et al (2017) Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem 50(16–17):956–958 source
Not checked in the free run.
- cites [52] Ljungstrom L, Pernestig AK, Jacobsson G et al (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12(7):e0181704 source
Not checked in the free run.
- Premisecitation
In another meta-analysis, there was no significant difference in mortality between septic patients resuscitated with a volume responsiveness-guided approach and standard resuscitative strategies.
“However, in one other meta-analysis, there was no significant difference in mortality between septic patients resuscitated with a volume responsiveness-guided approach compared with standard resuscitative strategies [68].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Ehrman RR, Gallien JZ, Smith RK et al (2019) Resuscitation guided by volume responsiveness does not reduce mortality in sepsis: a meta-analysis. Crit Care Explor. 1(5):e0015 source
Not checked in the free run.
- Premisecitation
The association of lactate level with mortality in patients with suspected infection and sepsis is well established.
“The association of lactate level with mortality in patients with suspected infection and sepsis is well established [45, 46].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [45] Borthwick HA, Brunt LK, Mitchem KL et al (2012) Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Ann Clin Biochem 49(Pt 4):391–394 source
Not checked in the free run.
- cites [46] Liu G, An Y, Yi X et al (2017) Early lactate levels for prediction of mortality in patients with sepsis or septic shock: a meta-analysis. Int J Exp Med 10:37–47
Not checked in the free run.
- Premisecitation
In resource-limited regions where cardiac output or stroke volume measurement is unavailable, a >15% increase in pulse pressure after a passive leg-raise test for 60-90 seconds could indicate fluid responsiveness.
“In resource-limited regions where measurement of CO or SV may not be possible, a > 15% increase in pulse pressure could indicate that the patient is fluid responsive utilizing a passive leg-raise test for 60–90 seconds [71, 72].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [71] Cherpanath TG, Hirsch A, Geerts BF et al (2016) Predicting fluid responsiveness by passive leg raising: a systematic review and meta-analysis of 23 clinical trials. Crit Care Med 44(5):981–991 source
Not checked in the free run.
- cites [72] Misango D, Pattnaik R, Baker T et al (2017) Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings. Trans R Soc Trop Med Hyg 111(11):483–489 source
Not checked in the free run.
- Premisecitation
The 2016 SSC guideline recommended a minimum of 30 ml/kg ideal body weight IV crystalloids in initial fluid resuscitation, based on observational evidence.
“The 2016 SSC guideline issued a recommendation for using a minimum of 30 ml/kg (ideal body weight) of IV crystalloids in initial fluid resuscitation. This fixed volume of initial resuscitation was based on observational evidence [62].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Levy MM, Dellinger RP, Townsend SR et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36(2):222–231 source
Not checked in the free run.
- Premisecitation
Lactate testing may not be readily available in many resource-limited settings.
“Lactate testing may not be readily available in many resource-limited settings [54–61].”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [54] Abdu M, Wilson A, Mhango C et al (2018) Resource availability for the management of maternal sepsis in Malawi, other low-income countries, and lower-middle-income countries. Int J Gynaecol Obstet 140(2):175–183 source
Not checked in the free run.
- cites [55] Baelani I, Jochberger S, Laimer T et al (2011) Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 15(1):R10 source
Not checked in the free run.
- cites [56] Baelani I, Jochberger S, Laimer T et al (2012) Identifying resource needs for sepsis care and guideline implementation in the Democratic Republic of the Congo: a cluster survey of 66 hospitals in four eastern provinces. Middle East J Anaesthesiol 21(4):559–575
Not checked in the free run.
- cites [57] Bataar O, Lundeg G, Tsenddorj G et al (2010) Nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia. Bull World Health Organ 88(11):839–846 source
Not checked in the free run.
- cites [58] Hernandez G, Ospina-Tascon GA, Damiani LP et al (2019) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA 321(7):654–664 source
Not checked in the free run.
- cites [59] Machado FR, Cavalcanti AB, Bozza FA et al (2017) The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis 17(11):1180–1189 source
Not checked in the free run.
- cites [60] Shrestha GS, Kwizera A, Lundeg G et al (2017) International Surviving Sepsis Campaign guidelines 2016: the perspective from low-income and middle-income countries. Lancet Infect Dis 17(9):893–895 source
Not checked in the free run.
- cites [61] Taniguchi LU, Azevedo LCP, Bozza FA et al (2019) Availability of resources to treat sepsis in Brazil: a random sample of Brazilian institutions. Rev Bras Ter Intensiva 31(2):193–201 source
Not checked in the free run.
- Interpretationreasoning
Lactate alone is neither sensitive nor specific enough to rule in or rule out sepsis.
“However, lactate alone is neither sensitive nor specific enough to rule-in or rule-out the diagnosis on its own.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [50] Contenti J, Corraze H, Lemoel F et al (2015) Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 33(2):167–172 source
Not checked in the free run.
- cites [51] Karon BS, Tolan NV, Wockenfus AM et al (2017) Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem 50(16–17):956–958 source
Not checked in the free run.
- cites [52] Ljungstrom L, Pernestig AK, Jacobsson G et al (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12(7):e0181704 source
Not checked in the free run.
- Premisecitation
A subgroup analysis of that RCT demonstrated a 10.5% absolute reduction in renal replacement therapy with higher MAP targets among patients with chronic hypertension.
“although a sub-group analysis demonstrated a 10.5% absolute reduction in renal replacement therapy (RRT) with higher MAP targets among patients with chronic hypertension.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370(17):1583–1593 source
Not checked in the free run.
- Premisecitation
In the ANDROMEDA-SHOCK study, at day 3 the capillary refill time group had significantly less organ dysfunction as assessed by SOFA score than the lactate group (mean SOFA 5.6 vs 6.6; p = 0.045).
“At day 3, the CRT group had significantly less organ dysfunction as assessed by SOFA score [mean SOFA score 5.6 (SD 4.3) versus 6.6 (SD 4.7); p = 0.045].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Hernandez G, Ospina-Tascon GA, Damiani LP et al (2019) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA 321(7):654–664 source
Not checked in the free run.
- Premisecitation
Targeting higher MAP with vasopressors was associated with a higher risk of atrial fibrillation.
“In addition, targeting higher MAP with vasopressors was associated with a higher risk of atrial fibrillation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370(17):1583–1593 source
Not checked in the free run.
- Premisecitation
The same Zambia RCT found higher hospital mortality (48.1% vs 33%) with early protocolised resuscitation than standard care.
“and higher hospital mortality (48.1% versus 33%) than standard care [69].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Andrews B, Semler MW, Muchemwa L et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA 318(13):1233–1240 source
Not checked in the free run.
- Premisecitation
In post-cardiac surgery patients, fluid challenges of 4 ml/kg compared with 1-3 ml/kg increased the sensitivity of detecting fluid responders and non-responders based on cardiac output measurement.
“In post-cardiac surgery patients, fluid challenges of 4 ml/kg compared to 1–3 ml/kg increased the sensitivity of detecting fluid responders and non-responders based on measurement of CO [70].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [70] Aya HD, Rhodes A, Chis Ster I et al (2017) Hemodynamic effect of different doses of fluids for a fluid challenge: a quasi-randomized controlled study. Crit Care Med 45(2):e161–e168 source
Not checked in the free run.
- Premisecitation
A meta-analysis of two RCTs supported that higher MAP targets did not improve survival in septic shock (RR 1.05; 95% CI 0.90-1.23).
“A meta-analysis of two RCTs on this topic supported that higher MAP targets did not improve survival in septic shock (RR 1.05; 95% CI 0.90–1.23) [81].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Hylands M, Moller MH, Asfar P et al (2017) A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension. Can J Anaesth 64(7):703–715 source
Not checked in the free run.
- Premisecitation
Failure to receive 30 ml/kg crystalloid within 3 h of sepsis onset in ED patients with sepsis or septic shock was associated with increased odds of in-hospital mortality, irrespective of comorbidities including end-stage kidney disease and heart failure.
“A retrospective analysis of adults presenting to an emergency department with sepsis or septic shock showed that failure to receive 30 ml/kg of crystalloid fluid therapy within 3 h of sepsis onset was associated with increased odds of in-hospital mortality, delayed resolution of hypotension and increased length of stay in ICU, irrespective of comorbidities, including end-stage kidney disease and”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Kuttab HI, Lykins JD, Hughes MD et al (2019) Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med 47(11):1582–1590 source
Not checked in the free run.
- Premisecitation
Among 2463 analysed patients in that RCT, the permissive hypotension group had significantly less exposure to vasopressors, measured by duration of vasopressor infusion and total vasopressor doses in norepinephrine equivalents.
“Among 2463 analysed patients, there was significantly less exposure to vasopressors in the intervention group, measured by duration of vasopressor infusion and total vasopressor doses expressed in norepinephrine equivalents.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [82] Lamontagne F, Meade MO, Hebert PC et al (2016) Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42(4):542–550 source
Not checked in the free run.
- cites [83] Lamontagne F, Richards-Belle A, Thomas K et al (2020) Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323(10):938–949 source
Not checked in the free run.
- Premisecitation
A RCT in septic shock comparing vasopressors to target MAP 65-70 mm Hg versus 80-85 mm Hg found no difference in mortality.
“The recommendation was based principally on a RCT in septic shock comparing patients who were given vasopressors to target a MAP of 65–70 mm Hg, versus a target of 80–85 mm Hg [80]. This study found no difference in mortality”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370(17):1583–1593 source
Not checked in the free run.
- Premisecitation
An RCT in Zambia in patients with sepsis and hypotension showed that early protocolised resuscitation with IV fluids guided by jugular venous pressure, respiratory rate, and arterial oxygen saturation only was associated with significantly more fluid administration in the first 6 h (median 3.5 L vs 2.0 L) than standard care.
“An RCT in patients with sepsis and hypotension in Zambia showed that early protocolised resuscitation with administration of IV fluids guided by jugular venous pressure, respiratory rate, and arterial oxygen saturation only, was associated with significantly more fluid administration in the first 6 h [median 3.5L (IQR 2.7–4.0) versus 2.0L (IQR 1.0–2.5)]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Andrews B, Semler MW, Muchemwa L et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA 318(13):1233–1240 source
Not checked in the free run.
- Interpretationcitation
Based on existing data, timely admission of critically ill patients to an ICU environment may result in better patient outcomes.
“Based on existing data, timely admission of critically ill patients to an ICU environment may result in better patient outcomes.”
Quote in the paperSubstantial claim- Rests on an assumption: The outcome of critically ill patients depends on timely application of critical care interventions in an appropriate environment.
- Interpretationreasoning
Since there is no gold standard test to diagnose sepsis, the bedside provider cannot have a differential diagnosis of sepsis alone in a patient with organ dysfunction.
“Since there is no “gold standard” test to diagnose sepsis, the bedside provider cannot have a differential diagnosis of sepsis alone in a patient with organ dysfunction.”
Quote in the paperSubstantial claim - Premisecitation
One of two published RCTs on time to antimicrobials in sepsis without shock failed to achieve a difference in time-to-antimicrobials between arms.
“One failed to achieve a difference in time-to-antimicrobials between arms [120].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Bloos F, Ruddel H, Thomas-Ruddel D et al (2017) Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43(11):1602–1612 source
Not checked in the free run.
- Premisecitation
In a meta-analysis of 30 studies (3244 patients), procalcitonin had a pooled sensitivity of 77% and specificity of 79% for sepsis in critically ill patients.
“In a meta-analysis of 30 studies (3244 patients), procalcitonin had a pooled sensitivity of 77% and specificity of 79% for sepsis in critically ill patients [128].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] Wacker C, Prkno A, Brunkhorst FM et al (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13(5):426–435 source
Not checked in the free run.
- Premisecitation
Early administration of appropriate antimicrobials is one of the most effective interventions to reduce mortality in patients with sepsis.
“Early administration of appropriate antimicrobials is one of the most effective interventions to reduce mortality in patients with sepsis [96–98].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [96] Ferrer R, Artigas A, Suarez D et al (2009) Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180(9):861–866 source
Not checked in the free run.
- cites [97] Kalil AC, Johnson DW, Lisco SJ et al (2017) Early goal-directed therapy for sepsis: a novel solution for discordant survival outcomes in clinical trials. Crit Care Med 45(4):607–614 source
Not checked in the free run.
- cites [98] Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244 source
Not checked in the free run.
- Premisecitation
A retrospective observational study of 14,788 critically ill patients in the Netherlands showed higher hospital mortality for higher ED to ICU time quintiles (2.4-3.7 h and >3.7 h) compared with the lowest quintile (<1.2 h).
“A retrospective observational study of 14,788 critically ill patients in the Netherlands showed a higher hospital mortality for the higher ED to ICU time quintiles (2.4–3.7 h and > 3.7 h) compared with the lowest ED to ICU time quintile (< 1.2 h) [86].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Groenland CNL, Termorshuizen F, Rietdijk WJR et al (2019) emergency department to icu time is associated with hospital mortality: a registry analysis of 14,788 patients from six University Hospitals in The Netherlands. Crit Care Med 47(11):1564–1571 source
Not checked in the free run.
- Premisecitation
In a study of 50,322 ED patients admitted to 120 US ICUs, mortality increased when ED stay exceeded 6 h (17% vs 12.9%, p < 0.001).
“Another study evaluated 50,322 ED patients admitted to 120 US ICUs [87]. Mortality increased when ED stay exceeded 6 h (17% vs 12.9%, p < 0.001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Chalfin DB, Trzeciak S, Likourezos A et al (2007) Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med 35(6):1477–1483 source
Not checked in the free run.
- Premisecitation
A meta-analysis of three RCTs (n = 1769 ICU patients) found no difference in short-term mortality between procalcitonin-guided protocols for antibiotic initiation and usual care (RR 0.99; 95% CI 0.86-1.15).
“A meta-analysis of the three trials (n = 1769 ICU patients) found no difference in short-term mortality (RR 0.99; 95% CI 0.86–1.15)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [129] Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048–2058 source
Not checked in the free run.
- cites [130] Layios N, Lambermont B, Canivet JL et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40(8):2304–2309 source
Not checked in the free run.
- cites [131] Najafi A, Khodadadian A, Sanatkar M et al (2015) The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran 53(9):562–567
Not checked in the free run.
- Premisecitation
When adjusted for severity of illness, an ED to ICU time >2.4 h was associated with increased hospital mortality in patients with higher illness severity (OR 1.20; 95% CI 1.03-1.39).
“When adjusted for severity of illness, an ED to ICU time > 2.4 h was associated with increased hospital mortality in patients with higher illness severity (ORs of 1.20 (95% CI 1.03–1.39).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Groenland CNL, Termorshuizen F, Rietdijk WJR et al (2019) emergency department to icu time is associated with hospital mortality: a registry analysis of 14,788 patients from six University Hospitals in The Netherlands. Crit Care Med 47(11):1564–1571 source
Not checked in the free run.
- Premisecitation
Observational studies suggest that mortality may increase after intervals exceeding 3-5 h from hospital arrival and/or sepsis recognition.
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3–5 h from hospital arrival and/or sepsis recognition [98, 111, 119, 120].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [98] Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244 source
Not checked in the free run.
- cites [111] Peltan ID, Brown SM, Bledsoe JR et al (2019) ED door-to-antibiotic time and long-term mortality in sepsis. Chest 155(5):938–946 source
Not checked in the free run.
- cites [119] Alam N, Oskam E, Stassen PM et al (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6(1):40–50 source
Not checked in the free run.
- cites [120] Bloos F, Ruddel H, Thomas-Ruddel D et al (2017) Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43(11):1602–1612 source
Not checked in the free run.
- Premisecitation
The other RCT found no significant difference in mortality despite a 90-min difference in median time interval to antimicrobial administration.
“The other found no significant difference in mortality despite a 90-min difference in median time interval to antimicrobial administration [119].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [119] Alam N, Oskam E, Stassen PM et al (2018) Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med 6(1):40–50 source
Not checked in the free run.
- Premisecitation
Access and availability of a wide range of antimicrobials in resource-limited settings may vary.
“Access and availability of a wide range of antimicrobials in such settings may however vary [54, 55, 57, 59, 61].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [54] Abdu M, Wilson A, Mhango C et al (2018) Resource availability for the management of maternal sepsis in Malawi, other low-income countries, and lower-middle-income countries. Int J Gynaecol Obstet 140(2):175–183 source
Not checked in the free run.
- cites [55] Baelani I, Jochberger S, Laimer T et al (2011) Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 15(1):R10 source
Not checked in the free run.
- cites [57] Bataar O, Lundeg G, Tsenddorj G et al (2010) Nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia. Bull World Health Organ 88(11):839–846 source
Not checked in the free run.
- cites [59] Machado FR, Cavalcanti AB, Bozza FA et al (2017) The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect Dis 17(11):1180–1189 source
Not checked in the free run.
- cites [61] Taniguchi LU, Azevedo LCP, Bozza FA et al (2019) Availability of resources to treat sepsis in Brazil: a random sample of Brazilian institutions. Rev Bras Ter Intensiva 31(2):193–201 source
Not checked in the free run.
- Premisecitation
In patients with sepsis without shock, the association between time to antimicrobials and mortality within the first few hours from presentation is less consistent.
“In patients with sepsis without shock, the association between time to antimicrobials and mortality within the first few hours from presentation is less consistent [98, 110].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [98] Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244 source
Not checked in the free run.
- cites [110] Liu VX, Fielding-Singh V, Greene JD et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196(7):856–863 source
Not checked in the free run.
- Premisecitation
A third or more of patients initially diagnosed with sepsis turn out to have non-infectious conditions.
“Indeed, a third or more of patients initially diagnosed with sepsis turn out to have non-infectious conditions [90, 93, 94].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [90] Klein Klouwenberg PM, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319 source
Not checked in the free run.
- cites [93] Heffner AC, Horton JM, Marchick MR et al (2010) Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 50(6):814–820 source
Not checked in the free run.
- cites [94] Tidswell R, Parker T, Brealey D, et al (2020) Sepsis–the broken code how accurately is sepsis being diagnosed? J Infect 81(6):e31–e32. source
Not checked in the free run.
- Premisecitation
In an observational study of 401 ICU patients, ICU mortality increased by 1.5% for each hour delay of ED to ICU transfer.
“In an observational study of 401 ICU patients, authors reported an increase in ICU mortality of 1.5% for each hour delay of ED to ICU transfer [85].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] Cardoso LT, Grion CM, Matsuo T et al (2011) Impact of delayed admission to intensive care units on mortality of critically ill patients: a cohort study. Crit Care 15(1):R28 source
Not checked in the free run.
- Premisecitation
Other studies did not observe an association between antimicrobial timing and mortality.
“Other studies, however, did not observe an association between antimicrobial timing and mortality [112–117].”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [112] Abe T, Kushimoto S, Tokuda Y et al (2019) Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: a descriptive analysis of a prospective observational study. Crit Care 23(1):360 source
Not checked in the free run.
- cites [113] Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045–1053 source
Not checked in the free run.
- cites [114] Ko BS, Choi SH, Kang GH et al (2020) Time to antibiotics and the outcome of patients with septic shock: a propensity score analysis. Am J Med 133(4):485-91e4 source
Not checked in the free run.
- cites [115] Puskarich MA, Trzeciak S, Shapiro NI et al (2011) Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 39(9):2066–2071 source
Not checked in the free run.
- cites [116] Rothrock SG, Cassidy DD, Barneck M, et al (2020) Outcome of immediate versus early antibiotics in severe sepsis and septic shock: a systematic review and meta-analysis. Ann Emerg Med 76(4):427–441 source
Not checked in the free run.
- cites [117] Ryoo SM, Kim WY, Sohn CH et al (2015) Prognostic value of timing of antibiotic administration in patients with septic shock treated with early quantitative resuscitation. Am J Med Sci 349(4):328–333 source
Not checked in the free run.
- Premisecitation
The same meta-analysis found no difference in length of ICU stay (MD 0.19 days; 95% CI −0.98 to 1.36).
“length of ICU stays (MD 0.19 days; 95% CI −0.98 to 1.36)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [129] Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048–2058 source
Not checked in the free run.
- cites [130] Layios N, Lambermont B, Canivet JL et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40(8):2304–2309 source
Not checked in the free run.
- cites [131] Najafi A, Khodadadian A, Sanatkar M et al (2015) The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran 53(9):562–567
Not checked in the free run.
- Interpretationreasoning
In the empiric phase, optimal antibiotic choice depends on local prevalence of resistant organisms, patient risk factors for resistant organisms, and severity of illness.
“In the empiric phase—before causative agent(s) and susceptibilities are known, the optimal choice of antibiotic therapy depends on the local prevalence of resistant organisms, patient risk factors for resistant organisms, and the severity of illness.”
Quote in the paperSubstantial claim - Premisecitation
A systematic review with meta-analysis of 10 RCTs found no differences in mortality or other patient-important outcomes between empiric mono- and combination antibiotic therapy in adult ICU patients with severe sepsis or septic shock, including when disease severity was considered.
“This was borne out in a recent systematic review with meta-analysis of 10 RCTs, no differences in mortality or other patient-important outcomes between empiric mono- vs. combination antibiotic therapy in adult ICU patients with severe sepsis or septic shock were observed, also when taking disease severity into consideration [160].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [160] Sjovall F, Perner A, Hylander MM (2017) Empirical mono- versus combination antibiotic therapy in adult intensive care patients with severe sepsis—a systematic review with meta-analysis and trial sequential analysis. J Infect 74(4):331–344 source
Not checked in the free run.
- Premisecitation
In undifferentiated patients with pneumonia or sepsis, broad-spectrum regimens active against MRSA are associated with higher mortality, especially in patients without MRSA.
“Among undifferentiated patients with pneumonia or sepsis, broad-spectrum regimens including agents active against MRSA were associated with higher mortality, particularly among patients without MRSA [137, 151, 155, 156].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [137] Rhee C, Kadri SS, Dekker JP et al (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3(4):e202899 source
Not checked in the free run.
- cites [151] Kett DH, Cano E, Quartin AA et al (2011) Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 11(3):181–189 source
Not checked in the free run.
- cites [155] Jones BE, Ying J, Stevens V, et al (2020) Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern Med 180(4):552–560 source
Not checked in the free run.
- cites [156] Webb BJ, Sorensen J, Jephson A, et al (2019) Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J 54(1):1900057 source
Not checked in the free run.
- Premisecitation
SARS-CoV-2 is now responsible for many cases of infection and sepsis.
“More recently, SARS-CoV-2 (causing COVID-19) is now responsible for many cases of infection and sepsis [223].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [223] Aziz S, Arabi YM, Alhazzani W, et al (2020) Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med 46(7):1303–1325 source
Not checked in the free run.
- Premisecitation
Beta-lactam antibiotics may undergo changes in important pharmacokinetic parameters in sepsis and septic shock, resulting in sub-therapeutic concentrations.
“Beta-lactam antibiotics may be subject to changes in important pharmacokinetic parameters in the setting of sepsis and septic shock resulting in sub-therapeutic concentrations [230, 231].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [230] Goncalves-Pereira J, Povoa P (2011) Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams. Crit Care 15(5):R206 source
Not checked in the free run.
- cites [231] Mohd Hafiz AA, Staatz CE, Kirkpatrick CM et al (2012) Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Minerva Anestesiol 78(1):94–104
Not checked in the free run.
- Premisecitation
In the EMPIRICUS RCT, there was no difference in outcome between patients receiving empiric micafungin and placebo.
“In the largest and most recent RCT—EMPIRICUS—there was also no difference in outcome between patients receiving empiric antifungal therapy (micafungin) and patients receiving placebo [174].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [174] Timsit JF, Azoulay E, Schwebel C et al (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS Randomized Clinical Trial. JAMA 316(15):1555–1564 source
Not checked in the free run.
- Interpretationcitation
In the directed/targeted phase, sustained double gram-negative coverage is rarely necessary except for patients with highly resistant organisms.
“In the directed/targeted phase, once causative agent(s) and susceptibilities are known, sustained double gram-negative coverage is rarely necessary except for patients with highly resistant organisms.”
Quote in the paperSubstantial claim - Premisecitation
Patients with febrile neutropenia who fail to defervesce after 4-7 days of broad-spectrum antibacterial therapy are at increased risk of fungal disease.
“patients with febrile neutropenia who fail to defervesce after 4–7 days of broad-spectrum antibacterial therapy are at increased risk of having fungal disease (Table 2) [175, 176].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [175] Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52(4):e56-93 source
Not checked in the free run.
- cites [176] Taplitz RA, Kennedy EB, Bow EJ et al (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 36(14):1443–1453 source
Not checked in the free run.
- Premisecitation
In a recent large international point prevalence study, viruses were documented in less than 4% of infections.
“In a recent large international point prevalence study, viruses were documented in less than 4% of infections [133].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Vincent JL, Sakr Y, Singer M, et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323(15):1478–1487 source
Not checked in the free run.
- Interpretationcitation
Given increasing MDR frequency and associations between delayed active therapy and worse outcomes, initial multidrug therapy is often required to ensure the empiric regimen includes at least one effective agent against the offending organism.
“Considering the increasing frequency of MDR bacteria in many parts of the world and associations between delays in active therapy and worse outcomes, the initial use of multidrug therapy is often required to ensure the empiric regimen includes at least one effective agent that is active against the offending organism [12, 13].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552 source
Not checked in the free run.
- cites [13] Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377 source
Not checked in the free run.
- Premisecitation
Results from the largest RCT in that meta-analysis, comparing sustained moxifloxacin plus meropenem versus meropenem alone in a low endemic resistance setting, were consistent with the meta-analysis.
“Results from the largest RCT included in the meta-analysis (a comparison of sustained courses of moxifloxacin and meropenem vs meropenem alone in a low endemic resistance setting) were consistent with the findings from the meta-analysis [161].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [161] Brunkhorst FM, Oppert M, Marx G et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307(22):2390–2399 source
Not checked in the free run.
- Premisecitation
Apart from specific clinical situations such as epidemics or pandemics, viral infections are rarely the primary cause of sepsis.
“Viral infections encompass a broad spectrum of pathogens and diseases in humans but—apart from specific clinical situations such as epidemics/pandemics—are rarely the primary cause of sepsis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Vincent JL, Sakr Y, Singer M, et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323(15):1478–1487 source
Not checked in the free run.
- Premisereasoning
Prolonged IV infusion of beta-lactams, either extended or continuous, results in sustained concentrations that align with their pharmacodynamics, unlike conventional intermittent infusion.
“As opposed to conventional intermittent infusion (infusion ≤ 30 min), administration by prolonged IV infusion, either as an extended infusion (antibiotic infused over at least half of the dosing interval) or as a continuous infusion, results in sustained beta-lactam concentrations which align with the pharmacodynamics of these drugs.”
Quote in the paperSubstantial claim - Premisecitation
Early discontinuation of MRSA coverage is associated with better outcomes in patients with negative nares or BAL MRSA PCR.
“studies showing an association between early discontinuation of MRSA coverage and better outcomes in patients with negative nares or bronchoalveolar lavage (BAL) MRSA PCR [157–159].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [157] Baby N, Faust AC, Smith T, et al (2017) Nasal methicillin-resistant Staphylococcus aureus (MRSA) PCR testing reduces the duration of MRSA-targeted therapy in patients with suspected MRSA pneumonia. Antimicrob Agents Chemother 61(4):e02432-16 source
Not checked in the free run.
- cites [158] Cowley MC, Ritchie DJ, Hampton N et al (2019) Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia. Chest 155(1):53–59 source
Not checked in the free run.
- cites [159] Paonessa JR, Shah RD, Pickens CI et al (2019) Rapid detection of methicillin-resistant Staphylococcus aureus in BAL: a pilot randomized controlled trial. Chest 155(5):999–1007 source
Not checked in the free run.
- Premisecitation
Published guidelines for community-acquired pneumonia recommend initiation of antimicrobials regardless of procalcitonin level.
“Published guidelines for the management of community-acquired pneumonia recommend initiation of antimicrobials for patients with community-acquired pneumonia regardless of procalcitonin level [132].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [132] Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):e45–e67 source
Not checked in the free run.
- Premisecitation
Two meta-analyses reported reduced short-term mortality with prolonged infusion of beta-lactams (RR 0.70; 95% CI 0.57-0.87).
“Two meta-analyses reported similar results supporting reduced short-term mortality (RR 0.70; 95% CI 0.57–0.87) with prolonged infusion of beta-lactams [232, 233].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [232] Roberts JA, Abdul-Aziz MH, Davis JS et al (2016) Continuous versus intermittent beta-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 194(6):681–691 source
Not checked in the free run.
- cites [233] Vardakas KZ, Voulgaris GL, Maliaros A et al (2018) Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 18(1):108–120 source
Not checked in the free run.
- Premisecitation
The same meta-analysis found no difference in length of hospitalisation (MD 7.00 days; 95% CI −26.24 to 12.24).
“or length of hospitalisation (MD 7.00 days; 95% CI −26.24 to 12.24).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [129] Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048–2058 source
Not checked in the free run.
- cites [130] Layios N, Lambermont B, Canivet JL et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40(8):2304–2309 source
Not checked in the free run.
- cites [131] Najafi A, Khodadadian A, Sanatkar M et al (2015) The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran 53(9):562–567
Not checked in the free run.
- Premisecitation
MRSA causes about 5% of culture-positive infections in critically ill patients.
“MRSA accounts for approximately 5% of culture-positive infections among critically ill patients [133]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [133] Vincent JL, Sakr Y, Singer M, et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323(15):1478–1487 source
Not checked in the free run.
- Interpretationreasoning
The failure to show benefit with source control implemented in less than 6 hours may be due to limited patient numbers and heterogeneity of the intervention.
“The failure to show benefit with source control implemented in less than 6 h may be a consequence of the limited number of patients and the heterogeneity of the intervention.”
Quote in the paperNot a substantial claim - Premisecitation
Removal of a potentially infected intravascular access device is considered part of adequate source control.
“Removal of a potentially infected intravascular access device is considered a part of adequate source control [262].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [262] Jimenez MF, Marshall JC, International Sepsis F (2001) Source control in the management of sepsis. Intensive Care Med 27(Suppl 1):S49-62 source
Not checked in the free run.
- Premisereasoning
There is considerable practice variation in duration of antimicrobial therapy for critically ill patients.
“Given the lack of definitive and generalizable data regarding the optimal duration of therapy for patients who are critically ill, it is not surprising that there is considerably practice variation [281, 294].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [281] Fernandez-Lazaro CI, Brown KA, Langford BJ et al (2019) Late-career physicians prescribe longer courses of antibiotics. Clin Infect Dis 69(9):1467–1475 source
Not checked in the free run.
- cites [294] Corona A, Bertolini G, Ricotta AM et al (2003) Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J Antimicrob Chemother 52(5):849–852 source
Not checked in the free run.
- Premisecitation
Dosing antibiotics according to PK/PD principles and using regimens developed in sepsis/septic shock patients is more likely to achieve effective and safe drug concentrations than using manufacturer's product information.
“Administration of antibiotics using an approach that adheres to PK/PD principles and using dosing regimens developed in patients with sepsis and septic shock is more likely to result in effective and safe drug concentrations compared to use of dosing recommendations provided in the manufacturer’s product information [247].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Guilhaumou R, Benaboud S, Bennis Y et al (2019) Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d’Anesthesie et Reanimation-SFAR). Crit Care 23(1):104 source
Not checked in the free run.
- Premisecitation
Administration of a loading dose before prolonged infusion is essential to avoid delays in achieving effective beta-lactam concentrations.
“Administration of a loading dose of antibiotic before prolonged infusion is essential to avoid delays to achieving effective beta-lactam concentrations [234].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [234] De Waele JJ, Lipman J, Carlier M et al (2015) Subtleties in practical application of prolonged infusion of beta-lactam antibiotics. Int J Antimicrob Agents 45(5):461–463 source
Not checked in the free run.
- Premisecitation
In the absence of septic shock or fungemia, some implanted tunnelled catheter infections may be treated effectively with prolonged antimicrobial therapy if catheter removal is not practical.
“In the absence of septic shock or fungemia, some implanted tunnelled catheter infections may be treated effectively with prolonged antimicrobial therapy if removal of the catheter is not practical [273].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [273] Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45 source
Not checked in the free run.
- Premisecitation
Augmented renal clearance, AKI, hypoalbuminemia, RRT, and ECMO are common scenarios that affect concentrations of some antibiotics.
“Augmented renal clearance [240], AKI [241], hypoalbuminemia [242], RRT [243, 244], and extracorporeal membrane oxygenation [245, 246] are examples of common scenarios that affect the concentrations of some antibiotics.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [240] Nelson NR, Morbitzer KA, Jordan JD et al (2019) The impact of capping creatinine clearance on achieving therapeutic vancomycin concentrations in neurocritically ill patients with traumatic brain injury. Neurocrit Care 30(1):126–131 source
Not checked in the free run.
- cites [241] Gregoire N, Marchand S, Ferrandiere M et al (2019) Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment. J Antimicrob Chemother 74(1):117–125
Not checked in the free run.
- cites [242] Ulldemolins M, Roberts JA, Rello J et al (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50(2):99–110 source
Not checked in the free run.
- Premisecitation
Appropriate source control is a key principle in managing sepsis and septic shock.
“Appropriate source control is a key principle in the management of sepsis and septic shock [12, 13].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552 source
Not checked in the free run.
- cites [13] Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377 source
Not checked in the free run.
- Premisecitation
Specialist consultation appears associated with improved patient outcomes for a variety of infectious syndromes.
“Specialist consultation appears to be associated with improved patient outcomes for a variety of infectious syndromes [295–300].”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [295] Burnham JP, Olsen MA, Stwalley D et al (2018) Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections. Open Forum Infect Dis 5(3):ofy06 source
Not checked in the free run.
- cites [296] Macheda G, Dyar OJ, Luc A et al (2018) Are infection specialists recommending short antibiotic treatment durations? An ESCMID international cross-sectional survey. J Antimicrob Chemother 73(4):1084–1090 source
Not checked in the free run.
- cites [297] Madaline T, Wadskier Montagne F, Eisenberg R et al (2019) Early infectious disease consultation is associated with lower mortality in patients with severe sepsis or septic shock who complete the 3-hour sepsis treatment bundle. Open Forum Infect Dis 6(10):ofz408 source
Not checked in the free run.
- cites [298] Schmitt S, McQuillen DP, Nahass R et al (2014) Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis 58(1):22–28 source
Not checked in the free run.
- cites [299] Turner RB, Valcarlos E, Won R et al (2016) Impact of infectious diseases consultation on clinical outcomes of patients with staphylococcus aureus bacteremia in a community health system. Antimicrob Agents Chemother 60(10):5682–5687 source
Not checked in the free run.
- cites [300] Viale P, Tedeschi S, Scudeller L et al (2017) Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department. Clin Infect Dis 65(8):1253–1259 source
Not checked in the free run.
- Premisecitation
Some studies in critically ill patients have reported benefits of PK/PD-based dosing in terms of clinical cure.
“Some studies in critically ill patients have reported benefits in terms of clinical cure [237, 250–253].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [237] Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14(6):498–509 source
Not checked in the free run.
- cites [250] McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31(4):345–351 source
Not checked in the free run.
- cites [251] Rayner CR, Forrest A, Meagher AK et al (2003) Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin Pharmacokinet 42(15):1411–1423 source
Not checked in the free run.
- cites [252] Rubino CM, Bhavnani SM, Forrest A et al (2012) Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia. Antimicrob Agents Chemother 56(1):130–136 source
Not checked in the free run.
- cites [253] Wong G, Taccone F, Villois P et al (2020) beta-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. J Antimicrob Chemother 75(2):429–433
Not checked in the free run.
- Premisecitation
The optimal duration of antimicrobial therapy for a patient with sepsis or septic shock depends on host, microbe, drug, and anatomical site factors.
“The optimal duration of antimicrobial therapy for a given patient with sepsis or septic shock depends on many factors, including host, microbe, drug, and anatomical site (Table 2) [99, 100].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [99] Klompas M, Calandra T, Singer M (2018) Antibiotics for sepsis-finding the equilibrium. JAMA 320(14):1433–1434 source
Not checked in the free run.
- cites [100] Prescott HC, Iwashyna TJ (2019) Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc 16(4):426–429 source
Not checked in the free run.
- Premisecitation
Data from critically ill patients support an increased likelihood of achieving effective and safe antibiotic concentrations when applying PK/PD principles to dosing.
“Although there are no data on this topic directly derived from adults with sepsis and septic shock, data from a broader patient population, critically ill patients, support an increased likelihood of achieving effective and safe antibiotic concentrations when applying PK/PD principles to dosing [248].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [248] Turner RB, Kojiro K, Shephard EA et al (2018) Review and validation of bayesian dose-optimizing software and equations for calculation of the vancomycin area under the curve in critically ill patients. Pharmacotherapy 38(12):1174–1183 source
Not checked in the free run.
- Premisecitation
Source control of infectious foci was associated with improved survival in recent observational and cluster randomised studies.
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomised studies [120, 263, 264].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [120] Bloos F, Ruddel H, Thomas-Ruddel D et al (2017) Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 43(11):1602–1612 source
Not checked in the free run.
- cites [263] Kim H, Chung SP, Choi SH et al (2019) Impact of timing to source control in patients with septic shock: a prospective multi-center observational study. J Crit Care 53:176–182 source
Not checked in the free run.
- cites [264] Martinez ML, Ferrer R, Torrents E et al (2017) Impact of Source Control in Patients With Severe Sepsis and Septic Shock. Crit Care Med 45(1):11–19 source
Not checked in the free run.
- Premisecitation
In the SMART trial sepsis subgroup, balanced solutions were associated with lower 30-day mortality than normal saline.
“In the pre-specified subgroup of patients admitted with sepsis in all participating ICUs, 30-day mortality was lower in those receiving balanced solutions, compared to normal saline (OR 0.80; 95% CI 0.67−0.94).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [334] Semler MW, Self WH, Wanderer JP et al (2018) Balanced crystalloids versus saline in critically ill adults. N Engl J Med 378(9):829–839 source
Not checked in the free run.
- Premisecitation
Another RCT found no effect of gelatin on mortality.
“Similarly, another RCT did not find an effect on mortality with gelatin use (RR 0.87; 95% CI 0.66–1.12) [344].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [344] Annane D, Siami S, Jaber S et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310(17):1809–1817 source
Not checked in the free run.
- Premisecitation
A meta-analysis found no difference in mortality between angiotensin II and norepinephrine.
“A meta-analysis found no difference in mortality rates between angiotensin II and norepinephrine (46.2% vs 54.2%; RR 0.85 (95% CI 0.69–1.06); very low quality).”
Quote in the paperSubstantial claim - Premisecitation
A network meta-analysis showed higher risk of renal replacement therapy with gelatin compared with normal saline and balanced crystalloids.
“Adverse effects of gelatin have been reviewed in a network meta-analysis, which demonstrated higher risk of RRT with gelatin use compared to normal saline (OR 1.27; 95% CrI 0.44–3.64) and balanced crystalloids (OR 1.50; 95% CrI 0.56–3.96) [345].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [345] Rochwerg B, Alhazzani W, Gibson A et al (2015) Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 41(9):1561–1571 source
Not checked in the free run.
- Premisecitation
Critically ill patients often receive antimicrobials for more days than necessary.
“however, critically ill patients often receive antimicrobials for more days than necessary [288, 301, 306].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [288] Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61–e111 source
Not checked in the free run.
- cites [301] Pugh R, Grant C, Cooke RP et al (2015) Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 8:CD007577
Not checked in the free run.
- cites [306] Mazuski JE, Sawyer RG, Nathens AB et al (2002) The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt) 3(3):175–233 source
Not checked in the free run.
- Premisecitation
A network meta-analysis in sepsis showed no clear effect of gelatin on mortality compared with crystalloids.
“In an indirect comparison, a 4-node network meta-analysis conducted in patients with sepsis, showed no clear effect on mortality when compared to crystalloids (OR 1.24; 95% credible interval [CrI] 0.61–2.55) [331].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [331] Rochwerg B, Alhazzani W, Sindi A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355 source
Not checked in the free run.
- Premisecitation
Selepressin at 2.5 ng/kg/min maintained MAP above 60 mmHg without norepinephrine in about 50% of patients at 12 hours and about 70% at 24 hours.
“Selepressin at a dose of 2.5 ng/kg/min was demonstrated to be effective in maintaining MAP > 60 mmHg without norepinephrine in about 50% of patients at 12 h and about 70% of patients at 24 h.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [363] Russell JA, Vincent JL, Kjolbye AL et al (2017) Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care 21(1):213 source
Not checked in the free run.
- Premisecitation
A larger RCT of 344 patients with vasodilatory shock found the primary endpoint of increased MAP was achieved in 69.9% with angiotensin II versus 23.4% with placebo.
“The primary endpoint, an increase of MAP of at least 10 mmHg or to at least 75 mmHg, was achieved in 114 of 163 patients in the angiotensin II group and in 37 of 158 patients in the placebo group (69.9% vs 23.4%, p < 0.001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [366] Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377(5):419–430 source
Not checked in the free run.
- Premisecitation
The VASST trial found no improvement in 28-day mortality with norepinephrine plus vasopressin compared with norepinephrine alone.
“the main study (the VASST trial) comparing norepinephrine alone to norepinephrine plus vasopressin (0.01–0.03 U/min) showed no improvement in 28-day mortality (39.3% vs 35.4%, p = 0.26) [356].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [356] Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887 source
Not checked in the free run.
- Premisecitation
A network meta-analysis in sepsis or septic shock showed higher risk of death and need for renal replacement therapy with starches compared with crystalloids.
“A network meta-analysis of patients with sepsis or septic shock also demonstrated a higher risk of death (OR 1.1; 95% CI 0.99–1.30) and need for RRT (OR 1.39; 95% CI 1.17–1.66) [331] with starches in a direct comparison with crystalloids.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [331] Rochwerg B, Alhazzani W, Sindi A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355 source
Not checked in the free run.
- Premisecitation
A systematic review in hypovolemia found gelatin increased risk of anaphylaxis compared with crystalloids.
“In a systematic review of RCTs including patients with hypovolemia, gelatin use increased the risk of anaphylaxis (RR 3.01; 95% CI 1.27–7.14) in comparison with crystalloids use [346].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [346] Moeller C, Fleischmann C, Thomas-Rueddel D et al (2016) How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 35:75–83 source
Not checked in the free run.
- Premisecitation
A single-centre study reported decreased hospital costs associated with PCT-guided antibiotics in medical ICU patients with undifferentiated sepsis.
“although a single centre study reported decreased hospital costs associated with PCT-guided antibiotic in medical ICU patient with undifferentiated sepsis [323].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [323] Collins CD, Brockhaus K, Sim T et al (2019) Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis. Am J Health Syst Pharm 76(16):1219–1225 source
Not checked in the free run.
- Premiseown data
A meta-analysis of two selepressin studies found no significant mortality difference compared with norepinephrine.
“The meta-analysis of the two studies did not show significant difference in mortality [selepressin: 41.8% vs norepinephrine: 40.45%; RR 0.99 (95% CI 0.84–1.18)].”
Quote in the paperSubstantial claim - Premisecitation
Colloids provide no clear benefit over crystalloids in resuscitation of sepsis and septic shock.
“The absence of clear benefit following the administration of colloids compared to crystalloid solutions supports the use of crystalloid solutions in the resuscitation of patients with sepsis and septic shock [324].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [324] Lewis SR, Pritchard MW, Evans DJ et al (2018) Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 8:CD000567
Not checked in the free run.
- Premisecitation
Procalcitonin has been studied most extensively in critically ill and non-critically ill patients for both initiation and discontinuation of therapy.
“Procalcitonin has been studied most extensively both in critically ill and non-critically ill patients, both for initiation and discontinuation of therapy [307].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [307] van Engelen TSR, Wiersinga WJ, Scicluna BP et al (2018) Biomarkers in Sepsis. Crit Care Clin 34(1):139–152 source
Not checked in the free run.
- Interpretationcitation
Routine albumin use has no clear benefit.
“it is more costly and there is no clear benefit with its routine use.”
Quote in the paperSubstantial claim- Rests on an assumption: Albumin is more costly than crystalloids.
- Premisecitation
The SPLIT trial found no difference between balanced solutions and normal saline in mortality or acute kidney injury.
“In the SPLIT multicentre, double-blinded clinical trial, the comparison between balanced solutions and normal saline yielded no differences in mortality or AKI [332].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [332] Young P, Bailey M, Beasley R et al (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT Randomized Clinical Trial. JAMA 314(16):1701–1710 source
Not checked in the free run.
- Interpretationreasoning
The SPLIT trial results have limited generalizability because of modest infused fluid volume, predominance of surgical patients, and a low proportion of septic patients.
“The modest volume of infused fluid, the predominance of surgical patients, and the low number of septic patients (4%) precludes generalizability of the results.”
Quote in the paperSubstantial claim - Premisecitation
In a network meta-analysis of 14 RCTs in sepsis, balanced crystalloids were associated with lower mortality than saline in an indirect comparison.
“a network meta-analysis of 14 RCTs of patients with sepsis showed in an indirect comparison that balanced crystalloids were associated with decreased mortality, compared to saline [331].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [331] Rochwerg B, Alhazzani W, Sindi A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355 source
Not checked in the free run.
- Premisecitation
The VANISH trial found no significant difference between vasopressin and norepinephrine in 28-day mortality.
“There was no significant difference between the vasopressin and norepinephrine groups in 28-day mortality [30.9% vs 27.5%; RR 1.13 (95% CI 0.85–1.51).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [354] Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518 source
Not checked in the free run.
- Premisecitation
In a VASST subgroup with less severe shock receiving norepinephrine less than 15 μg/min, addition of vasopressin improved survival.
“in a subgroup analysis, patients with less severe shock receiving norepinephrine < 15 μg/min had improved survival with the addition of vasopressin (26.5% vs. 35.7%, p = 0.05).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [356] Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887 source
Not checked in the free run.
- Interpretationcitation
Use of balanced solutions in sepsis may be associated with improved outcomes compared with chloride-rich solutions.
“However, the use of balanced solutions in sepsis may be associated with improved outcomes compared with chloride-rich solutions.”
Quote in the paperSubstantial claim - Premisecitation
The SALT pilot trial found similar MAKE30 between balanced solutions and normal saline.
“The primary outcome, a composite outcome including mortality, new RRT or persistent renal dysfunction (major adverse kidney event within 30 days, MAKE30), was similar between groups (24.6% vs. 24.7%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [333] Semler MW, Wanderer JP, Ehrenfeld JM et al (2017) Balanced crystalloids versus saline in the intensive care unit. The SALT Randomized Trial. Am J Respir Crit Care Med 195(10):1362–1372 source
Not checked in the free run.
- Premisecitation
The ALBIOS trial in 1,818 patients with sepsis or septic shock found no difference between albumin plus crystalloids and crystalloids alone in 28-day or 90-day mortality.
“The largest clinical trial in sepsis, the ALBIOS trial comparing a combination of albumin and crystalloids to crystalloids alone in 1818 patients with sepsis or septic shock did not demonstrate a difference in 28-day (RR 1.0; 95% CI 0.87–1.14) or 90-day mortality (RR 0.94; 95% CI 0.85–1.05) [339].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [339] Caironi P, Tognoni G, Gattinoni L (2014) Albumin replacement in severe sepsis or septic shock. N Engl J Med 371(1):84 source
Not checked in the free run.
- Premisecitation
A network meta-analysis found no significant difference between epinephrine and vasopressin in mortality.
“In an indirect comparison, a network meta-analysis did not find any significant difference between epinephrine and vasopressin in terms of mortality (RR 0.94; 95% CI 0.47–1.88) [362].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [362] Belletti A, Benedetto U, Biondi-Zoccai G et al (2017) The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 37:91–98 source
Not checked in the free run.
- Premiseown data
There was no clear increase in adverse events with angiotensin II.
“There was no clear increase in adverse events with the use of angiotensin II.”
Quote in the paperSubstantial claim - Premisecitation
VANISH and VASST demonstrated a catecholamine-sparing effect of vasopressin.
“Both VANISH and VASST demonstrated a catecholamine-sparing effect of vasopressin; as such, the early use of vasopressin in combination with norepinephrine may help reduce the adrenergic burden associated with traditional vasoactive agents [357].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [357] Ukor IF, Walley KR (2019) Vasopressin in Vasodilatory Shock. Crit Care Clin 35(2):247–261 source
Not checked in the free run.
- Premisecitation
A meta-analysis of RCTs on distributive shock found lower risk of atrial fibrillation with vasopressin plus norepinephrine compared with norepinephrine alone.
“Another meta-analysis of RCTs on distributive shock showed a lower risk of atrial fibrillation with the combination of vasopressin and norepinephrine compared to norepinephrine alone [358].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [358] McIntyre WF, Um KJ, Alhazzani W et al (2018) Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA 319(18):1889–1900 source
Not checked in the free run.
- Premisecitation
A meta-analysis of seven RCTs found levosimendan was not superior to dobutamine in adults with sepsis in terms of mortality.
“A meta-analysis of seven RCTs comparing levosimendan with dobutamine showed that levosimendan was not superior to dobutamine in adults with sepsis in terms of mortality (OR 0.80; 95% CI 0.48, 1.33; p = 0.39) [374].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [374] Bhattacharjee S, Soni KD, Maitra S et al (2017) Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: a meta-analysis of randomized controlled trials. J Clin Anesth 39:67–72 source
Not checked in the free run.
- Premisecitation
There were three cases of mesenteric ischaemia in the terlipressin group versus one in the norepinephrine group.
“There were three cases of mesenteric ischaemia in the terlipressin group versus one in the norepinephrine group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [367] Liu ZM, Chen J, Kou Q et al (2018) Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med 44(11):1816–1825 source
Not checked in the free run.
- Premisecitation
Other authors showed central lines could be avoided by peripheral line insertion.
“Other authors also showed that central lines could be avoided by peripheral line insertion [387].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [387] Cardenas-Garcia J, Schaub KF, Belchikov YG et al (2015) Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med 10(9):581–585 source
Not checked in the free run.
- Premisecitation
Local tissue injury may be more likely with prolonged administration of vasopressors.
“The occurrence of local tissue injury may be more likely with prolonged administration of vasopressors.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [389] Loubani OM, Green RS (2015) A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30(3):653e9-17 source
Not checked in the free run.
- Premisecitation
In sepsis, the inotropic response may be blunted with a preserved chronotropic effect causing tachycardia without increased stroke volume.
“In addition, the inotropic response may be blunted in sepsis with a preserved chronotropic effect causing tachycardia without an increase in stroke volume (SV) [370].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [370] Dubin A, Lattanzio B, Gatti L (2017) The spectrum of cardiovascular effects of dobutamine—from healthy subjects to septic shock patients. Rev Bras Ter Intensiva 29(4):490–498 source
Not checked in the free run.
- Premisecitation
Lack of availability and expertise in central venous catheter placement in different settings is an important consideration.
“The lack of availability and expertise in placement of central venous catheters in different settings is an important consideration [55].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55] Baelani I, Jochberger S, Laimer T et al (2011) Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers. Crit Care 15(1):R10 source
Not checked in the free run.
- Premisecitation
Delay in vasopressor initiation and achieving MAP of 65 is associated with increased mortality.
“Delay in vasopressor initiation and achieving MAP of 65 is associated with increased mortality [390, 391].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [390] Beck V, Chateau D, Bryson GL et al (2014) Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care 18(3):R97 source
Not checked in the free run.
- cites [391] Black LP, Puskarich MA, Smotherman C et al (2020) Time to vasopressor initiation and organ failure progression in early septic shock. J Am Coll Emerg Physicians Open 1(3):222–230 source
Not checked in the free run.
- Premisecitation
The four largest sepsis resuscitation trials administered moderate to large fluid volumes during the first 72 hours.
“The four largest clinical trials in sepsis resuscitation used moderate to large amounts of fluids in the first 72 h.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [393] Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377 source
Not checked in the free run.
- cites [64] Investigators P, Yealy DM, Kellum JA et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693 source
Not checked in the free run.
- cites [65] Peake SL, Delaney A, Bellomo R et al (2015) Goal-directed resuscitation in septic shock. N Engl J Med 372(2):190–191
Not checked in the free run.
- Premisecitation
In the Rivers trial, over 13 L of fluids were administered.
“Although Rivers [393] administered over 13 L of fluids”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [393] Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377 source
Not checked in the free run.
- Premisecitation
A systematic review found extravasation occurred in 3.4% of patients with no reported tissue necrosis or limb ischaemia.
“A recent systematic review showed that extravasation occurred in 3.4% (95% CI 2.5–4.7%) of patients with no reported episodes of tissue necrosis or limb ischaemia [388].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [388] Tian DH, Smyth C, Keijzers G et al (2020) Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas 32(2):220–227 source
Not checked in the free run.
- Premisecitation
Most patients who had vasopressors started peripherally achieved MAP above 65 mmHg within 1 hour.
“Moreover, most patients who had vasopressors started peripherally achieved a MAP > 65 mmHg within 1 h.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [385] Delaney A, Finnis M, Bellomo R et al (2020) Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas 32(2):210–219 source
Not checked in the free run.
- Interpretationreasoning
Given the low complication rate and likely higher accuracy of blood pressure measurement, benefits of arterial catheters probably outweigh the risks.
“In view of the low complication rate and likely higher accuracy of blood pressure measurement, the benefits of arterial catheters probably outweigh the risks.”
Quote in the paperSubstantial claim - Premisecitation
A meta-analysis of three RCTs found levosimendan compared with no inotropic agents did not impact mortality.
“A meta-analysis of three RCTs (n = 781) showed that levosimendan, compared to no inotropic agents, did not impact mortality (RR 0.87; 95% CI 0.59–1.28).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [373] Gordon AC, Perkins GD, Singer M et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638–1648 source
Not checked in the free run.
- Premisecitation
A network meta-analysis found dobutamine with norepinephrine had no clear impact on mortality compared with no inotropic agents.
“Indirect comparison from network meta-analysis showed that dobutamine with norepinephrine had no clear impact on mortality when compared to no inotropic agents (OR 0.69; 95% CI 0.32–1.47) [362].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [362] Belletti A, Benedetto U, Biondi-Zoccai G et al (2017) The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 37:91–98 source
Not checked in the free run.
- Interpretationcitation
Administration of vasopressors through peripheral IV catheters is generally safe.
“The administration of vasopressors through peripheral IV catheters is generally safe.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [388] Tian DH, Smyth C, Keijzers G et al (2020) Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas 32(2):220–227 source
Not checked in the free run.
- Premisecitation
A network meta-analysis found no clear effect on mortality for dobutamine compared with epinephrine.
“In an indirect comparison of dobutamine versus epinephrine, a network meta-analysis showed no clear effect on mortality (OR 1.18; 95% CI 0.47–3.97) [362].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [362] Belletti A, Benedetto U, Biondi-Zoccai G et al (2017) The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 37:91–98 source
Not checked in the free run.
- Premisecitation
Dobutamine effects may not be predictable.
“However, these effects may not be predictable [370].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [370] Dubin A, Lattanzio B, Gatti L (2017) The spectrum of cardiovascular effects of dobutamine—from healthy subjects to septic shock patients. Rev Bras Ter Intensiva 29(4):490–498 source
Not checked in the free run.
- Premisecitation
A study of mostly senior resident doctors in Nigeria concluded that knowledge of central venous catheter placement was limited.
“a study of mostly senior resident doctors in Nigeria concluded that knowledge of central venous catheter placement was limited [392].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [392] Edaigbini SAAM, Delia IZ, Ibrahim A, Okwunodulo O, Alegbejo-Olarinoye M (2017) Clinical competence with central venous lines by resident doctors in a Nigerian teaching hospital. Sub-Saharan Afr J Med 4:47–51 source
Not checked in the free run.
- Premisecitation
Administration of vasopressors for less than 6 hours in a well-placed peripheral catheter proximal to the antecubital fossa is unlikely to cause local tissue injury.
“Administration of vasopressors for a short period of time (< 6 h) in a well-placed peripheral catheter proximal to the antecubital fossa is unlikely to cause local tissue injury [389].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [389] Loubani OM, Green RS (2015) A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30(3):653e9-17 source
Not checked in the free run.
- Interpretationreasoning
Given the low complication rate of peripheral vasopressors and the possibility of restoring blood pressure faster, benefits of initiating vasopressors for a short period in a vein proximal to the antecubital fossa probably outweigh the risks.
“Given the low complication rate of peripheral vasopressors and the possibility of restoring blood pressure faster, the benefits of initiating vasopressors for a short period of time in a vein proximal to the antecubital fossa probably outweigh the risks.”
Quote in the paperSubstantial claim - Premisecitation
The current evidence evaluating a restrictive IV fluid strategy in septic patients varies in inclusion criteria, definitions of restrictive and liberal strategies, criteria for additional fluids, and duration of interventions.
“The current evidence evaluating a restrictive IV fluid strategy in the management of septic patients varies with respect to the inclusion criteria, the definition of restrictive and liberal fluid strategies, the criteria guiding the administration of additional IV fluids (e.g., perfusion parameters vs. haemodynamic variables), and the duration of the interventions [397–401].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [397] Chen C, Kollef MH (2015) Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chest 148(6):1462–1469 source
Not checked in the free run.
- cites [398] Corl KA, Prodromou M, Merchant RC et al (2019) The restrictive IV Fluid trial in severe sepsis and septic shock (RIFTS): a randomized pilot study. Crit Care Med 47(7):951–959 source
Not checked in the free run.
- cites [399] Hjortrup PB, Haase N, Bundgaard H et al (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42(11):1695–1705 source
Not checked in the free run.
- cites [400] Macdonald SPJ, Keijzers G, Taylor DM et al (2018) Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med 44(12):2070–2078 source
Not checked in the free run.
- cites [401] Semler MW, Janz DR, Casey JD, et al (2019) Conservative fluid management after sepsis resuscitation: a pilot randomized trial. J Intensive Care Med 35(12):1374–1382. https://doi.org/10.1177/0885066618823183 source
Not checked in the free run.
- Premisecitation
Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS.
“Several meta-analyses suggest decreased mortality in patients with a pressure- and volume-limited strategy for established ARDS [353, 354].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [353] Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122–1125 source
Not checked in the free run.
- cites [354] Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518 source
Not checked in the free run.
- Premisecitation
A recent systematic review including five RCTs identified a strong relationship between plateau pressure and mortality.
“A recent systematic review which included five RCTs also identified a strong relationship between plateau pressure and mortality [434].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [434] Papazian L, Aubron C, Brochard L et al (2019) Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 9(1):69 source
Not checked in the free run.
- Premisecitation
In that previous single-centre trial, conservative oxygen therapy in the ICU was associated with a markedly lower rate of death than usual oxygen therapy.
“In that trial, conservative oxygen therapy in the ICU was associated with a markedly lower rate of death than usual oxygen therapy [404].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [404] Girardis M, Busani S, Damiani E et al (2016) Effect of Conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA 316(15):1583–1589 source
Not checked in the free run.
- Premisecitation
Since the last guideline distribution, only one additional study was added for analysis.
“Since the last guideline distribution, only one additional study was added for analysis [420].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [420] Belenguer-Muncharaz A, Cubedo-Bort M, Blasco-Asensio D et al (2017) Non-invasive ventilation versus invasive mechanical ventilation in patients with hypoxemic acute respiratory failure in an Intensive Care Unit. A randomized controlled study. Minerva Pneumologica 56:1–10
Not checked in the free run.
- Premisenone given
No new trials evaluating plateau pressure have been published since the previous guidelines.
“This recommendation is unchanged from the previous guidelines, as no new trials evaluating plateau pressure have been published since then.”
Quote in the paperSubstantial claim - Premisecitation
The ICU-ROX findings are at variance with a previous single-centre trial that was stopped early after an unplanned interim analysis.
“These findings are at variance with the results of a previous single-centre trial, which was stopped early after an unplanned interim analysis.”
Quote in the paperSubstantial claim - Premisecitation
HFNC is less effective at reducing work of breathing and supplying a moderate or higher level of PEEP.
“However, HFNC is less effective at reducing work of breathing and supplying a moderate or higher level of PEEP [410].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [410] Mauri T, Turrini C, Eronia N et al (2017) Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 195(9):1207–1215 source
Not checked in the free run.
- Premisenone given
No single mode of ventilation (pressure control, volume control) has consistently been shown to be advantageous when compared with any other that respects the same principles of lung protection.
“No single mode of ventilation (pressure control, volume control) has consistently been shown to be advantageous when compared with any other that respects the same principles of lung protection.”
Quote in the paperSubstantial claim - Premisecitation
The evidence for the use of conservative oxygen targets and therapy in patients with sepsis is limited, with three randomised trials in the critically ill population.
“The evidence for the use of conservative oxygen targets (generally defined as PaO2 55–70 mmHg; SpO2 88–92%) and therapy in patients with sepsis is limited, with three randomised trials in the critically ill population [404–406].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [404] Girardis M, Busani S, Damiani E et al (2016) Effect of Conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA 316(15):1583–1589 source
Not checked in the free run.
- cites [405] Investigators I-R, the A, New Zealand Intensive Care Society Clinical Trials G et al (2020) Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med 382(11):989–998 source
Not checked in the free run.
- cites [406] Panwar R, Hardie M, Bellomo R et al (2016) Conservative versus liberal oxygenation targets for mechanically ventilated patients. A pilot multicenter randomized controlled trial. Am J Respir Crit Care Med 193(1):43–51 source
Not checked in the free run.
- Premisecitation
Several multicentre RCTs have been performed in patients with established ARDS to evaluate the effects of limiting inspiratory pressure through moderation of tidal volume.
“Several multicentre RCTs have been performed in patients with established ARDS to evaluate the effects of limiting inspiratory pressure through moderation of tidal volume [424–427].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [424] Brower RG, Matthay MA, Acute Respiratory Distress Syndrome N et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308 source
Not checked in the free run.
- cites [425] Amato MB, Barbas CS, Medeiros DM et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347–354 source
Not checked in the free run.
- cites [426] Brochard L, Roudot-Thoraval F, Roupie E et al (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 158(6):1831–1838 source
Not checked in the free run.
- cites [427] Brower RG, Shanholtz CB, Fessler HE et al (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27(8):1492–1498 source
Not checked in the free run.
- Premisecitation
A recent patient-level mediation analysis suggested that a tidal volume that results in a driving pressure below 12-15 cm H2O may be advantageous in patients without spontaneous breathing efforts.
“A recent patient-level mediation analysis suggested that a tidal volume that results in a driving pressure (plateau pressure minus set PEEP) below 12–15 cm H2O may be advantageous in patients without spontaneous breathing efforts [433].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [433] Amato MB, Meade MO, Slutsky AS et al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372(8):747–755 source
Not checked in the free run.
- Interpretationnone given
The precise tidal volume for an individual ARDS patient requires adjustment for factors such as plateau pressure, selected PEEP, thoracoabdominal compliance, and the patient's breathing effort.
“The use of lung-protective strategies for patients with ARDS is supported by clinical trials and has been widely accepted; however, the precise tidal volume for an individual ARDS patient requires adjustment for factors such as the plateau pressure, the selected positive end-expiratory pressure (PEEP), thoracoabdominal compliance, and the patient’s breathing effort.”
Quote in the paperSubstantial claim - Premisecitation
A few small RCTs have shown benefit with NIV for early or mild ARDS or de novo hypoxic respiratory failure.
“A few small RCTs have shown benefit with NIV for early or mild ARDS or de novo hypoxic respiratory failure [418, 419].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [418] Antonelli M, Conti G, Rocco M et al (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339(7):429–435 source
Not checked in the free run.
- cites [419] Honrubia T, Garcia Lopez FJ, Franco N et al (2005) Noninvasive vs conventional mechanical ventilation in acute respiratory failure: a multicenter, randomized controlled trial. Chest 128(6):3916–3924 source
Not checked in the free run.
- Premisecitation
In a post hoc analysis of patients with severe hypoxemia (PaO2/FiO2 ≤ 200 mmHg) from that trial, HFNC resulted in lower intubation rates compared with NIV (35 versus 58 percent).
“In a post hoc analysis of patients with severe hypoxemia (PaO2/FiO2 ≤ 200 mmHg) from the above trial, HFNC resulted in lower intubation rates compared with NIV (35 versus 58 percent, respectively).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [411] Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372(23):2185–2196 source
Not checked in the free run.
- Premisecitation
The studies that guide the recommendations in this section enrolled patients using criteria from the American-European Consensus Criteria Definition for Acute Lung Injury and ARDS.
“Of note, the studies that guide the recommendations in this section enrolled patients using criteria from the American-European Consensus Criteria Definition for Acute Lung Injury and ARDS [422].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [422] Bernard GR, Artigas A, Brigham KL et al (1994) The American-European Consensus Conference on ARDS definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818–824 source
Not checked in the free run.
- Premisecitation
In a recent systematic review and meta-analysis of multiple clinical syndromes, a conservative oxygen strategy was associated with a lower rate of death in acutely ill adults than a liberal oxygen strategy.
“In a recent systematic review and meta-analysis of multiple clinical syndromes, investigators found that a conservative oxygen strategy was associated with a lower rate of death in acutely ill adults than a liberal oxygen strategy [407].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [407] Chu DK, Kim LH, Young PJ et al (2018) Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 391(10131):1693–1705 source
Not checked in the free run.
- Premisecitation
The LUNG SAFE trial demonstrated that NIV was used in 15% of patients with ARDS with varying failure and mortality rates, depending on ARDS severity.
“For example, the LUNG SAFE trial demonstrated that NIV was used in 15% of patients with ARDS with varying failure and mortality rates, depending on ARDS severity [417].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [417] Bellani G, Laffey JG, Pham T et al (2017) Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE Study. Am J Respir Crit Care Med 195(1):67–77 source
Not checked in the free run.
- Premisecitation
A single, large randomised trial has directly compared NIV versus HFNC for acute hypoxemic respiratory failure despite conventional oxygen.
“When comparing the strategies of NIV versus HFNC for acute hypoxemic respiratory failure despite conventional oxygen, a single, large randomised trial has been conducted for direct comparison [411].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [411] Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372(23):2185–2196 source
Not checked in the free run.
- Premisecitation
The largest trial of a volume- and pressure-limited strategy showed a 9% absolute decrease in mortality in ARDS patients ventilated with tidal volumes of 6 mL/kg compared with 12 mL/kg predicted body weight, and aiming for plateau pressure ≤ 30 cm H2O.
“The largest trial of a volume- and pressure-limited strategy showed 9% absolute decrease in mortality in ARDS patients ventilated with tidal volumes of 6 mL/kg compared with 12 mL/ kg predicted body weight (PBW), and aiming for plateau pressure ≤ 30 cm H2O [424].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [424] Brower RG, Matthay MA, Acute Respiratory Distress Syndrome N et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308 source
Not checked in the free run.
- Interpretationreasoning
Patients with very stiff chest/abdominal walls and high pleural pressures may tolerate plateau pressures > 30 cm H2O because transpulmonary pressures will be lower.
“Conversely, patients with very stiff chest/ abdominal walls and high pleural pressures may tolerate plateau pressures > 30 cm H2O because transpulmonary pressures will be lower.”
Quote in the paperSubstantial claim - Premisecitation
A secondary analysis of five observational studies identified a plateau pressure cut-off value of 29 cm H2O, above which an ordinal increment was accompanied by an increment of risk of death.
“A secondary analysis of five observational studies identified a plateau pressure cut-off value of 29 cm H2O, above which an ordinal increment was accompanied by an increment of risk of death [436].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [436] Villar J, Martin-Rodriguez C, Dominguez-Berrot AM et al (2017) A quantile analysis of plateau and driving pressures: effects on mortality in patients with acute respiratory distress syndrome receiving lung-protective ventilation. Crit Care Med 45(5):843–850 source
Not checked in the free run.
- Premisecitation
In the 1000-participant ICU-ROX trial, conservative oxygen therapy did not significantly affect the primary outcome (ventilator-free days) compared with liberal oxygen therapy for ventilated adults in ICU.
“In the 1000-participant ICU-ROX trial [405], conservative oxygen therapy did not significantly affect the primary outcome, which was the number of ventilator-free days, compared with liberal oxygen therapy for ventilated adults in ICU.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [405] Investigators I-R, the A, New Zealand Intensive Care Society Clinical Trials G et al (2020) Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med 382(11):989–998 source
Not checked in the free run.
- Interpretationreasoning
At this point in time, there is insufficient evidence to make an evidence-based recommendation on conservative oxygen targets.
“At this point in time, there is insufficient evidence to make an evidence-based recommendation.”
Quote in the paperSubstantial claim - Interpretationnone given
Patients requiring HFNC for acute hypoxemic respiratory failure are at high risk of requiring intubation.
“Patients requiring HFNC for acute hypoxemic respiratory failure are at high risk of requiring intubation; therefore, such trials must be accompanied by careful surveillance for ventilatory failure.”
Quote in the paperSubstantial claim - Study design and conductreasoning
Due to the presence of significant statistical and clinical heterogeneity, a meta-analysis of all seven trials was not appropriate.
“Due to the presence of significant statistical and clinical heterogeneity, a meta-analysis of all seven trials was not appropriate.”
Quote in the paperSubstantial claim - Premisecitation
This repeat meta-analysis confirmed that in patients with ARDS and a PaO2/FiO2 ratio < 200, the use of prone compared with supine position within the first 36 h of intubation, when performed for > 12 h a day, showed improved survival.
“This repeat meta-analysis confirmed the results from the previous published work: In patients with ARDS and a PaO2/FiO2 ratio < 200, the use of prone compared with supine position within the first 36 h of intubation, when performed for > 12 h a day, showed improved survival.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [454] Munshi L, Del Sorbo L, Adhikari NKJ et al (2017) Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 14(Supplement_4):S280-s8 source
Not checked in the free run.
- Premisenone given
There were no new randomised, controlled trials evaluating the use of prone ventilation in sepsis induced severe ARDS published since the 2016 guidelines.
“There were no new randomised, controlled trials evaluating the use of prone ventilation in sepsis induced severe ARDS published since the 2016 guidelines.”
Quote in the paperSubstantial claim - Premisenone given
There are limited data on ventilation strategies for patients with sepsis-induced respiratory failure who do not meet criteria for ARDS.
“There are limited data on ventilation strategies for patients with sepsis-induced respiratory failure who do not meet criteria for ARDS.”
Quote in the paperSubstantial claim - Premisecitation
Previous versions of SSC guidelines issued a strong recommendation with moderate-quality evidence for using low tidal volume ventilation (Vt 4-8 mL/kg of predicted body weight) over higher tidal volumes (Vt > 8 mL/kg) in the management of patients with ARDS.
“Previous versions of SSC guidelines issued a strong recommendation with a moderate-quality evidence for using low tidal volume (Vt) ventilation (Vt 4–8 mL/kg of predicted body weight), over higher tidal volumes (Vt > 8 mL/kg) in the management of patients with ARDS [12, 13, 226].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [12] Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552 source
Not checked in the free run.
- cites [13] Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377 source
Not checked in the free run.
- cites [226] Alhazzani W, Moller MH, Arabi YM et al (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 46(5):854–887 source
Not checked in the free run.
- Premisecitation
We included three multicentre RCTs and one pilot RCT investigating use of higher PEEP versus lower PEEP strategies in conjunction with low tidal volumes for the management of patients with ARDS.
“We included three multicentre RCTs [439–441] and one pilot RCT [442], investigating use of higher PEEP versus lower PEEP strategies in conjunction with low tidal volumes for the management of patients with ARDS.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [439] Brower RG, Lanken PN, MacIntyre N et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336 source
Not checked in the free run.
- cites [440] Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645 source
Not checked in the free run.
- cites [441] Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655 source
Not checked in the free run.
- cites [442] Kacmarek RM, Villar J, Sulemanji D et al (2016) Open lung approach for the acute respiratory distress syndrome: a pilot randomized. controlled trial. Crit Care Med 44(1):32–42 source
Not checked in the free run.
- Premisecitation
A PEEP > 5 cm H2O is usually required to avoid lung collapse.
“A PEEP > 5 cm H2O is usually required to avoid lung collapse [446].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [446] Gattinoni L, Caironi P, Cressoni M et al (2006) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354(17):1775–1786 source
Not checked in the free run.
- Study design and conductown data
Our conclusions did not change in a sensitivity analysis which includes these two trials.
“Our conclusions did not change in a sensitivity analysis which includes these two trials.”
Quote in the paperSubstantial claim - Premisecitation
In addition, use of NMBA may reduce oxygen consumption by decreasing the work of breathing.
“In addition, use of NMBA may reduce oxygen consumption by decreasing the work of breathing [464].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [464] Hansenflaschen JH, Brazinsky S, Basile C et al (1991) USE OF sedating drugs and neuromuscular blocking-agents in patients requiring mechanical ventilation for respiratory-failure—a National Survey. JAMA 266(20):2870–2875 source
Not checked in the free run.
- Premisenone given
There is not as strong an evidence base for patients presenting with acute respiratory failure requiring mechanical ventilation who do not fulfil the criteria for ARDS.
“There is not as strong an evidence base, however, for the patients presenting with acute respiratory failure requiring mechanical ventilation who do not fulfil the criteria for ARDS.”
Quote in the paperSubstantial claim - Premisecitation
A 2015 systematic review and meta-analysis found a reduction in the risk of a composite endpoint of ARDS or pneumonia during the hospital stay in the low tidal volume ventilation group compared to the high tidal volume ventilation group (RR 0.72; 95% CI 0.52-0.98).
“A 2015 systematic review and meta-analysis found a reduction in the risk of a composite endpoint of ARDS or pneumonia during the hospital stay in the low tidal volume ventilation group compared to the high tidal volume ventilation group (RR 0.72; 95% CI 0.52–0.98) [450].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [450] Serpa Neto A, Cardoso SO, Manetta JA et al (2012) Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 308(16):1651–1659 source
Not checked in the free run.
- Premisecitation
Instead of the "traditional" recruitment maneuver which consists of the application of sustained continuous positive airway pressure (e.g., 30-40 cm H2O for 30-40 s), both trials conducted lung recruitment with incremental PEEP levels, followed by a decremental PEEP titration according to either best respiratory-system static compliance or oxygen saturation.
“Instead of the “traditional” recruitment maneuver which consists of the application of sustained continuous positive airway pressure (e.g., 30–40 cm H2O for 30–40 s), both trials conducted lung recruitment with incremental PEEP levels, followed by a decremental PEEP titration according to either best respiratory-system static compliance [452] or oxygen saturation [437].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [452] Cavalcanti AB, Suzumura ÉA, Laranjeira LN et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318(14):1335–1345 source
Not checked in the free run.
- cites [437] Hodgson CL, Cooper DJ, Arabi Y et al (2019) Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial. Am J Respir Crit Care Med 200(11):1363–1372 source
Not checked in the free run.
- Premisecitation
Esophageal pressure guided PEEP titration has been evaluated in two trials.
“Esophageal pressure guided PEEP titration has been evaluated in two trials [447, 448].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [447] Beitler JR, Sarge T, Banner-Goodspeed VM et al (2019) Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 321(9):846–857 source
Not checked in the free run.
- cites [448] Talmor D, Sarge T, Malhotra A et al (2008) Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 359(20):2095–2104 source
Not checked in the free run.
- Interpretationreasoning
The use of low tidal volume ventilation avoids the risk of promoting ventilator induced lung injury in septic patients in whom the diagnosis of ARDS has been missed.
“Furthermore, the use of low tidal volume ventilation avoids the risk of promoting ventilator induced lung injury in septic patients in whom the diagnosis of ARDS has been missed.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The evidence in this guideline was downgraded to very low quality due to indirectness.
“The evidence in this guideline was downgraded to very low quality due to indirectness.”
Quote in the paperSubstantial claim - Premisenone given
It may also be used to facilitate a reduction in the intensity of mechanical ventilation.
“It may also be used to facilitate a reduction in the intensity of mechanical ventilation.”
Quote in the paperNot a substantial claim - Premisecitation
In the TRICOP trial, at 90 days, mortality was lower in the liberal group (59% vs 70%) than in the restrictive group (HR 0.72; 95% CI 0.53-0.97).
“At 90 days after randomisation, mortality rate in the liberal group was lower (59% vs 70%) than in the restrictive group (hazard ratio, 0.72; 95% CI 0.53–0.97).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [487] Bergamin FS, Almeida JP, Landoni G et al (2017) Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 45(5):766–773 source
Not checked in the free run.
- Premisecitation
Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is used in patients with severe acute respiratory failure to facilitate gas exchange in the setting of refractory hypoxaemia or hypercapnic respiratory acidosis.
“Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is used in patients with severe acute respiratory failure to facilitate gas exchange in the setting of refractory hypoxaemia or hypercapnic respiratory acidosis [475].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [475] Munshi L, Walkey A, Goligher E et al (2019) Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med 7(2):163–172 source
Not checked in the free run.
- Premisecitation
Since then, three large RCTs have been published.
“Since then, three large RCTs have been published [354, 478, 479].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [354] Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518 source
Not checked in the free run.
- cites [478] Annane D, Renault A, Brun-Buisson C et al (2018) Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med 378(9):809–818 source
Not checked in the free run.
- cites [479] Venkatesh B, Finfer S, Cohen J et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797–808 source
Not checked in the free run.
- Premisecitation
In the 2016 guidance, the accumulated evidence did not support a recommendation for corticosteroid use if adequate fluid resuscitation and vasopressor therapy were able to restore haemodynamic stability.
“In the 2016 guidance, the accumulated evidence did not support a recommendation for their use if adequate fluid resuscitation and vasopressor therapy were able to restore haemodynamic stability [12, 13]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552 source
Not checked in the free run.
- cites [13] Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377 source
Not checked in the free run.
- Study design and conductcitation
Overall, the quality of evidence is judged as low.
“Overall, the quality of evidence is judged as low (Supplementary Appendix 5).”
Quote in the paperSubstantial claim - Premisecitation
An updated meta-analysis found systemic corticosteroid to accelerate resolution of shock (MD 1.52 days; 95% CI 1.71-1.32).
“An updated meta-analysis [480] found systemic corticosteroid to accelerate resolution of shock (MD 1.52 days; 95% CI 1.71–1.32).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [480] Rygård SL, Butler E, Granholm A et al (2018) Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44(7):1003–1016 source
Not checked in the free run.
- Interpretationreasoning
The overall balance of beneficial and undesirable effects for IV immunoglobulins remains uncertain.
“Overall, the balance of effects (beneficial and undesirable) remains uncertain.”
Quote in the paperSubstantial claim - Study design and conductreasoning
There were methodological limitations of the included studies.
“There were methodological limitations of the included studies.”
Quote in the paperSubstantial claim - Study design and conductown data
The overall quality of evidence for RBC transfusion strategies was judged moderate.
“Overall, the quality of evidence was judged moderate.”
Quote in the paperSubstantial claim - Premisecitation
A recent meta-analysis suggested a higher risk of recurrent Clostridioides difficile infections with proton pump inhibitors.
“A recent meta-analysis published since the finalisation of the literature searches has suggested that there is a higher risk of recurrent Clostridioides difficile infections with proton pump inhibitors [495].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [495] D'Silva KM, Mehta R, Mitchell M, et al (2021) Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clin Microbiol Infect source
Not checked in the free run.
- Interpretationreasoning
A restrictive transfusion strategy is feasible in low- and middle-income countries.
“A restrictive strategy is feasible in low- and middle-income countries.”
Quote in the paperSubstantial claim - Study design and conductcitation
In addition, some of the participants in this trial did not receive the intervention.
“In addition, some of the participants in this trial did not receive the intervention [477].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [477] Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363 source
Not checked in the free run.
- Premisecitation
In the TRICC trial, a restrictive transfusion threshold of 70 g/L versus 100 g/L in 838 euvolemic ICU patients showed no difference in 30-day mortality.
“The Transfusion requirements in in Critical Care trial (TRICC), which compared a restrictive transfusion threshold of 70 g/L versus 100 g/L in 838 euvolemic ICU patients, demonstrated no difference in the primary outcome (30-day mortality).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [484] Hébert PC, Wells G, Blajchman MA et al (1999) a multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340(6):409–417 source
Not checked in the free run.
- cites [485] Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391 source
Not checked in the free run.
- Study design and conductnone given
The overall quality of evidence was moderate.
“The overall quality of evidence was moderate.”
Quote in the paperSubstantial claim - Premisecitation
In the subgroup of 218 patients with sepsis or septic shock in the TRICC trial, 30-day mortality was similar between restrictive and liberal groups (22.8% vs 29.7%, p = 0.36).
“In the subgroup of 218 patients with sepsis or septic shock 30-day mortality was similar in the two groups (22.8% in the restrictive group vs. 29.7% in the liberal group, p = 0.36).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [484] Hébert PC, Wells G, Blajchman MA et al (1999) a multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340(6):409–417 source
Not checked in the free run.
- cites [485] Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391 source
Not checked in the free run.
- Interpretationown data
The lack of difference in 28-day mortality in the updated meta-analysis is due to the inclusion of the TRICOP study, where lower 28-day mortality was observed with a liberal strategy.
“This is due to the inclusion of the TRICOP study where lower 28 mortality was observed with a liberal strategy.”
Quote in the paperSubstantial claim - Study design and conductown data
A sensitivity analysis including only trials at low risk of bias provided similar results.
“A sensitivity analysis including only trials at low risk of bias provided similar results.”
Quote in the paperNot a substantial claim - Premisecitation
No dose response benefit was seen in a prior systematic review and meta-analysis.
“No dose response benefit was seen in a prior systematic review and meta-analysis [480].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [480] Rygård SL, Butler E, Granholm A et al (2018) Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44(7):1003–1016 source
Not checked in the free run.
- Premisenone given
The most widely investigated technique involves the use of polymyxin B-immobilised polystyrene-derived fibers.
“The most widely investigated technique involves the use of polymyxin B-immobilised polystyrene-derived fibers.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The cost of intravenous immunoglobulin limits its feasibility in countries with low- and middle-income economies.
“Its cost also limits its feasibility in countries with low- and middle-income economies.”
Quote in the paperSubstantial claim - Premisenone given
The inclusion criteria of the trials were strict and focused on a very sick population of patients with severe ARDS refractory to conventional ventilation strategies and other rescue therapies such as prone position.
“The inclusion criteria of the trials were strict and focused on a very sick population of patients with severe ARDS refractory to conventional ventilation strategies and other rescue therapies such as prone position.”
Quote in the paperSubstantial claim - Premisecitation
However, one recent systematic review found that VV ECMO delivered at expert centers reduced mortality for patients with severe ARDS.
“However, one recent systematic review found that VV ECMO delivered at expert centers reduced mortality for patients with severe ARDS [475].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [475] Munshi L, Walkey A, Goligher E et al (2019) Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med 7(2):163–172 source
Not checked in the free run.
- Study design and conductcitation
The quality of evidence for continuous versus intermittent RRT was judged low.
“The quality of evidence was judged as low.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The overall quality of evidence for LMWH versus UFH was rated moderate, downgraded for imprecision.
“The overall quality of evidence was rated as moderate: it was downgraded for imprecision.”
Quote in the paperSubstantial claim - Interpretationreasoning
The balance of overall effects favoured LMWH over UFH.
“It was determined that the balance of overall effects favoured LMWH over UFH.”
Quote in the paperSubstantial claim - Interpretationreasoning
The preference for delayed RRT is principally driven by a higher rate of CVAD infection in the early initiation group.
“This is principally driven by the higher rate of CVAD infection in the “early” initiation.”
Quote in the paperSubstantial claim - Premisecitation
Two systematic reviews and meta-analyses do not show a difference in mortality between continuous (CRRT) and intermittent haemodialysis (IHD).
“Two systematic reviews and meta-analyses [501, 502] summarised the total body of evidence: they do not show a difference in mortality between patients who receive continuous (CRRT) versus intermittent haemodialysis (IHD).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [501] Kellum JA, Angus DC, Johnson JP et al (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28(1):29–37 source
Not checked in the free run.
- cites [502] Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40(5):875–885 source
Not checked in the free run.
- Premisecitation
After excluding high risk of bias studies, chronic liver disease is a risk factor for clinically important GI bleeding (RE 7.64; 95% CI 3.32-17.58).
“and chronic liver disease (RE 7.64; 95% CI 3.32–17.58).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [496] Granholm A, Zeng L, Dionne JC et al (2019) Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 45(10):1347–1359 source
Not checked in the free run.
- Interpretationreasoning
The preference for initiating insulin at > 180 mg/dl was principally driven by the increased risk of hypoglycemia observed with lower targets.
“This was principally driven by the increased risk of hypoglycemia observed with lower targets.”
Quote in the paperSubstantial claim - Study design and conductcitation
The new RCT comparing early versus delayed RRT was stopped early after the second planned interim analysis for futility.
“It was stopped early, after the second planned interim analysis, for futility.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [507] Barbar SD, Clere-Jehl R, Bourredjem A et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442 source
Not checked in the free run.
- Premisecitation
After excluding high risk of bias studies, coagulopathy is a risk factor for clinically important GI bleeding (RE 4.76; 95% CI 2.62-8.63).
“After excluding high risk of bias studies, risk factors included: coagulopathy (relative effect (RE) 4.76; 95% CI 2.62–8.63)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [496] Granholm A, Zeng L, Dionne JC et al (2019) Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 45(10):1347–1359 source
Not checked in the free run.
- Premisecitation
No differential effect was observed in the a priori sepsis subgroup of 1689 patients in the STARRT-AKI trial.
“No differential effect was observed in the a priori sepsis subgroup of 1689 patients [508].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [508] Investigators S-A, Canadian Critical Care Trials G, Australian et al (2020) Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med 383(3):240–251 source
Not checked in the free run.
- Premisecitation
After excluding high risk of bias studies, shock is a risk factor for clinically important GI bleeding (RE 2.60; 95% CI 1.25-5.42).
“shock (RE 2.60; 95% CI 1.25–5.42)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [496] Granholm A, Zeng L, Dionne JC et al (2019) Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 45(10):1347–1359 source
Not checked in the free run.
- Premisecitation
Meta-analyses report a higher incidence of hypoglycemia (glucose < 40 mg/dL) in critically ill patients where blood glucose was targeted to 80-110 mg/dL.
“Meta-analyses also report a higher incidence of hypoglycemia (glucose < 40 mg/dL) in critically patients where blood glucose was targeted to 80–110 mg/dL [516, 517].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [516] Griesdale DE, de Souza RJ, van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180(8):821–827 source
Not checked in the free run.
- cites [517] Song F, Zhong LJ, Han L, et al (2014) Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2014:698265. https://doi.org/10.1155/2014/698265 source
Not checked in the free run.
- Interpretationreasoning
The evidence probably favours the administration of stress ulcer prophylaxis.
“Overall, it was judged that the evidence probably favoured the administration of stress ulcer prophylaxis.”
Quote in the paperSubstantial claim - Premisecitation
No difference in lower extremity ischaemia was demonstrated in the PREVENT study.
“No difference in lower extremity ischaemia was demonstrated.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [500] Arabi YM, Al-Hameed F, Burns KEA et al (2019) Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 380(14):1305–1315 source
Not checked in the free run.
- Premisecitation
In the Fujii et al. study, no difference was reported for the primary outcome of time alive and free of vasopressors up to 168 h between the intervention and control group (median 122.1 h vs 124.6 h; p = 0.83).
“The authors reported no difference for the primary outcome of time alive and free of vasopressors up to 168 h between the intervention and control group (median 122.1 h [IQR 76.3–145.4 h] vs 124.6 h [IQR 82.1–147 h]; p = 0.83).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [524] Fujii T, Luethi N, Young PJ et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS Randomized Clinical Trial. JAMA 323(5):423–431 source
Not checked in the free run.
- Interpretationcitation
Any effects of adding mechanical prophylaxis to pharmacologic prophylaxis, either beneficial or undesirable, were judged likely trivial.
“It was judged that any effects of the intervention (mechanical prophylaxis in addition to pharmacologic), either beneficial or undesirable, were likely trivial (Supplementary Appendix 5).”
Quote in the paperSubstantial claim - Interpretationcitation
The balance of effects favoured neither IHD nor CRRT.
“The balance of effects favoured neither (IHD) nor CRRT.”
Quote in the paperSubstantial claim - Interpretationreasoning
The effect favours pharmacologic VTE prophylaxis with moderate quality of evidence.
“On balance, the effect favours the intervention with a moderate quality of evidence.”
Quote in the paperSubstantial claim - Interpretationreasoning
Overall, the balance of effects favoured delayed rather than early initiation of RRT.
“Overall, the balance of effects favoured delayed rather than early initiation of RRT.”
Quote in the paperSubstantial claim - Interpretationreasoning
Overall, the balance of effects favoured initiation of insulin therapy at a glucose level of > 180 mg/dl.
“Overall, the balance of effects favoured initiation of insulin therapy at a glucose level of > 180 mg/dl.”
Quote in the paperSubstantial claim - Premisecitation
In the new trial, hypernatremia, hypocalcaemia, and metabolic alkalosis were observed more frequently in those randomised to bicarbonate.
“However, hypernatremia, hypocalcaemia, and metabolic alkalosis were observed more frequently in those randomised to bicarbonate.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [528] Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40 source
Not checked in the free run.
- Premisecitation
In the new multicentre trial, no between-group difference was observed in the primary outcome of a composite of 28-day mortality and organ failure at day 7.
“No between-group difference was observed in the primary outcome of a composite of 28-day mortality and organ failure at day 7.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [528] Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40 source
Not checked in the free run.
- Study design and conductcitation
Overall, the quality of evidence for bicarbonate therapy is low.
“Overall, the quality of evidence is low (Supplementary Appendix 5).”
Quote in the paperSubstantial claim - Premisecitation
In the Moskowitz et al. study, no difference in the primary outcome of mean SOFA score change at 72 h post enrolment was observed.
“No difference in the primary outcome of mean SOFA score change at 72 h post enrolment was observed.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [525] Moskowitz A, Huang DT, Hou PC et al (2020) Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS Randomized Clinical Trial. JAMA 324(7):642–650 source
Not checked in the free run.
- Interpretationreasoning
Although the available evidence is of low quality, it does not suggest harm following the institution of early enteral feeding.
“Although the available evidence is of low quality, it does not suggest harm following the institution of early enteral feeding.”
Quote in the paperSubstantial claim - Interpretationown data
The overall balance of effects did not favour either early enteral feeding (within 72 h) compared with enteral feeding commenced after that time.
“The overall balance of effects did not favour either early enteral feeding (within 72 h) compared with enteral feeding commenced after that time.”
Quote in the paperSubstantial claim - Interpretationcitation
The overall size of any desirable effect of vitamin C was judged as small with a low quality of evidence.
“The overall size of any desirable effect was judged as small with a low quality of evidence (Supplementary Appendix 5).”
Quote in the paperSubstantial claim - Premisecitation
Sepsis was present in 61% (238/389) of patients at the time of randomisation.
“Sepsis was present in 61% (238/389) of patients at the time of randomisation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [528] Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40 source
Not checked in the free run.
- Interpretationnone given
The institution of early enteral nutrition was considered feasible in low- and middle-income economies.
“The institution of early enteral nutrition was also considered feasible in low- and middle-income economies.”
Quote in the paperSubstantial claim - Premiseown data
No differential effect was observed between patients with vs without sepsis.
“No differential effect was observed between patients with vs without sepsis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [528] Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40 source
Not checked in the free run.
- Interpretationown data
When considering the subset of patients with septic shock, severe metabolic acidosis and AKI, the balance of effects probably favours IV bicarbonate.
“However, when considering the subset of patients with septic shock, severe metabolic acidosis and AKI, the balance of effects probably favours IV bicarbonate.”
Quote in the paperSubstantial claim - Premisecitation
The early administration of enteral nutrition in patients with sepsis and septic shock has potential physiologic advantages related to maintenance of gut integrity, prevention of intestinal permeability, dampening of the inflammatory response, and modulation of metabolic responses that may reduce insulin resistance.
“The early administration of enteral nutrition in patients with sepsis and septic shock has potential physiologic advantages related to the maintenance of gut integrity and prevention of intestinal permeability, dampening of the inflammatory response, and modulation of metabolic responses that may reduce insulin resistance [529, 530].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [529] Kudsk KA (2002) Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183(4):390–398 source
Not checked in the free run.
- cites [530] McClave SA, Heyland DK (2009) The physiologic response and associated clinical benefits from provision of early enteral nutrition. Nutr Clin Pract 24(3):305–315 source
Not checked in the free run.
- Interpretationnone given
Neither intervention was considered more beneficial when considering resources utilisation, cost effectiveness, and equity issues.
“Neither intervention was considered more beneficial when considering resources utilisation, cost effectiveness, and equity issues.”
Quote in the paperSubstantial claim - Interpretationreasoning
The balance of effects for vitamin C was judged as favouring neither the intervention nor the comparator.
“The balance of effects was accordingly judged as favouring neither the intervention nor the comparator.”
Quote in the paperSubstantial claim - Premisecitation
In the Moskowitz et al. study, at 30 days, 34.7% (35/101) of patients randomised to combination therapy had died versus 29.3% (29/99) randomised to placebo (HR 1.3; 95% CI 0.8-2.2; p = 0.26).
“At 30 days, 34.7% (35/101) of patients randomised to combination therapy had died vs. 29.3% (29/99) randomised to placebo (HR, 1.3; 95% CI 0.8–2.2; p = 0.26).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [525] Moskowitz A, Huang DT, Hou PC et al (2020) Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS Randomized Clinical Trial. JAMA 324(7):642–650 source
Not checked in the free run.
- Premisecitation
In the subgroup of patients with AKI defined as AKIN stage 2 or 3 at randomisation (182/389-47%), lower mortality was observed with bicarbonate therapy: control 57/90 (63%), bicarbonate 42/92 (46%), ARR −17.7% (−33.0 to −2.3), p = 0.016.
“In the subgroup of patients with AKI defined as AKI Network (AKIN) stage 2 or 3 at randomisation (182/389–47%), lower mortality was observed with bicarbonate therapy: control 57/90 (63%), bicarbonate (42/92–46%), absolute risk reduction (ARR) −17.7% (−33.0 to −2.3), p = 0.016.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [528] Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40 source
Not checked in the free run.
- Premisecitation
In the new multicentre trial, 1504 (62%) of the participants had sepsis.
“1504 (62%) of the participants had sepsis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [531] Reignier J, Boisramé-Helms J, Brisard L et al (2018) Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet 391(10116):133–143 source
Not checked in the free run.
- Premisecitation
In the Fujii et al. study, ninety-day mortality was 28.6% (30/105) in the vitamin C group and 24.5% (25/102) in the control group (HR 1.18; 95% CI 0.69-2.0).
“Ninety-day mortality was 28.6% (30/105) in the vitamin C group, and 24.5% (25/102) in the control group (HR 1.18; 95% CI 0.69–2.0).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [524] Fujii T, Luethi N, Young PJ et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS Randomized Clinical Trial. JAMA 323(5):423–431 source
Not checked in the free run.
- Interpretationreasoning
Indirect evidence from palliative care studies in ICU patients was judged likely to apply to patients with sepsis.
“However, indirect evidence from these studies was judged likely to apply to patients with sepsis.”
Quote in the paperSubstantial claim - Study design and conductown data
The quality of evidence for early enteral nutrition was assessed low or very low, with downgrades for risk of bias, inconsistency, and imprecision.
“The quality of evidence was assessed low or very low: downgrades were for risk of bias, inconsistency, and imprecision.”
Quote in the paperSubstantial claim - Premisecitation
There was a significant differential effect between patients with an AKIN score of 2 or 3 compared with those with a score of 0-1 (p for heterogeneity = 0.023).
“There was a significant differential effect between patients with an AKIN score of 2 or 3 compared with those with a score of 0–1 (p value for heterogeneity = 0.023).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [528] Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392(10141):31–40 source
Not checked in the free run.
- Interpretationcitation
Education would likely have variable acceptability, as a qualitative study showed diverse viewpoints among sepsis survivors.
“The panel judged that education would likely have variable acceptability, as a qualitative study showed that patients who survived sepsis had diverse viewpoints ranging from appreciating the education about sepsis to not being able to recall the education session, to even disliking it as a reminder of the severity of their condition [587].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [587] Gehrke-Beck S, Bänfer M, Schilling N et al (2017) The specific needs of patients following sepsis: a nested qualitative interview study. BJGP Open. 1(1):bjgpopen17X100725 source
Not checked in the free run.
- Interpretationreasoning
Social and economic screening may identify challenges sepsis survivors experience, allowing clinicians to identify resources and referrals that can improve long-term health outcomes.
“Despite these variations, social and economic screening may identify challenges that sepsis survivors are experiencing, allowing clinicians to identify potential resources and referrals, which can assist to improve long-term health outcomes.”
Quote in the paperSubstantial claim- Rests on an assumption: Non-medical social needs and modifiable factors such as economic and social support largely influence health outcomes.
- Rests on an assumption: Long-term health requires survivors to have the resources to recover and thrive.
- Interpretationreasoning
Sepsis education may have a role in timely healthcare seeking behavior in sepsis survivors who experience complications.
“Given the risk of post-sepsis morbidity, sepsis education may have a role in the timely healthcare seeking behavior in sepsis survivors who experience complications.”
Quote in the paperSubstantial claim - Interpretationcitation
With increased recognition of post-intensive care syndrome, peer support represents a patient-centered approach to improve long-term outcomes.
“With increased recognition of post-intensive care syndrome (PICS) in survivors of critical illness and their families, peer support represents a patient-centered approach to improve long-term outcomes [552, 553].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [552] McPeake J, Hirshberg EL, Christie LM et al (2019) Models of peer support to remediate post-intensive care xyndrome: a report developed by the Society of Critical Care Medicine Thrive International Peer Support Collaborative. Crit Care Med 47(1):e21–e27 source
Not checked in the free run.
- cites [553] Mikkelsen ME, Jackson JC, Hopkins RO et al (2016) Peer support as a novel strategy to mitigate post-intensive care syndrome. AACN Adv Crit Care 27(2):221–229 source
Not checked in the free run.
- Interpretationnone given
Shared decision making in discharge planning is more likely to result in decisions consistent with patient and family values and preferences.
“Despite the lack of evidence, SDM in discharge planning as in other care decisions is more likely to result in decisions consistent with the values and preferences of the patient and family.”
Quote in the paperNot a substantial claim- Rests on an assumption: Shared decision making is less routinely used in post-ICU and hospital discharge planning than in other aspects of acute patient care.
- Interpretationnone given
Patient and family involvement in discharge planning may increase family satisfaction.
“Patient and family involvement in discharge planning may also increase family satisfaction.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Improving handoff at transitions in care represents an opportunity to improve patient outcomes across the entire spectrum of sepsis care.
“Improving handoff at transitions in care represents an opportunity to improve patient outcomes across the entire spectrum of sepsis care, from hospitalisation to return to the community.”
Quote in the paperSubstantial claim - Premisenone given
Post-critical illness programmes have been developed as a means of screening for and addressing multi-faceted issues faced by ICU survivors.
“Post-critical illness programmes have been developed as a means of screening for and addressing the multi-faceted issues faced by ICU survivors.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Sepsis patients may be at particular risk for poor outcomes with transitions due to longer hospitalisations and higher comorbidity burden.
“Sepsis patients, with longer than average hospitalisations and higher comorbidity burden, may be at particular risk for poor outcomes with transitions.”
Quote in the paperSubstantial claim - Interpretationcitation
Timely, coordinated resources and provider follow-up may lead to improved quality of life for sepsis survivors.
“Timely, coordinated resources and provider follow-up may lead to improved QoL for sepsis survivors, however further research on the impact of post-discharge follow-up is needed.”
Quote in the paperSubstantial claim - Premisecitation
Hospitalisation and ICU admission are high-risk periods for unintentional medication error, including continuations of temporary medications and discontinuations of chronic medications.
“Hospitalisation and ICU admission are high-risk periods for unintentional medication error—both continuations of medications for temporary indications and unintentional discontinuations of chronic medications [596, 599, 600, 602].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [596] Bell CM, Brener SS, Gunraj N et al (2011) Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 306:840–847 source
Not checked in the free run.
- cites [599] Morandi A, Vasilevskis E, Pandharipande PP et al (2013) Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc 61:1128–1134 source
Not checked in the free run.
- cites [600] Scales DC, Fischer HD, Li P et al (2016) Unintentional continuation of medications intended for acute illness after hospital discharge: A population-based cohort study. J Gen Intern Med 31:196–202 source
Not checked in the free run.
- cites [602] Tomichek JE, Stollings JL, Pandharipande PP et al (2016) Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care 20:378 source
Not checked in the free run.
- Interpretationcitation
Long-term impairments in memory, attention, verbal fluency, decision-making, and executive functioning may be linked to mechanisms such as metabolic derangements, cerebral ischaemia, inflammation, blood-brain barrier disruption, oxidative stress, and microglial activation.
“Long-term impairments in memory, attention, verbal fluency, decision-making and executive functioning may be linked to a variety of mechanisms such as metabolic derangements, cerebral ischaemia, overwhelming inflammation, disrupted blood–brain barrier, oxidative stress, and severe microglial activation, particularly within the limbic system [632].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [632] Annane D, Sharshar T (2015) Cognitive decline after sepsis. Lancet Respir Med 3(1):61–69 source
Not checked in the free run.
- Premisecitation
Physical rehabilitation programmes have benefit in related populations such as older patients with cognitive impairment, patients following stroke or traumatic brain injury.
“Nonetheless, based on their strong rationale, and benefit in related populations [580] (e.g., older patients with cognitive impairment, patients following stroke or traumatic brain injury), we suggest referral to rehabilitation programmes in survivors of sepsis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [580] Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319(1):62–75 source
Not checked in the free run.
- May combine two claims. 234
- The quote only partly states this claim. 6
- Classified as probably not a substantial claim. 64
May combine two claims.
Findingown dataIn identified studies of intravascular device removal, there was no evidence of a difference in mortality, but studies had significant limitations including confounding by indication and imprecision.
“There was no evidence of a difference in mortality, however, the studies were hampered by significant limitations, including risk of confounding by indication (the observational studies) and imprecision (the RCT), which is why the results should be interpreted cautiously.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDe-escalation was associated with shorter hospital length of stay (MD −5.56 days; 95% CI −7.68 to −3.44) but not ICU length of stay (MD −2.6 days; 95% CI −5.91 to 0.72).
“De-escalation was associated with shorter length of stay in the hospital (MD −5.56 days; 95% CI −7.68 to −3.44), but not in the ICU (MD −2.6 days; 95% CI −5.91 to 0.72).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLong-term mortality was evaluated in one study only and did not show a difference (RR 0.99; 95% CI 0.64-1.52).
“Long-term mortality was evaluated in one study only and did not demonstrate a difference (RR 0.99; 95% CI 0.64–1.52).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAntibiotic exposure was consistently lower in patients managed with procalcitonin and clinical evaluation, but in many trials total therapy duration remained 7 days or longer in the intervention group.
“Antibiotic exposure was consistently lower in patients who were managed with procalcitonin and clinical evaluation, however, in many trials the total duration of therapy was still 7 days or longer in the intervention group.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenIncluded gelatin studies are generally small and mostly involve post-operative, non-critically ill patients.
“Included studies are generally small and include mostly post-operative, non-critically ill patients.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn a systematic review of 10 RCTs, vasopressin plus norepinephrine reduced mortality compared with norepinephrine alone but did not reduce need for renal replacement therapy.
“In our systematic review of 10 RCTs, vasopressin with norepinephrine reduced mortality as compared to norepinephrine alone (RR 0.91; 95% CI 0.83–0.99) but did not reduce the need for RRT (RR 0.79; 95% CI 0.57–1.10).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe systematic review found no difference in risks of digital ischaemia or arrhythmias.
“There was no difference in the risks of digital ischaemia (RR 1.01; 95% CI 0.33–9.84) or arrhythmias (RR 0.88; 95% CI 0.63–1.23).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA meta-analysis of terlipressin studies found no difference in mortality but an increase in adverse events.
“Our meta-analysis showed no difference in mortality (terlipressin: 42.9% vs 49.0%; RR 0.89 (95% CI 0.70–1.13); low quality) but an increase in adverse events.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOur analysis of three RCTs (1129 patients) showed no difference in mortality with low Vt ventilation (RR 1.07; 95% CI 0.91-1.26), with a trend towards lower risk of developing ARDs (RR 0.59; 95% CI 0.34-1.02).
“Our analysis of three RCTs (1129 patients) showed no difference in mortality with low Vt ventilation (RR 1.07; 95% CI 0.91–1.26), with a trend towards lower risk of developing ARDs (RR 0.59; 95% CI 0.34–1.02) (Supplementary Appendix 4).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWhen the incremental PEEP recruitment studies are analysed separately from studies utilizing traditional recruitment maneuvers, recruitment with incremental PEEP is associated with increased 28-day mortality (RR 1.12; 95% CI 1.00-1.25), which justifies the strong recommendation against using incremental PEEP titration for recruitment.
“When the incremental PEEP recruitment studies are analysed separately from studies utilizing traditional recruitment maneuvers, recruitment with incremental PEEP is associated with increased 28-day mortality RR 1.12; 95% CI 1.00–1.25), which justifies the strong recommendation against using incremental PEEP titration for recruitment.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationAmong patients with ARDS receiving lower VTs, we did not identify a significant benefit for use of a higher PEEP versus lower PEEP strategy for improving mortality (RR = 0.93; 95% CI 0.83-1.03), days on mechanical ventilation (RR = 0.00; 95% CI −1.02 to 1.02), or ventilator-free days (RR = 1.48; 95% CI 0.19-2.76); and there was no increase in the risk of barotrauma (RR = 1.49; 95% CI 0.99-2.23).
“Among patients with ARDS receiving lower VTs, we did not identify a significant benefit for use of a higher PEEP versus lower PEEP strategy for improving mortality (RR = 0.93; 95% CI 0.83–1.03), days on mechanical ventilation (RR = 0.00; 95% CI −1.02 to 1.02), or ventilator-free days (RR = 1.48; 95% CI 0.19–2.76); and there was no increase in the risk of barotrauma (RR = 1.49; 95% CI 0.99–2.23).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationOverall, continuous NMBA infusion reduced the risk of barotrauma (RR 0.55; 95% CI 0.35-0.85), but the effect on ventilator-free days, duration of mechanical ventilation, and ICU-acquired weakness was unclear.
“Overall, continuous NMBA infusion reduced the risk of barotrauma (RR 0.55; 95% CI 0.35–0.85), but the effect on ventilator-free days, duration of mechanical ventilation, and ICU-acquired weakness was unclear [472, 473].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [472] Alhazzani W, Belley-Cote E, Moller MH, et al (2020) Neuromuscular blockade in patients with ARDS: a rapid practice guideline. Intensive Care Med source
Not checked in the free run.
- cites [473] Tarazan N, Alshehri M, Sharif S et al (2020) Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials. Intensive Care Med Exp 8(1):61 source
Not checked in the free run.
May combine two claims.
FindingcitationA meta-analysis conducted for this guideline revision found an increase in vasopressor-free days (MD 1.5 days; 95% CI 0.8-3.11 days); however, corticosteroid use increased neuromuscular weakness (RR 1.21; 95% CI 1.01-1.45), without a clear effect on short- or long-term mortality.
“A meta-analysis conducted for this guideline revision (Supplementary Appendix 5) found an increase vasopressor-free days (MD 1.5 days; 95% CI 0.8–3.11 days); however, corticosteroid use increased neuromuscular weakness (RR 1.21; 95% CI 1.01–1.45), without a clear effect on short- or long-term mortality.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAn updated meta-analysis of all available RCTs demonstrated a possible reduction in mortality (RR 0.87; 95% CI 0.77-0.98, low quality), however this finding was challenged by sensitivity analyses: after excluding high risk of bias trials the risk ratio is 1.14 (95% CI 0.96-1.36); and after excluding trials published prior to 2010 we observed higher mortality with haemoperfusion (RR 1.23; 95% CI 1.
“An updated meta-analysis of all available RCTs (Supplementary Appendix 5) demonstrated a possible reduction in mortality (RR 0.87; 95% CI 0.77–0.98, low quality), however this finding was challenged by sensitivity analyses: after excluding high risk of bias trials the risk ratio is 1.14 (95% CI 0.96–1.36); and after excluding trials published prior to 2010 we observed higher mortality with haemope”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationThe IDEAL-ICU trial did not report central venous access device (CVAD) infections, and results for this outcome are unchanged from 2016.
“The IDEAL-ICU trial [507] did not report central venous access device (CVAD) infections: the results for this outcome are unchanged from 2016.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [507] Barbar SD, Clere-Jehl R, Bourredjem A et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442 source
Not checked in the free run.
May combine two claims.
FindingcitationThe updated literature search identified no new RCTs but two meta-analyses comparing continuous and intermittent renal replacement therapies.
“Our updated literature search identified no new RCTs but two meta-analysis comparing continuous and intermittent renal replacement therapies [503, 504].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [503] Zha J, Li C, Cheng G et al (2019) The efficacy of renal replacement therapy strategies for septic-acute kidney injury: a PRISMA-compliant network meta-analysis. Medicine (Baltimore) 98(16):e15257 source
Not checked in the free run.
- cites [504] Zhao Y, Chen Y (2020) Effect of renal replacement therapy modalities on renal recovery and mortality for acute kidney injury: A PRISMA-compliant systematic review and meta-analysis. Semin Dial 33(2):127–132 source
Not checked in the free run.
May combine two claims.
FindingcitationNo difference in rates of clinically significant bleeding, mortality, or PE were observed between LMWH and UFH.
“No difference in the rates of clinically significant bleeding, mortality or PE were observed.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
FindingcitationNo significant differences existed between the two insulin initiation blood glucose levels evaluated (> 180 vs > 150 mg/dl).
“No significant differences existed between the two-insulin initiation blood glucose levels evaluated.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe previous meta-analysis demonstrated a significant reduction in both DVT and PE and no increase in bleeding complications with pharmacologic VTE prophylaxis.
“Our previous meta-analysis demonstrated a significant reduction in both DVT and PE and no increase in bleeding complications.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationReductions in ICU and ventilator days in intervention patients who died before hospital discharge were found in two studies, and the third study found overall shorter ICU and hospital stay in the ethics consultation group.
“Reductions in ICU and ventilator days in intervention patients who died before hospital discharge were found in two studies [539, 540], and the third study found overall shorter ICU and hospital stay in the ethics consultation group [541].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [539] Schneiderman LJ, Gilmer T, Teetzel HD (2000) Impact of ethics consultations in the intensive care setting: a randomized, controlled trial. Crit Care Med 28(12):3920–3924 source
Not checked in the free run.
- cites [540] Schneiderman LJ, Gilmer T, Teetzel HD et al (2003) Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA 290(9):1166–1172 source
Not checked in the free run.
- cites [541] Chen C, Michaels J, Meeker MA (2019) Family outcomes and perceptions of end-of-life care in the intensive care unit: a mixed-methods review. J Palliat Care 35(3):143–153. https://doi.org/10.1177/0825859719874767 source
Not checked in the free run.
May combine two claims.
FindingcitationThere are limited available data on undesirable effects of vitamin C; the point estimate of the HR for 90-day mortality in the largest RCT was 1.18 (95% CI 0.69-2.00), favouring the control group.
“There are limited available data of any undesirable effects: it was noted that the point estimate of the HR for 90-day mortality in the largest RCT [524] was 1.18 (95% CI 0.69–2.00) i.e. favouring the control group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [524] Fujii T, Luethi N, Young PJ et al (2020) Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS Randomized Clinical Trial. JAMA 323(5):423–431 source
Not checked in the free run.
May combine two claims.
FindingcitationPalliative care meetings failed to show benefit in decreasing anxiety and depression in surrogate decision makers in the intervention group but did increase post-traumatic stress disorder (PTSD) symptoms.
“Palliative care meetings failed to show benefit in decreasing anxiety and depression in surrogate decision makers in the intervention group but did increase post-traumatic stress disorder (PTSD) symptoms.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [543] Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62 source
Not checked in the free run.
May combine two claims.
Findingnone givenWe identified several studies exploring the use of specific criteria to trigger a goals of care discussion in critically ill patients, though none report the proportion of patients with sepsis or septic shock.
“We identified several studies exploring the use of specific criteria to trigger a goals of care discussion in critically ill patients, though none report the proportion of patients with sepsis or septic shock.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe support intervention did not affect family psychological outcomes but did improve perceived quality of communication and perception of patient- and family-centeredness of care.
“The support intervention did not affect family psychological outcomes but did improve perceived quality of communication and perception of patient- and family-centeredness of care.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [538] White DB, Angus DC, Shields AM et al (2018) A randomized trial of a family-support intervention in intensive care units. N Engl J Med 378(25):2365–2375 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe outcomes of patients with both sepsis and AKI were not reported.
“The outcomes of patients with both sepsis and AKI were not reported.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationPalliative care interventions had no significant impact on family satisfaction, ICU length of stay, hospital length of stay, or mortality.
“Palliative care interventions had no significant impact on family satisfaction with care, ICU length of stay [543, 545–548], hospital length of stay [543, 545, 548], or mortality [543, 545, 548].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [543] Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62 source
Not checked in the free run.
- cites [545] Cheung W, Aggarwal G, Fugaccia E et al (2010) Palliative care teams in the intensive care unit: a randomised, controlled, feasibility study. Crit Care Resusc 12(1):28–35
Not checked in the free run.
- cites [546] Curtis JR, Nielsen EL, Treece PD et al (2011) Effect of a quality-improvement intervention on end-of-life care in the intensive care unit: a randomized trial. Am J Respir Crit Care Med 183(3):348–355 source
Not checked in the free run.
- cites [547] Lautrette A, Darmon M, Megarbane B et al (2007) A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med 356(5):469–478 source
Not checked in the free run.
- cites [548] Ma J, Chi S, Buettner B et al (2019) Early palliative care consultation in the medical ICU: a cluster randomized crossover trial. Crit Care Med 47(12):1707–1715 source
Not checked in the free run.
May combine two claims.
FindingcitationPalliative care interventions have been studied in ICU patients, but not specifically in patients with sepsis.
“Studies have evaluated palliative care interventions in the ICU but not specifically in patients with sepsis [543, 545–548].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [543] Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62 source
Not checked in the free run.
- cites [545] Cheung W, Aggarwal G, Fugaccia E et al (2010) Palliative care teams in the intensive care unit: a randomised, controlled, feasibility study. Crit Care Resusc 12(1):28–35
Not checked in the free run.
- cites [546] Curtis JR, Nielsen EL, Treece PD et al (2011) Effect of a quality-improvement intervention on end-of-life care in the intensive care unit: a randomized trial. Am J Respir Crit Care Med 183(3):348–355 source
Not checked in the free run.
- cites [547] Lautrette A, Darmon M, Megarbane B et al (2007) A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med 356(5):469–478 source
Not checked in the free run.
- cites [548] Ma J, Chi S, Buettner B et al (2019) Early palliative care consultation in the medical ICU: a cluster randomized crossover trial. Crit Care Med 47(12):1707–1715 source
Not checked in the free run.
May combine two claims.
FindingcitationThe early warning system did not impact hospital mortality or hospital length of stay, but did reduce ICU transfers and ICU length of stay and increased documentation of advance directives and resuscitation status compared to the usual care group.
“The early warning system did not impact hospital mortality or hospital length of stay, but did reduce ICU transfers and ICU length of stay and increased documentation of advance directives and resuscitation status compared to the usual care group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [544] Picker D, Dans M, Heard K et al (2017) A randomized trial of palliative care discussions linked to an automated early warning system alert. Crit Care Med 45(2):234–240 source
Not checked in the free run.
May combine two claims.
FindingcitationEthics consultation did not result in a reduction in ICU stay, hospital stay, or life-sustaining treatments in patients who did not survive to discharge.
“Ethics consultation did not result in a reduction in ICU stay, hospital stay, or life-sustaining treatments in patients who did not survive to discharge.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [542] Andereck WS, McGaughey JW, Schneiderman LJ et al (2014) Seeking to reduce nonbeneficial treatment in the ICU: an exploratory trial of proactive ethics intervention. Crit Care Med 42(4):824–830 source
Not checked in the free run.
May combine two claims.
FindingcitationNo benefit was demonstrated on family satisfaction, ICU days, or hospital days.
“No benefit was demonstrated on family satisfaction, ICU days, or hospital days.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [543] Carson SS, Cox CE, Wallenstein S et al (2016) Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial. JAMA 316(1):51–62 source
Not checked in the free run.
May combine two claims.
FindingcitationA reduction in ICU length of stay was noted, yet it is unknown if the reduction is due to increased mortality.
“A reduction in ICU length of stay was noted, yet it is unknown if the reduction is due to increased mortality.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [538] White DB, Angus DC, Shields AM et al (2018) A randomized trial of a family-support intervention in intensive care units. N Engl J Med 378(25):2365–2375 source
Not checked in the free run.
Classified as probably not a substantial claim.
FindingreasoningGenerating a robust evidence base for concrete recommendations about changes in the care paradigm for sepsis survivors has proven extraordinarily difficult.
“However, generating a robust evidence base upon which to make concrete recommendations about changes in the care paradigm has proven to be extraordinarily difficult.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationObservational studies suggest low SES, substance abuse, and poor nutritional status lead to poor outcomes, and critical illness itself results in lower SES post-illness.
“Many observational studies describe the relationship between various socioeconomic supports and patient outcomes that suggest that low SES, substance abuse and poor nutritional status lead to poor outcomes, and that critical illness itself results in lower SES post-illness.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationICU education did not appear to impact patients' anxiety and depression but did improve families' satisfaction with care.
“ICU education did not appear to impact patients’ anxiety and depression [584, 586, 588], but did improve families’ satisfaction with care [583].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [583] Azoulay E, Pochard F, Chevret S et al (2002) Impact of a family information leaflet on effectiveness of information provided to family members of intensive care unit patients: a multicenter, prospective, randomized, controlled trial. Am J Respir Crit Care Med 165(4):438–442 source
Not checked in the free run.
- cites [584] Bench S, Day T, Heelas K et al (2015) Evaluating the feasibility and effectiveness of a critical care discharge information pack for patients and their families: a pilot cluster randomised controlled trial. BMJ Open 5(11):e006852 source
Not checked in the free run.
- cites [586] Fleischer S, Berg A, Behrens J et al (2014) Does an additional structured information program during the intensive care unit stay reduce anxiety in ICU patients?: a multicenter randomized controlled trial. BMC Anesthesiol 14:48 source
Not checked in the free run.
- cites [588] Schmidt K, Worrack S, Von Korff M et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315(24):2703–2711 source
Not checked in the free run.
May combine two claims.
Findingown dataThe majority of handoff studies are observational pre-post studies and report process measures rather than clinical outcomes.
“The majority are observational pre-post studies and report process measures such as completeness and accuracy of communication rather than clinical outcomes.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationIn an international survey of sepsis survivors from 41 countries, 45% reported dissatisfaction with sepsis education at the acute phase and 63% at the post-acute phase.
“In an international survey of sepsis survivors from 41 countries, 45% and 63% reported dissatisfaction with sepsis education at the acute and post-acute phase, respectively [582].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [582] Huang CY, Daniels R, Lembo A et al (2019) Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome. Int J Qual Health Care 31(3):191–198 source
Not checked in the free run.
May combine two claims.
FindingcitationLiving in low-SES neighborhoods is associated with increased risk of sepsis, community-acquired bacteremia, death from bacteremia, and worse outcomes.
“Additionally, living in neighborhoods with low SES is associated with an increased risk of sepsis [575], community-acquired bacteremia [575] and death from bacteremia [576] and worse outcomes [577].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [575] Donnelly JP, Lakkur S, Judd SE et al (2018) Association of neighborhood socioeconomic status with risk of infection and sepsis. Clin Infect Dis 66(12):1940–1947 source
Not checked in the free run.
- cites [576] Koch K, Norgaard M, Schonheyder HC et al (2013) Effect of socioeconomic status on mortality after bacteremia in working-age patients A Danish population-based cohort study. PLoS One 8(7):e70082 source
Not checked in the free run.
- cites [577] Ho KM, Dobb GJ, Knuiman M et al (2008) The effect of socioeconomic status on outcomes for seriously ill patients: a linked data cohort study. Med J Aust 189(1):26–30 source
Not checked in the free run.
May combine two claims.
FindingcitationAlmost 40% of sepsis survivors are re-hospitalised within 3 months, often for preventable conditions, contributing to increased healthcare costs.
“Almost 40% of sepsis survivors are re-hospitalised within 3 months, often for preventable conditions [580], contributing to increased healthcare costs [581].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [580] Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319(1):62–75 source
Not checked in the free run.
- cites [581] Gruther W, Pieber K, Steiner I et al (2017) Can early rehabilitation on the general ward after an intensive care unit stay reduce hospital length of stay in survivors of critical illness?: A randomized controlled trial. Am J Phys Med Rehabil 96(9):607–615 source
Not checked in the free run.
May combine two claims.
FindingcitationFour observational studies examined peer support groups in ICU patients, though they were not specific to sepsis patients.
“Four observational studies examined the impact of peer support groups on ICU patients, though they were not specific to sepsis patients.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [554] Halm MA (1990) Effects of support groups on anxiety of family members during critical illness. Heart Lung 19(1):62–71
Not checked in the free run.
- cites [555] Fridlund B, Stener-Bengtsson A, Wannman AL (1993) Social support and social network after acute myocardial infarction; the critically ill male patient’s needs, choice and motives. Intensive Crit Care Nurs 9(2):88–94 source
Not checked in the free run.
- cites [556] McPeake J, Shaw M, Iwashyna TJ et al (2017) Intensive care syndrome: promoting independence and return to employment (InS:PIRE). Early evaluation of a complex intervention. PLoS One 12(11):e0188028 source
Not checked in the free run.
- cites [557] Sabo KA, Kraay C, Rudy E et al (1989) ICU family support group sessions: family members’ perceived benefits. Appl Nurs Res 2(2):82–89 source
Not checked in the free run.
- cites [558] Parent N, Fortin F (2000) A randomized, controlled trial of vicarious experience through peer support for male first-time cardiac surgery patients: impact on anxiety, self-efficacy expectation, and self-reported activity. Heart Lung 29(6):389–400 source
Not checked in the free run.
May combine two claims.
FindingreasoningOverall evidence for routine formal palliative care interventions in ICU patients is of low quality and shows mixed benefit.
“Overall evidence for routine formal palliative care interventions in ICU patients is of low quality and provides mixed evidence of benefit.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationA family care conference with nursing staff at ICU discharge resulted in lower anxiety scores for family members compared to control, though it is unclear families participated in shared decision making.
“A family care conference with nursing staff at the time of discharge from the ICU resulted in lower anxiety scores for family members compared to a control group although it is not clear that families participated in SDM [592].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [592] Bokinskie JC (1992) Family conferences: a method to diminish transfer anxiety. J Neurosci Nurs 24(3):129–133 source
Not checked in the free run.
May combine two claims.
FindingcitationFamily caregivers of critically ill patients discharged home felt overwhelmed, unprepared, and had difficulty managing expectations.
“Family caregivers of critically ill patients discharged home felt overwhelmed and unprepared and had difficulty managing expectations [593].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [593] Choi J, Lingler JH, Donahoe MP et al (2018) Home discharge following critical illness: a qualitative analysis of family caregiver experience. Heart Lung 47(4):401–407 source
Not checked in the free run.
May combine two claims.
FindingcitationOnly one of the six RCTs specifically studied patients with sepsis, evaluating a complex intervention including education, primary care follow-up, and post-discharge monitoring.
“Only one specifically studied patients with sepsis [588], evaluating a complex intervention, which included education along with primary care follow-up and post-discharge monitoring.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [588] Schmidt K, Worrack S, Von Korff M et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315(24):2703–2711 source
Not checked in the free run.
May combine two claims.
FindingcitationMedication reconciliation has been associated with fewer medication errors and may help reduce hospital readmission.
“Medication reconciliation has been associated with fewer medication errors [598, 612] and may help reduce hospital readmission [613, 614].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [598] Mekonnen AB, McLachlan AJ, Brien JA (2016) Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis. J Clin Pharm Ther 41(2):128–144 source
Not checked in the free run.
- cites [612] Pronovost P, Weast B, Schwarz M et al (2003) Medication reconciliation: a practical tool to reduce the risk of medication errors. J Crit Care 18(4):201–205 source
Not checked in the free run.
- cites [613] Ravn-Nielsen LV, Duckert ML, Lund ML et al (2018) Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med 178(3):375–382 source
Not checked in the free run.
- cites [614] Taylor SP, Chou SH, Sierra MF et al (2020) Association between Adherence to Recommended Care and Outcomes for Adult Survivors of Sepsis. Ann Am Thorac Soc 17(1):89–97 source
Not checked in the free run.
- Rests on an assumption: Medication reconciliation is broadly recognised to be important during patient transitions.
May combine two claims.
FindingcitationHospital readmission within 90 days of discharge occurs in approximately 40% of sepsis survivors and is associated with high costs.
“Hospital readmission within 90 days of discharge occurs in approximately 40% of sepsis survivors and is associated with high costs [624].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [624] Mayr FB, Talisa VB, Balakumar V et al (2017) Proportion and cost of unplanned 30-day readmissions after sepsis compared with other medical conditions. JAMA 317(5):530–531 source
Not checked in the free run.
May combine two claims.
Findingnone givenThere are insufficient data to suggest any specific tool to assess for physical, cognitive, and emotional problems after discharge, and the optimal approach will vary by patient and setting.
“There are insufficient data to suggest any specific tool to assess for these problems, and the optimal approach will vary by patient and setting.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThere were insufficient studies to allow meta-analysis and the limited evidence is of very low quality.
“There were insufficient studies to allow meta-analysis and the limited evidence is of very low quality.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationPost-critical illness programmes are consistently well-liked by patients and offer an environment to learn about challenges sepsis survivors face and to pilot and test interventions for enhancing recovery.
“While efficacy data are equivocal, these programmes are consistently well-liked by patients and offer an environment to learn about challenges sepsis survivors face, as well as to pilot and test interventions for enhancing recovery [637, 643].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [637] Teixeira C, Rosa RG (2018) Post-intensive care outpatient clinic: is it feasible and effective? A literature review. Rev Bras Ter Intensiva 30(1):98–111 source
Not checked in the free run.
- cites [643] Prescott HC, Iwashyna TJ, Blackwood B et al (2019) Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med 200(8):972–981 source
Not checked in the free run.
May combine two claims.
Findingown dataFew randomised studies have assessed post-critical illness clinics, and meta-analysis found no differences from usual care in mortality, quality of life, physical function, or cognition, with possible small improvements in psychological symptoms.
“Few randomised studies have assessed post-critical illness clinics [588, 628, 638, 639], and—consistent with a recent Cochrane review [640]—our meta-analysis found no differences from usual care in terms of mortality, QoL, physical function, or cognition, with possible small improvements in psychological symptoms (anxiety, depression, PTSD).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [588] Schmidt K, Worrack S, Von Korff M et al (2016) Effect of a primary care management intervention on mental health-related quality of life among survivors of sepsis: a randomized clinical trial. JAMA 315(24):2703–2711 source
Not checked in the free run.
- cites [628] Douglas SL, Daly BJ, Kelley CG et al (2007) Chronically critically ill patients: health-related quality of life and resource use after a disease management intervention. Am J Crit Care 16(5):447–457 source
Not checked in the free run.
- cites [638] Cuthbertson BH, Rattray J, Campbell MK et al (2009) The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ 339:b3723 source
Not checked in the free run.
- cites [639] Jensen JF, Egerod I, Bestle MH et al (2016) A recovery program to improve quality of life, sense of coherence and psychological health in ICU survivors: a multicenter randomized controlled trial, the RAPIT study. Intensive Care Med 42(11):1733–1743 source
Not checked in the free run.
- cites [640] Schofield-Robinson OJ, Lewis SR, Smith AF et al (2018) Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors. Cochrane Database Syst Rev 11:CD012701
Not checked in the free run.
May combine two claims.
Findingnone givenNone of the three studies specifically evaluated a sepsis population or reported the proportion of sepsis patients.
“None of the three studies specifically evaluated a sepsis population or reported the proportion of sepsis patients.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationSepsis survivors are at increased risk for recurrent infection, AKI, and new cardiovascular events compared to patients hospitalised for other diagnoses.
“In addition, sepsis survivors are at increased risk for recurrent infection, AKI and new cardiovascular events compared to patients hospitalised for other diagnoses [580].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [580] Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319(1):62–75 source
Not checked in the free run.
May combine two claims.
FindingcitationA prospective cohort study of cognitive training from ICU up to 2 months found overall minimal clinical relevance, with some meaningful results in younger patients but not middle-aged or older patients.
“In addition, a prospective cohort study testing a series of cognitive training sessions starting in the ICU and continued for up to 2 months, found overall minimal clinical relevance as Minimum Clinically Important Difference (MID) of Montreal Cognitive Assessment (MOCA) was small, with some meaningful results in younger patients, but not in the middle-aged or older population [635, 636].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [635] Zhao J, Yao L, Li M et al (2019) Effects of early intervention training on cognitive impairment in critical patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 31(3):298–302
Not checked in the free run.
- cites [636] Wong GKC, Mak JSY, Wong A et al (2017) Minimum clinically important difference of Montreal Cognitive Assessment in aneurysmal subarachnoid hemorrhage patients. J Clin Neurosci 46:41–44 source
Not checked in the free run.
May combine two claims.
FindingcitationA proof-of-concept single-centre pilot study found the multi-faceted early cognitive intervention feasible and safe, but underpowered and inconclusive regarding clinical effects on cognitive function and health-related quality of life at 3 months.
“The results demonstrated that the intervention was feasible and safe, but the study was underpowered and therefore inconclusive regarding its clinical effects on cognitive function and health-related QoL outcomes at 3-month follow-up.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [634] Brummel NE, Girard TD, Ely EW et al (2014) Feasibility and safety of early combined cognitive and physical therapy for critically ill medical and surgical patients: the Activity and Cognitive Therapy in ICU (ACT-ICU) trial. Intensive Care Med 40(3):370–379 source
Not checked in the free run.
May combine two claims.
FindingcitationMeta-analysis suggests critical care transition programmes reduce risk of in-hospital mortality and potentially reduce risk of ICU readmission.
“Meta-analysis of these studies suggests that critical care transition programmes reduce risk of in-hospital mortality and potentially reduce risk of ICU readmission.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThere are a growing number of online resources and informational brochures regarding post intensive care and post-sepsis syndrome.
“There are a growing number of online resources and informational brochures regarding “post intensive care” / “post-sepsis syndrome”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [580] Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319(1):62–75 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationMore studies of post-sepsis follow-up programmes are in process.
“More studies of post-sepsis follow-up programmes are in process [641, 642].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [641] Kowalkowski M, Chou SH, McWilliams A et al (2019) Structured, proactive care coordination versus usual care for Improving Morbidity during Post-Acute Care Transitions for Sepsis (IMPACTS): a pragmatic, randomized controlled trial. Trials 20(1):660 source
Not checked in the free run.
- cites [642] Paratz JD, Kenardy J, Mitchell G et al (2014) IMPOSE (IMProving Outcomes after Sepsis)-the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes-a double-blinded randomised controlled trial: protocol. BMJ Open 4(5):e004966 source
Not checked in the free run.
May combine two claims.
FindingreasoningThe interventions and quality of life measures varied among the three studies, each with severe limitations.
“The interventions and QoL measures varied among the three studies each with severe limitations.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationSepsis survivors are at risk for hospital readmission, which has been associated with increased mortality or discharge to hospice.
“Sepsis survivors are at risk for hospital readmission, which has been associated with increased mortality or discharge to hospice [622, 623].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [622] Dietz BW, Jones TK, Small DS et al (2017) The relationship between index hospitalizations, sepsis, and death or transition to hospice care during 30-day hospital readmissions. Med Care 55(4):362–370 source
Not checked in the free run.
- cites [623] Ortego A, Gaieski DF, Fuchs BD et al (2015) Hospital-based acute care use in survivors of septic shock. Crit Care Med 43(4):729–737 source
Not checked in the free run.
May combine two claims.
FindingcitationPost-critical illness programmes vary in structure and are not consistently available worldwide.
“These programmes vary in their structure, and are not consistently available worldwide [637].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [637] Teixeira C, Rosa RG (2018) Post-intensive care outpatient clinic: is it feasible and effective? A literature review. Rev Bras Ter Intensiva 30(1):98–111 source
Not checked in the free run.
May combine two claims.
Findingnone givenThese physical rehabilitation studies focused on critically ill patients, generally defined by days in ICU or days with mechanical ventilation, and begin on the floor or post-hospital setting.
“These studies focused on critically ill patients, generally defined by days in ICU or days with mechanical ventilation and begin on the floor or post-hospital setting.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationMeta-analysis suggests possible small improvements in quality of life and depressive symptoms from physical rehabilitation, but no difference in mortality, physical function, or anxiety.
“Meta-analysis suggests possible small improvements in QoL and depressive symptoms, but no difference in mortality, physical function, or anxiety.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThis suggestion is consistent with the guidance of several expert panels.
“This suggestion is consistent with the guidance of several expert panels [646, 652, 653].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [646] Connolly B, Thompson A, Douiri A et al (2015) Exercise-based rehabilitation after hospital discharge for survivors of critical illness with intensive care unit-acquired weakness: a pilot feasibility trial. J Crit Care 30(3):589–598 source
Not checked in the free run.
- cites [652] Health NIf, Excellence C (2014) Rehabilitation after critical illness in adults: NICE Reino Unido; 2014. https://www.nice.org.uk/guidance/qs158/resources/rehabilitation-after-critical-illness-in-adults-pdf-75545546693317. Accessed 17 Mar 2021
Not checked in the free run.
- cites [653] Major ME, Kwakman R, Kho ME et al (2016) Surviving critical illness: what is next? An expert consensus statement on physical rehabilitation after hospital discharge. Crit Care 2016 20:354
Not checked in the free run.
May combine two claims.
PremisecitationThe analysis supporting the 3rd International Consensus Conference identified qSOFA as a predictor of poor outcome in patients with known or suspected infection, but no analysis supported its use as a screening tool.
“Data analysis used to support the recommendations of the 3rd International Consensus Conference on the Definitions of Sepsis identified qSOFA as a predictor of poor outcome in patients with known or suspected infection, but no analysis was performed to support its use as a screening tool [5].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Seymour CW, Liu VX, Iwashyna TJ et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):762–774 source
Not checked in the free run.
May combine two claims.
PremisecitationSepsis performance improvement programmes are associated with better adherence to sepsis bundles and reduced mortality in patients with sepsis and septic shock (OR 0.66; 95% CI 0.61-0.72).
“a meta-analysis of 50 observational studies on the effect of performance improvement programmes showed that these programmes were associated with better adherence to sepsis bundles along with a reduction in mortality (OR 0.66; 95% CI 0.61–0.72) in patients with sepsis and septic shock [27].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Damiani E, Donati A, Serafini G et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One 10(5):e0125827 source
Not checked in the free run.
May combine two claims.
PremisecitationSepsis screening tools vary widely in diagnostic accuracy, with most having poor predictive values, although use of some is associated with improvements in care processes.
“There is wide variation in diagnostic accuracy of these tools with most having poor predictive values, although the use of some was associated with improvements in care processes [28–31].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [28] Alberto L, Marshall AP, Walker R et al (2017) Screening for sepsis in general hospitalized patients: a systematic review. J Hosp Infect 96(4):305–315 source
Not checked in the free run.
- cites [29] Bhattacharjee P, Edelson DP, Churpek MM (2017) Identifying patients with sepsis on the hospital wards. Chest 151(4):898–907 source
Not checked in the free run.
- cites [30] Makam AN, Nguyen OK, Auerbach AD (2015) Diagnostic accuracy and effectiveness of automated electronic sepsis alert systems: a systematic review. J Hosp Med 10(6):396–402 source
Not checked in the free run.
- cites [31] Warttig S, Alderson P, Evans DJ et al (2018) Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients. Cochrane Database oSyste Rev. 6(6):CD012404-CD
Not checked in the free run.
May combine two claims.
PremisecitationWhile some tissues such as brain and kidneys auto-regulate blood flow, MAPs below a threshold usually understood as approximately 60 mm Hg are associated with decreased organ perfusion, which tracks linearly with MAP.
“While some tissues, such as the brain and kidneys have the ability to auto-regulate blood flow, MAPs below a threshold, usually understood to be approximately 60 mm Hg, are associated with decreased organ perfusion, which tracks linearly with MAP [79].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] LeDoux D, Astiz ME, Carpati CM et al (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28(8):2729–2732 source
Not checked in the free run.
May combine two claims.
PremisecitationLactate cutoffs for an elevated level ranged from 1.6 to 2.5 mmol/L, with similar diagnostic characteristics regardless of cutoff.
“The lactate cutoffs determining an elevated level ranged from 1.6 to 2.5 mmol/L, although diagnostic characteristics were similar regardless of the cutoff.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [50] Contenti J, Corraze H, Lemoel F et al (2015) Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 33(2):167–172 source
Not checked in the free run.
- cites [51] Karon BS, Tolan NV, Wockenfus AM et al (2017) Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem 50(16–17):956–958 source
Not checked in the free run.
- cites [52] Ljungstrom L, Pernestig AK, Jacobsson G et al (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12(7):e0181704 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a systematic review and meta-analysis, dynamic assessment to guide fluid therapy was associated with reduced mortality (RR 0.59; 95% CI 0.42-0.83), ICU length of stay (MD −1.16 days; 95% CI −1.97 to −0.36), and duration of mechanical ventilation (−2.98 h; 95% CI −5.08 to −0.89).
“In a systematic review and meta-analysis, dynamic assessment to guide fluid therapy was associated with reduced mortality (RR 0.59; 95% CI 0.42–0.83), ICU length of stay (MD −1.16 days; 95% CI −1.97 to −0.36), and duration of mechanical ventilation (−2.98 h; 95% CI −5.08 to −0.89) [3].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Fleischmann-Struzek C, Mellhammar L, Rose N et al (2020) Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 46(8):1552–1562 source
Not checked in the free run.
May combine two claims.
PremisecitationqSOFA is more specific but less sensitive than two of four SIRS criteria for early identification of infection-induced organ dysfunction.
“Studies have shown that qSOFA is more specific but less sensitive than having two of four SIRS criteria for early identification of infection induced organ dysfunction [40–43].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [40] Fernando SM, Tran A, Taljaard M et al (2018) Prognostic accuracy of the quick sequential organ failure assessment for mortality in patients with suspected infection: a systematic review and meta-analysis. Ann Intern Med 168(4):266–275 source
Not checked in the free run.
- cites [41] Herwanto V, Shetty A, Nalos M et al (2019) Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis. Crit Care Explor. 1(9):e0043 source
Not checked in the free run.
- cites [42] Serafim R, Gomes JA, Salluh J et al (2018) A comparison of the Quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest 153(3):646–655 source
Not checked in the free run.
- cites [43] Cinel I, Kasapoglu US, Gul F et al (2020) The initial resuscitation of septic shock. J Crit Care 57:108–117 source
Not checked in the free run.
May combine two claims.
PremisecitationSerum lactate is an important biomarker of tissue hypoxia and dysfunction but is not a direct measure of tissue perfusion.
“Serum lactate is an important biomarker of tissue hypoxia and dysfunction, but is not a direct measure of tissue perfusion [73].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Levy B (2006) Lactate and shock state: the metabolic view. Curr Opin Crit Care 12(4):315–321 source
Not checked in the free run.
May combine two claims.
PremisecitationFailure to receive 30 ml/kg crystalloid within 3 h was associated with delayed resolution of hypotension and increased ICU length of stay.
“failure to receive 30 ml/kg of crystalloid fluid therapy within 3 h of sepsis onset was associated with increased odds of in-hospital mortality, delayed resolution of hypotension and increased length of stay in ICU”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Kuttab HI, Lykins JD, Hughes MD et al (2019) Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med 47(11):1582–1590 source
Not checked in the free run.
May combine two claims.
PremisecitationTemperature of the extremities, skin mottling, and capillary refill time have been validated and shown to be reproducible signs of tissue perfusion.
“Temperature of the extremities, skin mottling and capillary refill time (CRT) have been validated and shown to be reproducible signs of tissue perfusion [76, 77].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [76] Cecconi M, Hernandez G, Dunser M et al (2019) Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force. Intensive Care Med 45(1):21–32 source
Not checked in the free run.
- cites [77] Lara B, Enberg L, Ortega M et al (2017) Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality. PLoS One 12(11):e0188548 source
Not checked in the free run.
May combine two claims.
PremisecitationFor lactate as a sepsis screen, sensitivities range from 66 to 83% and specificities from 80 to 85%.
“Sensitivities range from 66 to 83%, with specificities ranging from 80 to 85%.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [50] Contenti J, Corraze H, Lemoel F et al (2015) Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 33(2):167–172 source
Not checked in the free run.
- cites [51] Karon BS, Tolan NV, Wockenfus AM et al (2017) Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem 50(16–17):956–958 source
Not checked in the free run.
- cites [52] Ljungstrom L, Pernestig AK, Jacobsson G et al (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12(7):e0181704 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the PROCESS, ARISE, and PROMISE trials, the average volume of fluid received pre-randomisation was in the range of 30 ml/kg, suggesting this fluid volume has been adopted in routine clinical practice.
“In the PROCESS [64], ARISE [65] and PROMISE [66] trials, the average volume of fluid received pre-randomisation was also in the range of 30 ml/kg, suggesting that this fluid volume has been adopted in routine clinical practice [67].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Rowan KM, Angus DC, Bailey M et al (2017) Early, goal-directed therapy for septic shock—a patient-level meta-analysis. N Engl J Med 376(23):2223–2234 source
Not checked in the free run.
May combine two claims.
PremisecitationIn ANDROMEDA-SHOCK, 28-day mortality was 34.9% in the peripheral perfusion group and 43.4% in the lactate group, but the difference did not reach statistical significance (HR 0.75; 95% CI 0.55-1.02).
“28-day mortality was 34.9% in the peripheral perfusion group and 43.4% in the lactate group, but this difference did not reach statistical significance (HR 0.75; 95% CI 0.55–1.02).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Hernandez G, Ospina-Tascon GA, Damiani LP et al (2019) Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA 321(7):654–664 source
Not checked in the free run.
May combine two claims.
PremisecitationA recent RCT in patients aged 65 years and older with septic shock compared permissive hypotension (MAP 60-65 mm Hg) with usual care; the intervention group achieved a mean MAP of 66.7 mm Hg versus 72.6 mm Hg in usual care.
“A recent RCT, monitored to ensure protocol and MAP target compliance, compared a “permissive hypotension” (MAP 60–65 mm Hg) group with a “usual care” group that received vasopressors and MAP targets set by the treating physician in patients aged 65 years and older with septic shock [82, 83]. The intervention group in this study achieved a mean MAP of 66.7 mm Hg, compared with 72.6 mm Hg in the”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [82] Lamontagne F, Meade MO, Hebert PC et al (2016) Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42(4):542–550 source
Not checked in the free run.
- cites [83] Lamontagne F, Richards-Belle A, Thomas K et al (2020) Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA 323(10):938–949 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAn elevated lactate level increases and a normal lactate level decreases the likelihood of a final diagnosis of sepsis in patients with suspected sepsis.
“In summary, the presence of an elevated or normal lactate level significantly increases or decreases, respectively, the likelihood of a final diagnosis of sepsis in patients with suspected sepsis.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [50] Contenti J, Corraze H, Lemoel F et al (2015) Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 33(2):167–172 source
Not checked in the free run.
- cites [51] Karon BS, Tolan NV, Wockenfus AM et al (2017) Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients. Clin Biochem 50(16–17):956–958 source
Not checked in the free run.
- cites [52] Ljungstrom L, Pernestig AK, Jacobsson G et al (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12(7):e0181704 source
Not checked in the free run.
May combine two claims.
PremisecitationStudies show an association between point-of-care lactate measurement at presentation and reduced mortality, but results are inconsistent.
“Studies showed an association between the use of point-of-care lactate measurements at presentation and reduced mortality; however, the results are inconsistent [53].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Morris E, McCartney D, Lasserson D et al (2017) Point-of-care lactate testing for sepsis at presentation to health care: a systematic review of patient outcomes. Br J Gen Pract 67(665):e859–e870 source
Not checked in the free run.
May combine two claims.
InterpretationcitationNormal serum lactate levels are not achievable in all patients with septic shock, but studies support resuscitative strategies that decrease lactate toward normal.
“The panel recognises that normal serum lactate levels are not achievable in all patients with septic shock, but these studies support resuscitative strategies that decrease lactate toward normal.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [74] Gu WJ, Zhang Z, Bakker J (2015) Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41(10):1862–1863 source
Not checked in the free run.
- cites [75] Simpson SQ, Gaines M, Hussein Y et al (2016) Early goal-directed therapy for severe sepsis and septic shock: a living systematic review. J Crit Care 36:43–48 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the original qSOFA derivation study, only 24% of infected patients had a qSOFA score of 2 or 3, but these patients accounted for 70% of poor outcomes.
“In the original derivation study, authors found that only 24% of infected patients had a qSOFA score 2 or 3, but these patients accounted for 70% of poor outcomes [5].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Seymour CW, Liu VX, Iwashyna TJ et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):762–774 source
Not checked in the free run.
May combine two claims.
InterpretationcitationNeither SIRS nor qSOFA are ideal sepsis screening tools.
“Neither SIRS nor qSOFA are ideal screening tools for sepsis and the bedside clinician needs to understand the limitations of each.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [40] Fernando SM, Tran A, Taljaard M et al (2018) Prognostic accuracy of the quick sequential organ failure assessment for mortality in patients with suspected infection: a systematic review and meta-analysis. Ann Intern Med 168(4):266–275 source
Not checked in the free run.
- cites [41] Herwanto V, Shetty A, Nalos M et al (2019) Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis. Crit Care Explor. 1(9):e0043 source
Not checked in the free run.
- cites [42] Serafim R, Gomes JA, Salluh J et al (2018) A comparison of the Quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest 153(3):646–655 source
Not checked in the free run.
- cites [43] Cinel I, Kasapoglu US, Gul F et al (2020) The initial resuscitation of septic shock. J Crit Care 57:108–117 source
Not checked in the free run.
May combine two claims.
PremisecitationA study of 12,380 ward patients in 48 UK hospitals showed that delayed admission to ICU led to higher 90-day mortality and further physiological deterioration.
“Similarly, another study of 12,380 ward patients in 48 UK hospitals showed that [88] delayed admission to ICU led to higher 90-day mortality and further physiological deterioration.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Harris S, Singer M, Sanderson C et al (2018) Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain. Intensive Care Med 44(5):606–615 source
Not checked in the free run.
May combine two claims.
PremisecitationThere is evidence of improved patient satisfaction, increased patient safety, better patient flow, and improved staff morale with timely ICU admission.
“There is also evidence of improved patient satisfaction, increased patient safety, better patient flow and improved staff morale [89].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Montgomery A, Panagopoulou E, Kehoe I et al (2011) Connecting organisational culture and quality of care in the hospital: is job burnout the missing link? J Health Organ Manag 25(1):108–123 source
Not checked in the free run.
May combine two claims.
PremisecitationProcalcitonin is undetectable in healthy states but rises rapidly in response to pro-inflammatory stimuli, especially bacterial infections.
“Procalcitonin is undetectable in healthy states, but rises rapidly in response to pro-inflammatory stimuli, especially bacterial infections [127].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [127] Peng F, Chang W, Xie JF et al (2019) Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: a meta-analysis. Int J Infect Dis 85:158–166 source
Not checked in the free run.
May combine two claims.
PremisecitationAll the aforementioned studies on antimicrobial timing were observational analyses and hence at risk of bias due to insufficient sample size, inadequate risk-adjustment, blending together effects of large delays with short delays, or other study design issues.
“It should be noted that all the aforementioned studies were observational analyses and hence at risk of bias due to insufficient sample size, inadequate risk-adjustment, blending together the effects of large delays until antibiotics with short delays, or other study design issues [118].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] Weinberger J, Rhee C, Klompas M (2020) A critical analysis of the literature on time-to-antibiotics in suspected sepsis. J Infect Dis 222(Supplement_2):S110–S118 source
Not checked in the free run.
May combine two claims.
PremisecitationDelayed admissions of critically ill patients from the emergency department are associated with decreased sepsis bundle compliance and increased mortality, ventilator duration, and ICU and hospital length of stay.
“Delayed admissions of critically ill patients from ED are associated with decreased sepsis bundle compliance and increased mortality, ventilator duration, and ICU and hospital length of stay [84].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [84] Mohr NM, Wessman BT, Bassin B et al (2020) Boarding of critically ill patients in the emergency department. Crit Care Med 48(8):1180–1187 source
Not checked in the free run.
May combine two claims.
PremisecitationThe signs and symptoms of sepsis are nonspecific and often mimic multiple other diseases.
“The signs and symptoms of sepsis are nonspecific and often mimic multiple other diseases [90–92].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [90] Klein Klouwenberg PM, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319 source
Not checked in the free run.
- cites [91] Levin PD, Idrees S, Sprung CL et al (2012) Antimicrobial use in the ICU: indications and accuracy—an observational trial. J Hosp Med 7(9):672–678 source
Not checked in the free run.
- cites [92] Minderhoud TC, Spruyt C, Huisman S et al (2017) Microbiological outcomes and antibiotic overuse in Emergency Department patients with suspected sepsis. Neth J Med 75(5):196–203
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationIn a study of 10,811 patients treated in four Utah hospitals, each hour delay from ED arrival to antimicrobial administration was associated with 1.16 increased odds of in-hospital mortality and 1.10 increased odds of 1-year mortality (1.13 in patients with hypotension vs 1.09 in patients without hypotension).
“Finally, in a study of 10,811 patients treated in four Utah hospitals, each hour delay in time from ED arrival to administration of antimicrobials was associated with 1.16 increased odds of in-hospital and 1.10 increased odds of 1-year mortality (1.13 in patients with”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [111] Peltan ID, Brown SM, Bledsoe JR et al (2019) ED door-to-antibiotic time and long-term mortality in sepsis. Chest 155(5):938–946 source
Not checked in the free run.
May combine two claims.
PremisecitationPotential harms of unnecessary antimicrobials include allergic or hypersensitivity reactions, kidney injury, thrombocytopenia, Clostridioides difficile infection, and antimicrobial resistance.
“These include a range of adverse events such as allergic or hypersensitivity reactions, kidney injury, thrombocytopenia, Clostridioides difficile infection, and antimicrobial resistance [101–106].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [101] Baggs J, Jernigan JA, Halpin AL et al (2018) Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure. Clin Infect Dis 66(7):1004–1012 source
Not checked in the free run.
- cites [102] Branch-Elliman W, O’Brien W, Strymish J et al (2019) Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg 154(7):590–598 source
Not checked in the free run.
- cites [103] Hranjec T, Rosenberger LH, Swenson B et al (2012) Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 12(10):774–780 source
Not checked in the free run.
- cites [104] Ong DSY, Frencken JF, Klein Klouwenberg PMC et al (2017) Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: a prospective observational cohort study. Clin Infect Dis 64(12):1731–1736 source
Not checked in the free run.
- cites [105] Tamma PD, Avdic E, Li DX et al (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177(9):1308–1315 source
Not checked in the free run.
- cites [106] Teshome BF, Vouri SM, Hampton N et al (2019) Duration of exposure to antipseudomonal beta-lactam antibiotics in the critically ill and development of new resistance. Pharmacotherapy 39(3):261–270 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe imperative to provide antimicrobials as early as possible must be balanced against potential harms associated with administering unnecessary antimicrobials to patients without infection.
“The imperative to provide antimicrobials as early as possible, however, must be balanced against the potential harms associated with administering unnecessary antimicrobials to patients without infection [99, 100].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [99] Klompas M, Calandra T, Singer M (2018) Antibiotics for sepsis-finding the equilibrium. JAMA 320(14):1433–1434 source
Not checked in the free run.
- cites [100] Prescott HC, Iwashyna TJ (2019) Improving sepsis treatment by embracing diagnostic uncertainty. Ann Am Thorac Soc 16(4):426–429 source
Not checked in the free run.
May combine two claims.
PremisecitationAccurately diagnosing sepsis is challenging because sepsis can present subtly, and some presentations that first appear to be sepsis turn out to be non-infectious conditions.
“Accurately diagnosing sepsis is challenging as sepsis can present in subtle ways, and some presentations that first appear to be sepsis turn out to be non-infectious conditions [90, 93, 107, 108].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [90] Klein Klouwenberg PM, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319 source
Not checked in the free run.
- cites [93] Heffner AC, Horton JM, Marchick MR et al (2010) Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 50(6):814–820 source
Not checked in the free run.
- cites [107] Contou D, Roux D, Jochmans S et al (2016) Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study. Crit Care 20(1):360 source
Not checked in the free run.
- cites [108] Rhee C, Kadri SS, Danner RL et al (2016) Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care 20:89 source
Not checked in the free run.
May combine two claims.
PremisecitationAmong hospital survivors in that study, the delayed admission group had a longer hospital stay, higher mortality, and higher rates of mechanical ventilation and central venous catheterisation.
“Among hospital survivors, the delayed admission group had a longer hospital stay, higher mortality, and higher rates of mechanical ventilation and central venous catherisation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Chalfin DB, Trzeciak S, Likourezos A et al (2007) Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med 35(6):1477–1483 source
Not checked in the free run.
May combine two claims.
PremisecitationThe mortality reduction associated with early antimicrobials appears strongest in patients with septic shock, with weaker associations in patients without septic shock.
“The mortality reduction associated with early antimicrobials appears strongest in patients with septic shock, where a number of studies have reported a strong association between time-to-antibiotics and death in patients with septic shock but weaker associations in patients without septic shock [98, 109, 110].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [98] Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244 source
Not checked in the free run.
- cites [109] Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596 source
Not checked in the free run.
- cites [110] Liu VX, Fielding-Singh V, Greene JD et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196(7):856–863 source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationIn a study of 35,000 patients at Kaiser Permanente Northern California, each additional hour from ER arrival to antimicrobial administration was associated with 1.09 increased odds of in-hospital mortality (1.07 for severe sepsis and 1.14 for septic shock), equating to a 0.4% absolute mortality increase for severe sepsis and 1.8% for septic shock.
“In a study of 35,000 patients treated at Kaiser Permanente Northern California, each additional hour of time from ER arrival to administration of antimicrobials was associated with 1.09 increased odds of in-hospital mortality (1.07 for patients with “severe” sepsis (lactate ≥ 2, at least one episode of hypotension, required non-invasive or invasive mechanical ventilation or has organ dysfunction)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Liu VX, Fielding-Singh V, Greene JD et al (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 196(7):856–863 source
Not checked in the free run.
May combine two claims.
PremisecitationIn a study of 49,331 patients treated at 149 New York hospitals, each additional hour from ED arrival to antimicrobial administration was associated with 1.04 increased odds of in-hospital mortality (p < 0.001), with 1.07 for patients receiving vasopressors and 1.01 for patients not on vasopressors.
“In a study of 49,331 patients treated at 149 New York hospitals, each additional hour of time from ED arrival to administration of antimicrobials was associated with 1.04 increased odds of in-hospital mortality, p < 0.001 (1.07 (95% CI 1.05–1.09) for patients receiving vasopressors vs. 1.01 (95% CI 0.99–1.04) for patients not on vasopressors) [98].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [98] Seymour CW, Gesten F, Prescott HC et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244 source
Not checked in the free run.
May combine two claims.
PremisecitationLimited data from resource-limited settings suggest that timely administration of antimicrobials in patients with sepsis and septic shock is beneficial and potentially feasible.
“Limited data from resource-limited settings suggest that timely administration of antimicrobials in patients with sepsis and septic shock is beneficial and potentially feasible [121–126].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [121] Chalya PL, Mabula JB, Koy M et al (2012) Typhoid intestinal perforations at a University teaching hospital in Northwestern Tanzania: a surgical experience of 104 cases in a resource-limited setting. World J Emerg Surg 7:4 source
Not checked in the free run.
- cites [122] Phua J, Koh Y, Du B et al (2011) Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ 342:d3245 source
Not checked in the free run.
- cites [123] Thwaites CL, Lundeg G, Dondorp AM et al (2016) Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive Care Med 42(12):2040–2042 source
Not checked in the free run.
- cites [124] Urayeneza O, Mujyarugamba P, Rukemba Z et al (2018) Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, Rwanda. Crit Care Med 46(8):1357–1366 source
Not checked in the free run.
- cites [125] Urayeneza O, Mujyarugamba P, Rukemba Z et al (2018) Increasing evidence-based interventions in patients with acute infections in a resource-limited setting: a before-and-after feasibility trial in Gitwe, Rwanda. Intensive Care Med 44(9):1436–1446 source
Not checked in the free run.
- cites [126] Yokota PK, Marra AR, Martino MD et al (2014) Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock—a quality improvement study. PLoS One 9(11):e104475 source
Not checked in the free run.
May combine two claims.
InterpretationcitationIn patients at low risk for MDR organisms, there are no apparent benefits of using two gram-negative agents and there is risk of antimicrobial-associated undesirable effects including direct toxicity, C. difficile infection, and development of antibiotic resistance.
“while in patients with a low risk for MDR organisms, we suggest using a single agents for empiric treatment, as there are no apparent benefits of using two agents and the a risk of antimicrobial-associated undesirable effects, including direct toxicity, Clostridioides difficile infection and development of antibiotic resistance [165].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [165] Arulkumaran N, Routledge M, Schlebusch S et al (2020) Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 46(2):225–235 source
Not checked in the free run.
May combine two claims.
PremisecitationThe desirable effects of empiric antiviral therapy are unknown, and there is a risk of undesirable effects.
“The desirable effects of empiric antiviral therapy are unknown, and as for other antimicrobial agents there is a risk of undesirable effects [165].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [165] Arulkumaran N, Routledge M, Schlebusch S et al (2020) Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 46(2):225–235 source
Not checked in the free run.
- Rests on an assumption: Effective therapies are lacking for most zoonotic viruses that can manifest with clinical signs of sepsis.
May combine two claims.
PremisecitationIn documented MRSA infections, delays of more than 24-48 hours before antibiotic administration are associated with increased mortality in some studies but not in others.
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [143] Gasch O, Camoez M, Dominguez MA et al (2013) Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 68(6):1423–1430 source
Not checked in the free run.
- cites [144] Gasch O, Camoez M, Dominguez MA et al (2013) Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. Clin Microbiol Infect 19(11):1049–1057 source
Not checked in the free run.
- cites [145] Lodise TP, McKinnon PS, Swiderski L et al (2003) Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36(11):1418–1423 source
Not checked in the free run.
- cites [146] Paul M, Kariv G, Goldberg E et al (2010) Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 65(12):2658–2665 source
Not checked in the free run.
- cites [147] Schramm GE, Johnson JA, Doherty JA et al (2006) Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med 34(8):2069–2074 source
Not checked in the free run.
- cites [148] Fang CT, Shau WY, Hsueh PR et al (2006) Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. J Antimicrob Chemother 57(3):511–519 source
Not checked in the free run.
- cites [149] Gomez J, Garcia-Vazquez E, Banos R et al (2007) Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 26(4):239–245 source
Not checked in the free run.
- cites [150] Griffin AT, Peyrani P, Wiemken TL et al (2013) Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia. Infection 41(2):517–523 source
Not checked in the free run.
- cites [151] Kett DH, Cano E, Quartin AA et al (2011) Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 11(3):181–189 source
Not checked in the free run.
- cites [152] Khatib R, Saeed S, Sharma M et al (2006) Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 25(3):181–185 source
Not checked in the free run.
May combine two claims.
PremisecitationImmunocompromised patients, including those with neutropenia, HIV, haematological malignancies, stem cell or solid organ transplants, are particularly vulnerable to viral infections, and certain viruses can cause severe disease.
“Immunocompromised patients are particularly vulnerable to viral infections, including patients with neutropenia, human immunodeficiency virus (HIV) infection, haematological malignancies and haematopoietic stem cell transplantation or solid organ transplants”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [229] Lin GL, McGinley JP, Drysdale SB et al (2018) Epidemiology and immune pathogenesis of viral sepsis. Front Immunol 9:2147 source
Not checked in the free run.
May combine two claims.
PremisecitationPatient-related risk factors for MRSA include prior MRSA infection or colonisation, recent IV antibiotics, recurrent skin infections or chronic wounds, invasive devices, haemodialysis, recent hospital admissions, and severity of illness.
“Patient-related risk factors for MRSA include prior history of MRSA infection or colonisation, recent IV antibiotics, history of recurrent skin infections or chronic wounds, presence of invasive devices, haemodialysis, recent hospital admissions and severity of illness [136, 138–142].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [136] Aliberti S, Reyes LF, Faverio P et al (2016) Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 16(12):1364–1376 source
Not checked in the free run.
- cites [138] Callejo-Torre F, Eiros Bouza JM, Olaechea Astigarraga P et al (2016) Risk factors for methicillin-resistant Staphylococcus aureus colonisation or infection in intensive care units and their reliability for predicting MRSA on ICU admission. Infez Med 24(3):201–209
Not checked in the free run.
- cites [139] Epstein L, Mu Y, Belflower R et al (2016) Risk factors for invasive methicillin-resistant Staphylococcus aureus infection after recent discharge from an acute-care hospitalization, 2011–2013. Clin Infect Dis 62(1):45–52 source
Not checked in the free run.
- cites [140] Shorr AF, Myers DE, Huang DB et al (2013) A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis 13:268 source
Not checked in the free run.
- cites [141] Torre-Cisneros J, Natera C, Mesa F et al (2018) Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study. Eur J Clin Microbiol Infect Dis 37(1):51–56 source
Not checked in the free run.
- cites [142] Wooten DA, Winston LG (2013) Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia. Respir Med 107(8):1266–1270 source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningThe decision to start empiric antifungal therapy depends on the type and number of risk factors and local epidemiology of fungal infections.
“Importantly, the decision to start empiric antifungal therapy depends on the type and number of risk factors, along with the local epidemiology of fungal infections.”
Quote in the paperSubstantial claim- Rests on an assumption: The risk of Candida sepsis or septic shock in immunosuppressed populations other than febrile neutropenia is highly disease- and therapy-specific.
May combine two claims.
PremisecitationSome observational studies suggested prompt appropriate empiric antifungal therapy may be associated with reduced mortality, but these do not prove causality or clarify timing, and other studies failed to show the association.
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [167] Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54(12):1739–1746 source
Not checked in the free run.
- cites [171] Garey KW, Rege M, Pai MP et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43(1):25–31 source
Not checked in the free run.
- cites [172] Marriott DJ, Playford EG, Chen S et al (2009) Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13(4):R115 source
Not checked in the free run.
- cites [173] Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49(9):3640–3645 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningFailure to cover MRSA in a patient with MRSA may be harmful, and unnecessary MRSA coverage in a patient without MRSA may also be harmful.
“Failure to cover for MRSA in a patient with MRSA may be harmful, but unnecessary MRSA coverage in a patient without MRSA may also be harmful.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSepsis and septic shock due to fungi are most commonly observed in ICUs and are associated with poor outcomes.
“Sepsis and septic shock due to fungi are most commonly observed in ICUs and are associated with poor outcomes [166–170].”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [166] Bassetti M, Righi E, Ansaldi F et al (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40(6):839–845 source
Not checked in the free run.
- cites [167] Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54(12):1739–1746 source
Not checked in the free run.
- cites [168] Magill SS, Edwards JR, Bamberg W et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208 source
Not checked in the free run.
- cites [169] Mean M, Marchetti O, Calandra T (2008) Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 12(1):204 source
Not checked in the free run.
- cites [170] Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1-50 source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningEmpiric double coverage of gram-negative bacilli is most important in patients at high risk for resistant organisms with severe illness, particularly septic shock.
“Empiric double coverage of gram-negative bacilli is most important in patients at high risk for resistant organisms with severe illness, particularly septic shock.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationFactors guiding double gram-negative coverage include proven infection or colonisation with resistant organisms in the prior year, local prevalence, hospital-acquired/healthcare-associated infection, broad-spectrum antibiotics in prior 90 days, concurrent SDD, travel to a highly endemic country in prior 90 days, and hospitalisation abroad in prior 90 days.
“Factors to guide this decision include: proven infection or colonisation with antibiotic-resistant organisms within the preceding year, local prevalence of antibiotic-resistant organisms, hospital-acquired/healthcare associated (versus community-acquired infection), broad-spectrum antibiotic use within the preceding 90 days”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [162] Alevizakos M, Karanika S, Detsis M et al (2016) Colonisation with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 48(6):647–654 source
Not checked in the free run.
- cites [163] Rottier WC, Bamberg YR, Dorigo-Zetsma JW et al (2015) Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis 60(11):1622–1630 source
Not checked in the free run.
- cites [164] Rottier WC, van Werkhoven CH, Bamberg YRP et al (2018) Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study. Clin Microbiol Infect 24(12):1315–1321 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMRSA incidence may be decreasing according to some reports.
“and may be decreasing according to some reports [134, 135]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [134] Jernigan JA, Hatfield KM, Wolford H et al (2020) Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012–2017. N Engl J Med 382(14):1309–1319 source
Not checked in the free run.
- cites [135] Jones M, Jernigan JA, Evans ME et al (2019) Vital Signs: trends in Staphylococcus aureus infections in veterans affairs medical centers—United States, 2005–2017. MMWR Morb Mortal Wkly Rep 68(9):220–224 source
Not checked in the free run.
May combine two claims.
PremisecitationMRSA incidence varies by region, from about 2% in Western Europe to 10% in North America, and by patient-related characteristics.
“The incidence of MRSA varies, however, by region (ranging from ~ 2% in Western Europe to 10% in North America) and by patient-related characteristics [133, 136, 137].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [133] Vincent JL, Sakr Y, Singer M, et al (2020) Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA 323(15):1478–1487 source
Not checked in the free run.
- cites [136] Aliberti S, Reyes LF, Faverio P et al (2016) Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 16(12):1364–1376 source
Not checked in the free run.
- cites [137] Rhee C, Kadri SS, Dekker JP et al (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3(4):e202899 source
Not checked in the free run.
May combine two claims.
PremisecitationThere appears to be no overall effect of neuraminidase inhibitors on mortality in patients with influenza-related pneumonia, but there may be an effect when administered early.
“While there appears to be no overall effect of neuraminidase inhibitors on mortality in patients with influenza-related pneumonia, there may be an effect when administered early in the course of the disease [225].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [225] Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2(5):395–404 source
Not checked in the free run.
May combine two claims.
Premiseown dataLong-term mortality, readmission rates, and hospital-free days were not reported in any of the procalcitonin trials, and no relevant studies on costs were found.
“Long-term mortality, readmission rates and hospital-free days were not reported in any of the trials, and no relevant studies on the costs associated with use of procalcitonin were found.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [129] Jensen JU, Hein L, Lundgren B et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39(9):2048–2058 source
Not checked in the free run.
- cites [130] Layios N, Lambermont B, Canivet JL et al (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40(8):2304–2309 source
Not checked in the free run.
- cites [131] Najafi A, Khodadadian A, Sanatkar M et al (2015) The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran 53(9):562–567
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationApplying a PK/PD approach to antibiotic dosing requires support from knowledgeable clinicians, a population-specific guideline, therapeutic drug monitoring, and/or dosing software.
“Applying a PK/PD approach to antibiotic dosing requires support from knowledgeable clinician team members [254], use of a patient population-specific guideline document [255], use of therapeutic drug monitoring [256], and/or use of dosing software [238, 248].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [254] Fleuren LM, Roggeveen LF, Guo T et al (2019) Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study. Crit Care 23(1):185 source
Not checked in the free run.
- cites [255] Ehmann L, Zoller M, Minichmayr IK et al (2019) Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis. Int J Antimicrob Agents 54(3):309–317 source
Not checked in the free run.
- cites [256] Wong G, Briscoe S, McWhinney B et al (2018) Therapeutic drug monitoring of beta-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. J Antimicrob Chemother 73(11):3087–3094 source
Not checked in the free run.
May combine two claims.
PremisecitationSmaller studies suggest that source control within 6-12 hours is advantageous, and studies generally show reduced survival beyond that point.
“smaller studies suggest that source control within 6–12 h is advantageous [265–271]. Studies generally show reduced survival beyond that point.”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [265] Azuhata T, Kinoshita K, Kawano D et al (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18(3):R87 source
Not checked in the free run.
- cites [266] Bloos F, Thomas-Ruddel D, Ruddel H et al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18(2):R42 source
Not checked in the free run.
- cites [267] Buck DL, Vester-Andersen M, Moller MH (2013) Surgical delay is a critical determinant of survival in perforated peptic ulcer. Br J Surg 100(8):1045–1049 source
Not checked in the free run.
- cites [268] Chao WN, Tsai CF, Chang HR et al (2013) Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg 206(1):32–39 source
Not checked in the free run.
- cites [269] Karvellas CJ, Abraldes JG, Zepeda-Gomez S et al (2016) The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol Ther 44(7):755–766 source
Not checked in the free run.
- cites [270] Moss RL, Musemeche CA, Kosloske AM (1996) Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 31(8):1142–1146 source
Not checked in the free run.
- cites [271] Wong CH, Chang HC, Pasupathy S et al (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85(8):1454–1460 source
Not checked in the free run.
May combine two claims.
PremisecitationAntibiotics undergo changes in PK/PD parameters in sepsis and septic shock, with concentrations that may be too low risking clinical failure or too high causing toxicity.
“Antibiotics are subject to changes in PK/PD parameters in sepsis and septic shock where resultant concentrations may be too low risking clinical failure, or too high leading to toxicity (Table 3) [237–239].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [237] Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14(6):498–509 source
Not checked in the free run.
- cites [238] Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072–1083 source
Not checked in the free run.
- cites [239] Veiga RP, Paiva JA (2018) Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Crit Care 22(1):233 source
Not checked in the free run.
May combine two claims.
PremisecitationExtended and continuous infusions occupy a venous catheter/lumen more than intermittent infusion, and drug-stability and drug-drug compatibility considerations are important for effectiveness.
“Over the course of therapy, both extended and continuous infusions will occupy a venous catheter/lumen more than an intermittent infusion and drug-stability and drug-drug compatibility considerations are important to ensure effectiveness of antibiotic and other IV drug therapies [235].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [235] Roberts JA, Paratz J, Paratz E et al (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30(1):11–18 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIt is possible that reducing duration of unnecessary therapy accounts for at least part of the benefit of specialist consultation.
“However, it is also possible that reducing the duration of unnecessary therapy may account for at least part of the benefit.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn many RCTs of shorter versus longer antimicrobial courses for specific conditions, the shorter course was as effective as the longer course but associated with fewer adverse consequences.
“In many of the trials, the shorter course was just as effective as the longer course but associated with fewer adverse consequences.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [286] Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(19):2588–2598 source
Not checked in the free run.
- cites [287] Choudhury G, Mandal P, Singanayagam A et al (2011) Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis. Clin Microbiol Infect 17(12):1852–1858 source
Not checked in the free run.
- cites [288] Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61–e111 source
Not checked in the free run.
- cites [289] Vaughn VM, Flanders SA, Snyder A et al (2019) Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study. Ann Intern Med 171(3):153–163 source
Not checked in the free run.
- cites [290] Eliakim-Raz N, Yahav D, Paul M et al (2013) Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection—7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 68(10):2183–2191 source
Not checked in the free run.
- cites [291] Runyon BA, McHutchison JG, Antillon MR et al (1991) Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100(6):1737–1742 source
Not checked in the free run.
- cites [292] Yahav D, Franceschini E, Koppel F et al (2019) Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled Trial. Clin Infect Dis 69(7):1091–1098 source
Not checked in the free run.
- cites [293] Sawyer RG, Claridge JA, Nathens AB et al (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372(21):1996–2005 source
Not checked in the free run.
May combine two claims.
Study design and conductcitationMost studies of de-escalation were observational, and concerns exist that de-escalation is used primarily in patients who are improving, so the improved short-term mortality should be interpreted cautiously.
“Most studies were observational, and there are concerns that de-escalation is used primarily in patients who are getting better, which is why the reported improved short-term mortality should be interpreted with caution [277, 279].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [277] Tabah A, Bassetti M, Kollef MH et al (2020) Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 46(2):245–265 source
Not checked in the free run.
- cites [279] Tabah A, Cotta MO, Garnacho-Montero J et al (2016) A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 62(8):1009–1017 source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe reduction in short-term mortality from prolonged beta-lactam infusion is significant, the intervention is feasible with negligible cost implications, and no data suggest inferior outcomes.
“The reduction in short-term mortality from prolonged infusion of beta-lactams is significant with the intervention being feasible with negligible cost implications and no data suggesting inferior outcomes with prolonged infusion.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDe-escalation is generally safe, may offer cost savings, and may reduce antimicrobial resistance, toxicity, and side-effects.
“De-escalation is in generally safe, may offer cost savings when unnecessary antibiotics are discontinued, and reduced risk of antimicrobial resistance and reduced toxicity and side-effects may be important [280].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [280] De Bus L, Depuydt P, Steen J, et al (2020) Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study. Intensive Care Med 46(7):1404–1417 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationRestricting antimicrobial therapy to the shortest course associated with better outcomes is an important part of antimicrobial stewardship.
“Restricting antimicrobial therapy to the shortest course associated with better outcomes is an important part of antimicrobial stewardship [281–285].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [281] Fernandez-Lazaro CI, Brown KA, Langford BJ et al (2019) Late-career physicians prescribe longer courses of antibiotics. Clin Infect Dis 69(9):1467–1475 source
Not checked in the free run.
- cites [282] Hanretty AM, Gallagher JC (2018) Shortened courses of antibiotics for bacterial infections: a systematic review of randomized controlled trials. Pharmacotherapy 38(6):674–687 source
Not checked in the free run.
- cites [283] Royer S, DeMerle KM, Dickson RP et al (2018) shorter versus longer courses of antibiotics for infection in hospitalized patients: a systematic review and meta-analysis. J Hosp Med 13(5):336–342 source
Not checked in the free run.
- cites [284] Spellberg B (2016) The new antibiotic mantra-"Shorter Is Better". JAMA Intern Med 176(9):1254–1255 source
Not checked in the free run.
- cites [285] Wald-Dickler N, Spellberg B (2019) Short-course antibiotic therapy-replacing constantine units with “Shorter Is Better.” Clin Infect Dis 69(9):1476–1479 source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenVery few trials focused exclusively on critically ill patients with sepsis or septic shock, and the overall quality of evidence was very low.
“Very few trials, however, focussed exclusively on critically ill patients with sepsis or septic shock, and the overall quality of evidence was very low.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningCatheter removal with adequate antimicrobial therapy is definitive and preferred in most cases.
“However, catheter removal with adequate antimicrobial therapy is definitive and is the preferred treatment in most cases.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAntimicrobial exposure is linked to development of antimicrobial resistance, and reducing the number and spectrum of antibiotics is an important strategy in sepsis and septic shock.
“Antimicrobial exposure is linked to the development of antimicrobial resistance and efforts to reduce both the number of antibiotics administered and their spectrum of therapy are therefore important strategies in patients with sepsis and septic shock [165].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [165] Arulkumaran N, Routledge M, Schlebusch S et al (2020) Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 46(2):225–235 source
Not checked in the free run.
May combine two claims.
Study design and conductown dataAlgorithms for antimicrobial therapy, frequency of procalcitonin monitoring, and thresholds for discontinuation differed across trials.
“Also, the algorithms for antimicrobial therapy, frequency of procalcitonin monitoring and the thresholds (or percentage change in procalcitonin concentration) for discontinuation differed across the trials.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe SMART trial had limitations including single-centre design, no individual patient randomisation, no blinded assignment, moderate fluid volume, sepsis subgroup identification by ICD-10 codes, and a composite outcome that may not be patient-centered.
“The SMART trial was a single-centre study without individual patient randomisation and no blinded assignment of the intervention, it exposed participants to moderate amount of fluid volume, identification of sepsis subgroups was based on ICD-10 codes, and it used a composite outcome which may not be as relevant as a patient-centered outcome [336].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [336] Myburgh J (2018) Patient-Centered Outcomes and Resuscitation Fluids. N Engl J Med 378(9):862–863 source
Not checked in the free run.
May combine two claims.
PremisecitationNormal saline may cause hyperchloremic metabolic acidosis, renal vasoconstriction, increased cytokine secretion, and concern for acute kidney injury.
“potential adverse effects that include hyperchloremic metabolic acidosis, renal vasoconstriction, increased cytokine secretion and concern about acute kidney injury (AKI) have led to increased interest in chloride-restrictive solutions, known as balanced or buffered solutions [326–330].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [326] Chowdhury AH, Cox EF, Francis ST et al (2012) A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 256(1):18–24 source
Not checked in the free run.
- cites [327] Kellum JA (2002) Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 30(2):300–305 source
Not checked in the free run.
- cites [328] Kellum JA, Song M, Almasri E (2006) Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 130(4):962–967 source
Not checked in the free run.
- cites [329] Waters JH, Gottlieb A, Schoenwald P et al (2001) Normal saline versus lactated Ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 93(4):817–822 source
Not checked in the free run.
- cites [330] Williams EL, Hildebrand KL, McCormick SA et al (1999) The effect of intravenous lactated Ringer’s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 88(5):999–1003
Not checked in the free run.
May combine two claims.
PremisecitationThe VANISH trial found no difference in kidney injury but vasopressin reduced risk of renal replacement therapy.
“Although there was no difference with respect to kidney injury (RR 0.89; 95% CI 0.72–1.11), vasopressin use reduced the risk of RRT (RR 0.71; 95% CI 0.53–0.97) [354].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [354] Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518 source
Not checked in the free run.
May combine two claims.
PremisecitationA meta-analysis of septic patients found no significant mortality difference and no difference in new organ failures, ventilator-free days, or vasopressor-free days.
“A meta-analysis of studies including septic patients did not show a significant difference in mortality (RR 0.98; 95% CI 0.89–1.08). In addition, the risk of new organ failures (RR 1.02; 95% CI 0.93–1.11), ventilator-free days or vasopressor-free days did not differ.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEvidence shows higher blood pressure at early and later time points, higher static filling pressures, and lower net fluid balance with albumin.
“The suggestion to consider albumin in patients who received large volumes of crystalloids is informed by evidence showing higher blood pressure at early and later time points [339], higher static filling pressures [340], and lower net fluid balance [339] with albumin.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [339] Caironi P, Tognoni G, Gattinoni L (2014) Albumin replacement in severe sepsis or septic shock. N Engl J Med 371(1):84 source
Not checked in the free run.
- cites [340] Martin GS, Bassett P (2019) Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: a systematic review and meta-analysis. J Crit Care 50:144–154 source
Not checked in the free run.
May combine two claims.
InterpretationcitationUndesirable effects of using procalcitonin with clinical evaluation to decide when to discontinue antimicrobials are considered minimal and do not outweigh potential benefits.
“The undesirable effects of using procalcitonin along with clinical evaluation to decide when to discontinue antimicrobials are considered minimal, and do not outweigh the potential benefits [322].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [322] Arulkumaran N, Khpal M, Tam K et al (2020) Effect of antibiotic discontinuation strategies on mortality and infectious complications in critically ill septic patients: a meta-analysis and trial sequential analysis. Crit Care Med 48(5):757–764 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlbumin is theoretically more likely to maintain oncotic pressure than crystalloids.
“Although albumin is theoretically more likely to maintain oncotic pressure than crystalloids [339]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [339] Caironi P, Tognoni G, Gattinoni L (2014) Albumin replacement in severe sepsis or septic shock. N Engl J Med 371(1):84 source
Not checked in the free run.
May combine two claims.
Premiseown dataAlbumin had a larger treatment effect in the septic shock subgroup than in the sepsis subgroup, but the subgroup analysis did not detect a subgroup effect.
“Although albumin use resulted in a larger treatment effect in the septic shock subgroup (RR 0.88; 95% CI 0.77–0.99) than in the sepsis subgroup (RR 1.03; 95% CI 0.91–1.17), the subgroup analysis did not detect a subgroup effect (P-interaction = 0.19).”
Quote in the paperSubstantial claimMay combine two claims.
Premiseown dataGelatins may affect haemostasis and the effect on blood transfusions was unclear.
“Furthermore, gelatins may affect haemostasis and the effect on blood transfusions was unclear (RR 1.10; 95% CI 0.86–1.41).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAn individual patient data meta-analysis of 4 RCTs in septic shock found vasopressin alone or with norepinephrine led to higher risk of digital ischaemia but lower risk of arrhythmia compared with norepinephrine alone.
“a recent individual patient data meta-analysis of patients with septic shock from 4 RCTs showed that vasopressin alone or in combination with norepinephrine led to higher risk of digital ischaemia (risk difference [RD] 1.7%; 95% CI 0.3–3.2) but lower risk of arrhythmia (RD −2.8%; 95% CI −0.2 to −5.3) compared to norepinephrine alone [359].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [359] Nagendran M, Russell JA, Walley KR et al (2019) Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med 45(6):844–855 source
Not checked in the free run.
May combine two claims.
PremisecitationA systematic review and meta-analysis of 11 RCTs found norepinephrine resulted in lower mortality and lower risk of arrhythmias compared with dopamine.
“In a systematic review and meta-analysis of 11 RCTs, norepinephrine resulted in a lower mortality (RR 0.89; 95% CI 0.81–0.98) and lower risk of arrhythmias (RR 0.48; 95% CI 0.40–0.58) compared with dopamine [347].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [347] Avni T, Lador A, Lev S et al (2015) Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS One 10(8):e0129305 source
Not checked in the free run.
May combine two claims.
PremisecitationA second meta-analysis found crystalloid use associated with lower static filling pressures and lower mean arterial pressure, but no difference in 28-day or 90-day mortality.
“A second meta-analysis, which also included critically ill patients, found lower static filling pressures (MD −2.3 cm H2O; 95% CI 3.02–1.05) and mean arterial pressure (MAP) (MD −3.53 mmHg; 95% CI −6.71 to −0.36) with crystalloid use, but no difference in mortality at 28 days (RR 1.0; 95% CI 0.92–1.10) or 90 days (RR 1.32; 95% CI 0.76–2.29) [340].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [340] Martin GS, Bassett P (2019) Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: a systematic review and meta-analysis. J Crit Care 50:144–154 source
Not checked in the free run.
May combine two claims.
PremisecitationA Cochrane review of 12,492 patients found no difference between albumin and crystalloids in 30-day mortality, 90-day mortality, or need for renal replacement therapy.
“A Cochrane review including RCTs with 12,492 patients comparing albumin versus crystalloids found no difference in 30-day (RR 0.98; 95% CI 0.92–1.04) or 90-day mortality (RR 0.98; 95% CI 0.92–1.04) or need for RRT between groups (RR 1.11; 95% CI 0.96–1.27) [324].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [324] Lewis SR, Pritchard MW, Evans DJ et al (2018) Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 8:CD000567
Not checked in the free run.
May combine two claims.
InterpretationreasoningFor adults with an initial diagnosis of sepsis or septic shock and adequate source control, a shorter course of antibiotics is less costly and has fewer undesirable effects without adversely impacting outcomes.
“Thus, for adults with an initial diagnosis of sepsis or septic shock and adequate source control, we suggest a shorter course of antibiotics, as this is less costly, has fewer undesirable effects without impacting adversely on outcomes (see Table 4).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Study design and conductreasoningThe overall quality of evidence for procalcitonin-guided discontinuation was judged low.
“Therefore, the overall quality of evidence was judged to be low.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA phase IIb/III selepressin trial was stopped for futility after 828 patients with no significant differences in key endpoints including ventilator- and vasopressor-free days, 90-day mortality, RRT-free days, and ICU-free days.
“The study was stopped for futility after enrolment of 828 patients, with no significant differences between any of the key endpoints [ventilator- and vasopressor-free days, 15.0 (selepressin) versus 14.5 (placebo), p = 0.30; 90-day all-cause mortality, 40.6% vs 39.4%, p = 0.77; 30-day RRT-free days, 18.5 vs 18.2, p = 0.85; 30-day ICU-free days, 12.6 vs 12.2, p = 0.41]; adverse event rates were als”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [364] Laterre PF, Berry SM, Blemings A, et al (2019) Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial. JAMA 322(15):1476–1485 source
Not checked in the free run.
May combine two claims.
PremisecitationA randomized blinded study comparing epinephrine with norepinephrine in shock found no difference in 90-day mortality and vasopressor-free days.
“A randomised blinded study comparing epinephrine with norepinephrine in patients with shock showed no difference in 90-day mortality (HR 0.88; 95% CI 0.63–1.25) and vasopressor-free days [351].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [351] Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34(12):2226–2234 source
Not checked in the free run.
May combine two claims.
PremisecitationVasopressin concentration is elevated in early septic shock but decreases to normal range in most patients between 24 and 48 hours as shock continues.
“Studies show that vasopressin concentration is elevated in early septic shock but decreases to normal range in the majority of patients between 24 and 48 h as shock continues [352, 353].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [352] Holmes CL, Patel BM, Russell JA et al (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120(3):989–1002 source
Not checked in the free run.
- cites [353] Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122–1125 source
Not checked in the free run.
May combine two claims.
PremisecitationA small pilot in 20 patients with vasodilatory septic shock showed physiological efficacy without obvious safety issues for angiotensin II.
“After a small, short-term pilot of 20 patients with vasodilatory (septic) shock 10 patients in each group which showed physiological efficacy without obvious safety issues [365]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [365] Chawla LS, Busse L, Brasha-Mitchell E et al (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18(5):534 source
Not checked in the free run.
May combine two claims.
PremisecitationA previous meta-analysis of RCTs in septic patients showed higher risk of renal replacement therapy with HES 130/0.38-0.45 and higher risk of death in low risk of bias trials.
“A previous meta-analysis of RCTs in septic patients showed a higher risk of RRT with the use of HES 130/0.38–0.45 (RR 1.36; 95% CI 1.08–1.72) and a higher risk of death in a pre-defined analysis of low risk of bias trials (RR 1.11; 95% CI 1.0–1.2) [343].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [343] Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839 source
Not checked in the free run.
May combine two claims.
PremisecitationSepsis-induced myocardial dysfunction is recognized as a major contributor to haemodynamic instability and is associated with worse outcomes in septic shock.
“Sepsis-induced myocardial dysfunction is recognised as a major contributor to the haemodynamic instability and is associated with worse outcomes of patients with septic shock [368].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [368] Walley KR (2018) Sepsis-induced myocardial dysfunction. Curr Opin Crit Care 24(4):292–299 source
Not checked in the free run.
May combine two claims.
PremisecitationRecent data from Africa showed that higher volume fluid resuscitation in adults was associated with increased mortality, but the generalizability of these data is limited due to high prevalence of HIV/AIDS and malnutrition and resource-scarce conditions with limited ICU access.
“Recent data emerging from Africa showed that higher volume fluid resuscitation in adults was associated with increased mortality, but the generalizability of these data is limited due to the high prevalence of HIV/AIDS and malnutrition in the patients enrolled and the resource-scarce conditions with limited access to ICUs [69].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [69] Andrews B, Semler MW, Muchemwa L et al (2017) Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA 318(13):1233–1240 source
Not checked in the free run.
May combine two claims.
PremisecitationArterial catheter insertion permits safe, reliable, continuous arterial pressure measurement and real-time analysis for therapeutic decisions.
“Insertion of an arterial catheter permits safe, reliable and continuous measurement of arterial pressure and allows real time analysis so that therapeutic decisions can be based on immediate and accurate blood pressure information [380].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [380] Vincent J (2019) Arterial, central venous, and pulmonary artery catheters. In: JE P (ed) Critical care medicine: principles and diagnosis and management in the adult, 5th edn. Elsevier, Philadelphia, pp 40–49
Not checked in the free run.
May combine two claims.
PremisecitationThe LeoPARDS trial found levosimendan compared with no inotropic agents was associated with lower likelihood of successful weaning from mechanical ventilation and higher risk of supraventricular tachyarrhythmia.
“Data from the LeoPARDS trial (n = 515) showed that levosimendan versus no inotropic agents was associated with a lower likelihood of successful weaning from mechanical ventilation and a higher risk of supraventricular tachyarrythmia [373].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [373] Gordon AC, Perkins GD, Singer M et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638–1648 source
Not checked in the free run.
May combine two claims.
PremisecitationUltrasound guidance may increase first attempt success rate and decrease complication rate.
“Ultrasound guidance may increase the first attempt success rate and decrease the complication rate [382, 383].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [382] Bhattacharjee S, Maitra S, Baidya DK (2018) Comparison between ultrasound guided technique and digital palpation technique for radial artery cannulation in adult patients: an updated meta-analysis of randomized controlled trials. J Clin Anesth 47:54–59 source
Not checked in the free run.
- cites [383] Gu WJ, Wu XD, Wang F et al (2016) Ultrasound guidance facilitates radial artery catheterization: a meta-analysis with trial sequential analysis of randomized controlled trials. Chest 149(1):166–179 source
Not checked in the free run.
May combine two claims.
PremisecitationThe largest terlipressin study in 617 septic shock patients found 28-day mortality of 40% with terlipressin versus 38% with norepinephrine and no differences in SOFA score at day 7 or vasopressor-free days.
“The 28-day mortality in the two groups was 40% for terlipressin and 38% for norepinephrine (OR 0.93; 95% CI 0.55–1.56, p = 0.80), and there were no differences in SOFA score at day 7 or vasopressor free days.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [367] Liu ZM, Chen J, Kou Q et al (2018) Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med 44(11):1816–1825 source
Not checked in the free run.
May combine two claims.
PremisecitationMost studies reported no need for active treatment of extravasation, and a systematic review concluded most patients with extravasation have no long-term sequelae.
“Most of the studies reported no need for active treatment of the extravasation, and a systematic review concluded that most patients who experience extravasation events have no long-term sequelae [389].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [389] Loubani OM, Green RS (2015) A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30(3):653e9-17 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the largest terlipressin study, more patients receiving terlipressin had serious adverse events, including digital ischaemia and diarrhea.
“More patients who received terlipressin had serious adverse events; 33 of 260 (12%) patients experienced digital ischaemia after receiving terlipressin, versus only one patient who received norepinephrine (p < 0.0001); diarrhea was also more common in the terlipressin group (2.7% versus 0.35%, p = 0.037).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [367] Liu ZM, Chen J, Kou Q et al (2018) Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med 44(11):1816–1825 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the ProCESS, ARISE, and ProMISe trials, approximately 7-8 L of fluids were administered in the usual care groups, with a reported low mortality rate.
“ProCESS[64], ARISE [65] and ProMISe [66] administered approximately 7–8 L in the usual care groups with a reported low mortality rate.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [64] Investigators P, Yealy DM, Kellum JA et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693 source
Not checked in the free run.
- cites [65] Peake SL, Delaney A, Bellomo R et al (2015) Goal-directed resuscitation in septic shock. N Engl J Med 372(2):190–191
Not checked in the free run.
- cites [66] Mouncey PR, Osborn TM, Power GS et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372(14):1301–1311 source
Not checked in the free run.
May combine two claims.
PremisecitationA systematic review of observational studies found risk of limb ischaemia and bleeding less than 1% for radial catheters, and less than 1% and 1.58% for femoral catheters, with localised haematoma the most common complication.
“A systematic review of observational studies showed that the risk of limb ischaemia and bleeding was less than 1% for radial catheters, and the risk of limb ischaemia and bleeding was less than 1% and 1.58%, respectively, for femoral catheters. The most common complication was localised haematoma, 14% for radial and 6% for femoral catheters [381].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [381] Scheer B, Perel A, Pfeiffer UJ (2002) Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 6(3):199–204 source
Not checked in the free run.
May combine two claims.
InterpretationcitationRecent evidence suggests that IV fluids used to restore organ perfusion may damage vascular integrity and lead to organ dysfunction.
“recent evidence suggests that IV fluids used to restore organ perfusion may damage vascular integrity and lead to organ dysfunction [394].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [394] Alphonsus CS, Rodseth RN (2014) The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia 69(7):777–784 source
Not checked in the free run.
May combine two claims.
Premisenone givenDobutamine infusion may produce severe vasodilation and lower mean arterial pressure.
“Dobutamine infusion may produce severe vasodilation and result in lower MAP.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNon-invasive cuff blood pressure estimation tends to be inaccurate, with discrepancy more pronounced in shock states.
“Estimation of blood pressure using a non-invasive cuff tends to be inaccurate and the discrepancy more pronounced in shock states [375–379].”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [375] Araghi A, Bander JJ, Guzman JA (2006) Arterial blood pressure monitoring in overweight critically ill patients: invasive or noninvasive? Crit Care 10(2):R64 source
Not checked in the free run.
- cites [376] Bur A, Hirschl MM, Herkner H et al (2000) Accuracy of oscillometric blood pressure measurement according to the relation between cuff size and upper-arm circumference in critically ill patients. Crit Care Med 28(2):371–376 source
Not checked in the free run.
- cites [377] Kaur B, Kaur S, Yaddanapudi LN et al (2019) Comparison between invasive and noninvasive blood pressure measurements in critically ill patients receiving inotropes. Blood Press Monit 24(1):24–29 source
Not checked in the free run.
- cites [378] Lehman LW, Saeed M, Talmor D et al (2013) Methods of blood pressure measurement in the ICU. Crit Care Med 41(1):34–40 source
Not checked in the free run.
- cites [379] Riley LE, Chen GJ, Latham HE (2017) Comparison of noninvasive blood pressure monitoring with invasive arterial pressure monitoring in medical ICU patients with septic shock. Blood Press Monit 22(4):202–207 source
Not checked in the free run.
May combine two claims.
PremisecitationObservational studies have shown an association between high-volume fluid resuscitation and increased mortality, but these studies are likely affected by unmeasured variables such as administering higher amounts of fluids to sicker patients.
“Data from observational studies have shown an association of high-volume fluid resuscitation and increased mortality, but these studies are likely affected by unmeasured variables (i.e. the administration of higher amounts of fluids to sicker patients) [395, 396].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [395] Boyd JH, Forbes J, Nakada TA et al (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39(2):259–265 source
Not checked in the free run.
- cites [396] Marik PE, Linde-Zwirble WT, Bittner EA et al (2017) Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med 43(5):625–632 source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationA small study randomizing peripheral versus central access found major catheter-related complications were higher with peripheral lines, no significant difference in minor complications, difficulty in placement was the most common peripheral complication, and almost half of the peripheral group did not need a central line during ICU stay.
“A small study (n = 263) randomly allocated patients to receive peripheral vascular access or a central access [386]. The need for vasopressor was the indication for venous access in 70% of the patients. The incidence of major catheter-related complications was higher in those randomised to peripheral venous lines with no significant difference in the incidence of minor catheter-related complicatio”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [386] Ricard JD, Salomon L, Boyer A et al (2013) Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med 41(9):2108–2115 source
Not checked in the free run.
May combine two claims.
PremisecitationA post-hoc analysis of the ARISE trial found 42% of patients had vasopressors initiated via peripheral catheter with shorter time to initiation.
“A post-hoc analysis of the ARISE trial showed that 42% of patients had vasopressors initiated via a peripheral catheter with a shorter time to initiation of vasopressors (2.4 [1.3–3.9] vs. 4.9 h [3.5–6.6], p < 0.001) [385].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [385] Delaney A, Finnis M, Bellomo R et al (2020) Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas 32(2):210–219 source
Not checked in the free run.
May combine two claims.
PremisecitationA systematic review found higher risk of infections with femoral compared with radial arterial catheters, and pooled incidence of bloodstream infection was 0.96 per 1000 catheter days.
“A systematic review showed higher risk of infections when femoral arterial catheters were used compared to radial artery catheters (RR 1.93; 95% CI 1.32–2.84), and the overall pooled incidence of bloodstream infection was 0.96 per 1000 catheter days [384].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [384] O’Horo JC, Maki DG, Krupp AE et al (2014) Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. Crit Care Med 42(6):1334–1339 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe observational analysis adjusted only for baseline characteristics and did not account for time-varying confounders such as patient condition at initiation of inotropes, which may explain the mortality association.
“However, the analysis adjusted only to baseline characteristics, without accounting for time-varying confounders including the patient condition at the time of initiating inotropes which may explain the association with mortality.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationExtravasation may occur more frequently if vasopressors are infused distal to the antecubital fossa; a meta-analysis found 85% of reported extravasation events occurred with a catheter distal to the antecubital fossa.
“Extravasation may occur more frequently if vasopressors are infused distally to the antecubital fossa; a meta-analysis showed that 85% of reported extravasation events occurred when vasopressors were infused by a catheter that was located distal to the antecubital fossa [389].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [389] Loubani OM, Green RS (2015) A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 30(3):653e9-17 source
Not checked in the free run.
May combine two claims.
PremisecitationDobutamine increases cardiac output and oxygen transport, increases splanchnic perfusion and tissue oxygenation, and improves intramucosal acidosis and hyperlactatemia.
“Physiologic studies demonstrate that dobutamine increases CO and oxygen transport, increases splanchnic perfusion and tissue oxygenation, improves intramucosal acidosis and hyperlactatemia [369].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [369] Cunha-Goncalves D, Perez-de-Sa V, Larsson A et al (2009) Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine. Anesth Analg 109(5):1576–1583 source
Not checked in the free run.
May combine two claims.
PremisecitationThe 3 RCTs that guide the plateau pressure recommendation enrolled patients using the American-European Consensus Criteria Definition for Acute Lung Injury and ARDS, whereas the current document uses the 2012 Berlin definition.
“Of note, the 3 RCTs that guide this recommendation [424, 426, 427] enrolled patients using the criteria from the American-European Consensus Criteria Definition for Acute Lung Injury and ARDS [422] whereas the current document use the 2012 Berlin definition and the terms mild, moderate, and severe ARDS (PaO2/FiO2 ≤ 300, ≤ 200, and ≤ 100 mm Hg, respectively) [423].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [424] Brower RG, Matthay MA, Acute Respiratory Distress Syndrome N et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308 source
Not checked in the free run.
- cites [426] Brochard L, Roudot-Thoraval F, Roupie E et al (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 158(6):1831–1838 source
Not checked in the free run.
- cites [427] Brower RG, Shanholtz CB, Fessler HE et al (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27(8):1492–1498 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe plateau pressure is only truly valuable if the patient is passive during the inspiratory hold.
“The plateau pressure is only truly valuable if the patient is passive during the inspiratory hold.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThese three RCTs compared a strategy of low tidal volume and limited plateau pressure with a strategy using higher tidal volume and plateau pressure; pooled data suggest reduced mortality (RR 0.83; 95% CI 0.70-0.97) and more ventilator-free days (MD 1.8 days; 95% CI 0.35-3.25) in patients managed with low plateau pressures.
“These three RCTS compared a strategy of low tidal volume and limited plateau pressure with a strategy using higher tidal volume and plateau pressure; pooled data suggest reduced mortality (RR 0.83; 95% CI 0.70–0.97) and more ventilator-free days (MD 1.8 days; 95% CI 0.35–3.25) in patients managed with low plateau pressures.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [424] Brower RG, Matthay MA, Acute Respiratory Distress Syndrome N et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308 source
Not checked in the free run.
- cites [426] Brochard L, Roudot-Thoraval F, Roupie E et al (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 158(6):1831–1838 source
Not checked in the free run.
- cites [427] Brower RG, Shanholtz CB, Fessler HE et al (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27(8):1492–1498 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenVolume- and pressure-limited ventilation may lead to hypercapnia even with maximum-tolerated set respiratory rates; this appears to be tolerated and safe in the absence of contraindications.
“Volume- and pressure-limited ventilation may lead to hypercapnia even with these maximum-tolerated set respiratory rates; this appears to be tolerated and safe in the absence of contraindications (e.g., high intracranial pressure, sickle cell crisis).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe use of NIV for the rescue of patients with exclusively acute hypoxic respiratory failure ("de novo respiratory failure") is less well studied, but not uncommon.
“Patients with sepsis-induced hypoxemic respiratory failure may or may not have a competing chronic respiratory disease (ex. COPD, obesity) and the use of NIV for the rescue of patients with exclusively acute hypoxic respiratory failure (“de novo respiratory failure”) is less well studied, but not uncommon.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenIn the comparison of NIV versus HFNC, the NIV technique was not standardised and the experience of the centers varied.
“However, the NIV technique was not standardised and the experience of the centers varied.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H2O because lower plateau pressures were associated with reduced hospital mortality.
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H2O [431] because lower plateau pressures were associated with reduced hospital mortality [432].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [431] Hager DN, Krishnan JA, Hayden DL et al (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172(10):1241–1245 source
Not checked in the free run.
- cites [432] Checkley W, Brower R, Korpak A et al (2008) Effects of a clinical trial on mechanical ventilation practices in patients with acute lung injury. Am J Respir Crit Care Med 177(11):1215–1222 source
Not checked in the free run.
May combine two claims.
PremisecitationIn that trial, the primary outcome of intubation rate at 28 days was not different between HFNC and NIV, but 90-day survival was improved with HFNC (OR 0.42; 95% CI 0.21-0.85) and HFNC patients had significantly more days free of mechanical ventilation during a 28-day study period.
“Although the primary outcome of intubation rate at 28 days was not different, this study demonstrated improved 90-day survival with HFNC compared with NIV (OR 0.42; 95% CI 0.21–0.85) and HFNC patients experienced significantly more days free of mechanical ventilation during a 28-day study period [411].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [411] Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372(23):2185–2196 source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenAcute hypoxemic respiratory failure can result from causes of sepsis such as pneumonia or non-pulmonary infections resulting in ARDS.
“Acute hypoxemic respiratory failure can result from causes of sepsis such as pneumonia or non-pulmonary infections resulting in ARDS.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningIn studies of restrictive IV fluid strategies, primary outcomes were mostly related to IV fluid volumes administered, and given small sample sizes, they were not powered to identify differences in patient-centered outcomes.
“Moreover, the primary outcomes were mostly related to IV fluid volumes administered during the study period and given the small sample sizes, they were not powered to identify differences in patient-centered outcomes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenIn addition to improving gas exchange, NIV may help to reduce work of breathing in select patients.
“In addition to improving gas exchange, NIV may help to reduce work of breathing in select patients.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone givenComplications with HFNC are possible; however, they are usually self-limited and do not require discontinuing therapy.
“Complications with HFNC are possible; however, they are usually self-limited and do not require discontinuing therapy.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenNIV can cause mask-related discomfort, unrecognised patient-ventilator asynchrony due to leaks, and gastric insufflation.
“In contrast, NIV can cause mask-related discomfort, unrecognised patient-ventilator asynchrony due to leaks, and gastric insufflation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenWhen directly compared to invasive positive pressure ventilation, NIV may achieve similar physiologic benefits including improved gas exchange and reduced work of breathing in select patients, while avoiding complications associated with intubation, invasive ventilation, and accompanying sedation.
“When directly compared to invasive positive pressure ventilation, NIV may be able to achieve similar physiologic benefits including improved gas exchange and reduced work of breathing in select patients, while avoiding complications associated with intubation, invasive ventilation, and accompanying sedation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationStudies have suggested that NIV failure is an independent risk factor for mortality specifically in this population, although careful patient selection may reduce this risk.
“Studies have suggested that NIV failure is an independent risk factor for mortality specifically in this population, although careful patient selection may reduce this risk [415, 416].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [415] Demoule A, Chevret S, Carlucci A et al (2016) Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med 42(1):82–92 source
Not checked in the free run.
- cites [416] Demoule A, Girou E, Richard JC et al (2006) Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med 32(11):1756–1765 source
Not checked in the free run.
May combine two claims.
PremisecitationLUNGSAFE, a large international observational study, reported that plateau pressure correlated with mortality; however, the relationship was not evident when plateau pressure was below 20 cm H2O.
“LUNGSAFE, a large international observational study, which reported that plateau pressure correlated with mortality; however, the relationship between the two was not evident when plateau pressure was below 20 cm H2O [435].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [435] Laffey JG, Bellani G, Pham T et al (2016) Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med 42(12):1865–1876 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe conservative use of oxygen may reduce oxygen exposure and diminish lung and systemic oxidative injury.
“The conservative use of oxygen may reduce oxygen exposure and diminish lung and systemic oxidative injury.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenPatients undergoing mechanical ventilation in the ICU often receive a high fraction of inspired oxygen and have a high arterial oxygen tension.
“Patients who are undergoing mechanical ventilation in the ICU often receive a high fraction of inspired oxygen and have a high arterial oxygen tension.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenThe main risk of NIV for acute respiratory failure is the potential for delaying needed intubation and increasing the risk of interval aspiration events.
“The main risk of NIV for the indication of acute respiratory failure is the potential for delaying needed intubation and increasing the risk of an interval aspiration events.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenHigh flow nasal cannula (HFNC) is a non-invasive, high concentration oxygen delivery interface that confers warming and humidification of secretions, high flow rates to better match patient demand, washout of nasopharyngeal dead space, and modest positive airway pressure effect.
“High flow nasal cannula (HFNC) is a non-invasive, high concentration oxygen delivery interface that confers warming and humidification of secretions, high flow rates to better match patient demand, washout of nasopharyngeal dead space, and modest positive airway pressure effect.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThese studies showed differing results, which may have been caused by differences in airway pressures in the treatment and control groups.
“These studies showed differing results, which may have been caused by differences in airway pressures in the treatment and control groups [423, 424, 428].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [423] Force ADT, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533
Not checked in the free run.
- cites [424] Brower RG, Matthay MA, Acute Respiratory Distress Syndrome N et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308 source
Not checked in the free run.
- cites [428] Eichacker PQ, Gerstenberger EP, Banks SM et al (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166(11):1510–1514 source
Not checked in the free run.
May combine two claims.
PremisecitationThe LOCO-2 study was terminated early by the data safety and monitoring board and reported no difference in 28-day survival in ARDS patients managed with a conservative oxygenation strategy.
“The LOCO-2 study was terminated early by the data safety and monitoring board and reported no difference in 28-day survival in ARDS patients managed with a conservative oxygenation strategy [409].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [409] Barrot L, Asfar P, Mauny F et al (2020) Liberal or conservative oxygen therapy for acute respiratory distress syndrome. N Engl J Med 382(11):999–1008 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningDue to small number of patients studied, low quality of evidence, uncertainty regarding whether clinicians can identify hypoxic patients in respiratory failure in whom NIV might be beneficial, and observational data suggesting potential harm with NIV in this setting, no clear recommendation can be made.
“Due to small number of patients studied, low quality of evidence, uncertainty regarding whether clinicians can identify hypoxic patients in respiratory failure in whom NIV might be beneficial, and observational data that suggest the potential for harm with NIV in this setting, no clear recommendation can be made.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenThe single inspiratory limb of HFNC allows for airflows as high as 60 L per minute to achieve inspired oxygen fractions (FiO2) as high as 95-100%.
“The single inspiratory limb of HFNC allows for airflows as high as 60 L per minute to achieve inspired oxygen fractions (FiO2) as high as 95–100%.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the ICU-ROX trial, mortality at 90 and 180 days did not differ between conservative and liberal oxygen therapy.
“Mortality at 90 and 180 days did not differ.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [405] Investigators I-R, the A, New Zealand Intensive Care Society Clinical Trials G et al (2020) Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med 382(11):989–998 source
Not checked in the free run.
May combine two claims.
PremisecitationA systematic review and meta-analysis of nine RCTs showed that HFNC reduces intubation compared with conventional oxygen (RR 0.85; 95% CI 0.74-0.99) but does not affect the risk of death or ICU length of stay.
“A systematic review and meta-analysis of nine RCTs [2] showed that HFNC reduces intubation compared with conventional oxygen (RR 0.85; 95% CI 0.74–0.99) but does not affect the risk of death or ICU length of stay [412–414].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [2] Fleischmann C, Scherag A, Adhikari NK et al (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193(3):259–272 source
Not checked in the free run.
- cites [412] Ni YN, Luo J, Yu H et al (2018) The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis. Am J Emerg Med 36(2):226–233 source
Not checked in the free run.
- cites [413] Ou X, Hua Y, Liu J et al (2017) Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. CMAJ 189(7):E260–E267 source
Not checked in the free run.
- cites [414] Rochwerg B, Granton D, Wang DX et al (2019) High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author’s reply. Intensive Care Med 45(8):1171 source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningPatients with profound metabolic acidosis, high minute ventilation, or short stature may require additional manipulation of tidal volumes.
“Patients with profound metabolic acidosis, high minute ventilation, or short stature may require additional manipulation of tidal volumes.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenNIV use can be associated with complications including increased risk of gastric insufflation and aspiration, facial skin breakdown, excessively high tidal volumes, and patient discomfort related to inability to eat or effectively phonate during therapy.
“However, NIV use can be associated with development of complications including increased risk of gastric insufflation and aspiration, facial skin breakdown, excessively high tidal volumes as well as patient discomfort related to inability to eat or effectively phonate during therapy.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenVery low tidal volumes may result in significant patient-ventilatory dyssynchrony and patient discomfort.
“The clinician should keep in mind that very low tidal volumes may result in significant patient-ventilatory dyssynchrony and patient discomfort.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenBoth NIV and high flow oxygen avoid the complications of intubation and invasive mechanical ventilation and promote patient interaction.
“Both therapies avoid the complications of intubation and invasive mechanical ventilation and promote patient interaction.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenSepsis is an independent risk factor for the development of ARDS, and delays in diagnosing ARDS may result in delayed use of low tidal volumes.
“However, sepsis is an independent risk factor for the development of ARDS, and delays in diagnosing ARDS may result in delayed use of low tidal volumes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMany strategies exist for treating refractory hypoxemia in patients with severe ARDS.
“Many strategies exist for treating refractory hypoxemia in patients with severe ARDS [451].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [451] Pipeling MR, Fan E (2010) Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA 304(22):2521–2527 source
Not checked in the free run.
May combine two claims.
InterpretationcitationSelected patients with severe hypoxemia may benefit from recruitment maneuvers in conjunction with higher levels of PEEP, but little evidence supports the routine use in all ARDS patients, so recommendations are focused to patients with moderate-to-severe ARDS.
“Selected patients with severe hypoxemia may benefit from recruitment maneuvers in conjunction with higher levels of PEEP, but little evidence supports the routine use in all ARDS patients, so we have focused our recommendations to patients with moderate-to-severe ARDS [453].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [453] Fan E, Wilcox ME, Brower RG et al (2008) Recruitment maneuvers for acute lung injury a systematic review. Am J Respir Crit Care Med 178(11):1156–1163 source
Not checked in the free run.
May combine two claims.
PremisecitationThis recommendation was based on a meta-analysis of 3 trials that examined the role of NMBAs in ARDS, showing reduced risks of death (RR 0.72; 95% CI 0.58-0.91) and barotrauma (RR 0.43; 95% CI 0.20-0.90) with the use of cisatracurium infusion.
“This recommendation was based on a meta-analysis of 3 trials that examined the role of NMBAs in ARDS [465–467], showing reduced risks of death (RR 0.72; 95% CI 0.58–0.91) and barotrauma (RR 0.43; 95% CI 0.20–0.90) with the use of cisatracurium infusion [468].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [465] Forel JM, Roch A, Marin V et al (2006) Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34(11):2749–2757 source
Not checked in the free run.
- cites [466] Gainnier M, Roch A, Forel JM et al (2004) Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 32(1):113–119 source
Not checked in the free run.
- cites [467] Papazian L, Forel JM, Gacouin A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363(12):1107–1116 source
Not checked in the free run.
- cites [468] Alhazzani W, Alshahrani M, Jaeschke R et al (2013) Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 17(2):R43 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe most common indication for neuromuscular blocking agents (NMBAs) use in the ICU is to facilitate mechanical ventilation.
“The most common indication for neuromuscular blocking agents (NMBAs) use in the ICU is to facilitate mechanical ventilation [462].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [462] Klessig HT, Geiger HJ, Murray MJ et al (1992) A National Survey on the practice patterns of anesthesiologist intensivists in the use of muscle-relaxants. Crit Care Med 20(9):1341–1345 source
Not checked in the free run.
May combine two claims.
PremisecitationA patient-level analysis of two of the randomised PEEP trials suggested that patients with ARDS who respond to increased PEEP with improved oxygenation have a lower risk of death; this association was stronger in patients with more severe ARDS (PaO2/FiO2 < 150 mmHg) compared with patients with less severe ARDS.
“A patient-level analysis of two of the randomised PEEP trials [440, 441] suggested that patients with ARDS who respond to increased PEEP with improved oxygenation have a lower risk of death; this association was stronger in patients with more severe ARDS (PaO2/FiO2 < 150 mmHg) compared with patients with less severe ARDS [444].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [440] Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645 source
Not checked in the free run.
- cites [441] Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655 source
Not checked in the free run.
- cites [444] Goligher EC, Kavanagh BP, Rubenfeld GD et al (2014) Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med 190(1):70–76 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationOne option for selecting higher PEEP is to titrate PEEP according to bedside measurements of thoracopulmonary compliance with the objective of obtaining the best compliance or lowest driving pressure, reflecting a favourable balance of lung recruitment and overdistension.
“One option is to titrate PEEP according to bedside measurements of thoracopulmonary compliance with the objective of obtaining the best compliance or lowest driving pressure, reflecting a favourable balance of lung recruitment and overdistension [445].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [445] Amato MB, Barbas CS, Medeiros DM et al (1995) Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 152(6 Pt 1):1835–1846 source
Not checked in the free run.
May combine two claims.
PremisecitationMost patients respond to the prone position with improved oxygenation and may also have improved lung compliance.
“Most patients respond to the prone position with improved oxygenation and may also have improved lung compliance [457–459].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [457] Jolliet P, Bulpa P, Chevrolet JC (1998) Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Med 26(12):1977–1985 source
Not checked in the free run.
- cites [458] Lamm WJ, Graham MM, Albert RK (1994) Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150(1):184–193 source
Not checked in the free run.
- cites [459] Stocker R, Neff T, Stein S et al (1997) Prone postioning and low-volume pressure-limited ventilation improve survival in patients with severe ARDS. Chest 111(4):1008–1017 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenApplying higher PEEP in patients with ARDS may open lung units to participate in gas exchange and may increase PaO2.
“Applying higher PEEP in patients with ARDS may open lung units to participate in gas exchange and may increase PaO2.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA third option is to use a PEEP/FiO2 titration table that titrates PEEP based on the combination of FiO2 and PEEP required to maintain adequate oxygenation.
“A third option is to use a PEEP/FiO2 titration table that titrates PEEP based on the combination of FiO2 and PEEP required to maintain adequate oxygenation [439–441].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [439] Brower RG, Lanken PN, MacIntyre N et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336 source
Not checked in the free run.
- cites [440] Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645 source
Not checked in the free run.
- cites [441] Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655 source
Not checked in the free run.
May combine two claims.
PremisecitationSince then, several RCTs have been published, the largest of which is the ROSE Trial.
“Since then, several RCTs have been published [469–471], the largest of which is the ROSE Trial [471].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [469] Guervilly C, Bisbal M, Forel JM et al (2017) Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome. Intensive Care Med 43(3):408–418 source
Not checked in the free run.
- cites [470] Lyu G, Wang X, Jiang W et al (2014) Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26(5):325–329
Not checked in the free run.
- cites [471] National Heart L, Blood Institute PCTN, Moss M et al (2019) Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med 380(21):1997–2008 source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenThe optimal method of selecting a higher PEEP level is not clear.
“The optimal method of selecting a higher PEEP level is not clear.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationWhile the pilot study suggested benefit, the subsequent 200 patient multicentre RCT that compared PEEP titration guided by esophageal (PES) measurement versus empirical high PEEP-FiO2 titration, showed no significant difference in a composite outcome of death and days free from mechanical ventilation through day 28.
“While the pilot study suggested benefit [448], the subsequent 200 patient multicentre RCT that compared PEEP titration guided by esophageal (PES) measurement versus empirical high PEEP-FiO2 titration, showed no significant difference in a composite outcome of death and days free from mechanical ventilation through day 28 [449].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [448] Talmor D, Sarge T, Malhotra A et al (2008) Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 359(20):2095–2104 source
Not checked in the free run.
- cites [449] Turbil E, Galerneau LM, Terzi N et al (2019) Positive-end expiratory pressure titration and transpulmonary pressure: the EPVENT 2 trial. J Thorac Dis 11(Suppl 15):S2012–S2017 source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningTwo RCTs were published since the 2016 Guidelines, but they were not included in the meta-analyses because both studies applied recruitment maneuvers to titrate PEEP levels.
“Two RCTs [437, 438] were published since the 2016 Guidelines [12, 13], but we did not include these trials in the meta-analyses because both studies applied recruitment maneuvers to titrate PEEP levels.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [437] Hodgson CL, Cooper DJ, Arabi Y et al (2019) Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial. Am J Respir Crit Care Med 200(11):1363–1372 source
Not checked in the free run.
- cites [438] Cavalcanti AB, Suzumura EA, Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318(14):1335–1345 source
Not checked in the free run.
May combine two claims.
PremisecitationWhile prone position may be associated with potentially life-threatening complications including accidental removal of the endotracheal tube, this was not evident in pooled analysis (RR 1.09; 95% CI 0.85-1.39).
“While prone position may be associated with potentially life-threatening complications including accidental removal of the endotracheal tube, this was not evident in pooled analysis (RR 1.09; 95% CI 0.85–1.39).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [454] Munshi L, Del Sorbo L, Adhikari NKJ et al (2017) Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 14(Supplement_4):S280-s8 source
Not checked in the free run.
May combine two claims.
PremisecitationAlthough the effects of recruitment maneuvers improve oxygenation initially, the effects can be transient.
“Although the effects of recruitment maneuvers improve oxygenation initially, the effects can be transient [453].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [453] Fan E, Wilcox ME, Brower RG et al (2008) Recruitment maneuvers for acute lung injury a systematic review. Am J Respir Crit Care Med 178(11):1156–1163 source
Not checked in the free run.
May combine two claims.
PremisecitationMeta-analysis including this study demonstrated reduced mortality in severe ARDS patients treated with prone compared with supine position (RR 0.74; 95% CI 0.56-0.99) as well as improved oxygenation as measured by change in PaO2/FiO2 ratio (median 23.5 higher; 95% CI 12.4-34.5 higher).
“Meta-analysis including this study demonstrated reduced mortality in severe ARDS patients treated with prone compared with supine position (RR 0.74; 95% CI 0.56–0.99) as well as improved oxygenation as measured by change in PaO2/FiO2 ratio (median 23.5 higher; 95% CI 12.4–34.5 higher) [454].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [454] Munshi L, Del Sorbo L, Adhikari NKJ et al (2017) Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 14(Supplement_4):S280-s8 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationIn the SSC 2016 guidelines, a weak recommendation was issued for using NMBA infusion for 48 h in sepsis-induced moderate to severe ARDS.
“In the SSC 2016 guidelines, we issued a weak recommendation for using NMBA infusion for 48 h in sepsis-induced moderate to severe ARDS [12, 13].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552 source
Not checked in the free run.
- cites [13] Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377 source
Not checked in the free run.
May combine two claims.
PremisecitationProne position was associated with an increase in pressure sores (RR 1.22; 95% CI 1.05-1.41), and some patients have contraindications to the prone position.
“However, prone position was associated with an increase in pressure sores (RR 1.22; 95% CI 1.05–1.41) [460, 461], and some patients have contraindications to the prone position [460, 461].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [460] Gattinoni L, Tognoni G, Pesenti A et al (2001) Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345(8):568–573 source
Not checked in the free run.
- cites [461] Guerin C, Gaillard S, Lemasson S et al (2004) Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 292(19):2379–2387 source
Not checked in the free run.
May combine two claims.
InterpretationcitationTemporarily raising transpulmonary pressure may facilitate opening atelectatic alveoli to permit gas exchange, but could also over distend aerated lung units leading to ventilator-induced lung injury and transient hypotension.
“Temporarily raising transpulmonary pressure may facilitate opening atelectatic alveoli to permit gas exchange [446], but could also over distend aerated lung units leading to ventilator-induced lung injury and transient hypotension.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [446] Gattinoni L, Caironi P, Cressoni M et al (2006) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354(17):1775–1786 source
Not checked in the free run.
May combine two claims.
PremisecitationThese drugs may improve chest wall compliance, prevent respiratory dyssynchrony, and reduce peak airway pressures.
“These drugs may improve chest wall compliance, prevent respiratory dyssynchrony, and reduce peak airway pressures [463].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [463] Murray MJ, Cowen J, DeBlock H et al (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30(1):142–156 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationA second option is to titrate PEEP upward while the patient is receiving a tidal volume of 6 mL/kg PBW, until the plateau airway pressure is 28 cm H2O.
“The second option is to titrate PEEP upward while the patient is receiving a tidal volume of 6 mL/kg PBW, until the plateau airway pressure is 28 cm H2O [441].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [441] Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655 source
Not checked in the free run.
May combine two claims.
PremisereasoningSince the publication of the previous SSC Guidelines, two important RCTs were published both of which utilised a "non-traditional" approach to recruitment maneuvers.
“Since the publication of the previous SSC Guidelines, two important RCTs were published both of which utilised a “non-traditional” approach to recruitment maneuvers.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn 2017, a meta-analysis was published that was updated from a previous meta-analysis published in 2010, to which only 1 study, the PROSEVA trial, published in 2013 was added.
“In 2017, a meta-analysis was published [454] that was updated from a previous meta-analysis published in 2010 [455], to which only 1 study, the PROSEVA trial, published in 2013 [456] was added.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [454] Munshi L, Del Sorbo L, Adhikari NKJ et al (2017) Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 14(Supplement_4):S280-s8 source
Not checked in the free run.
- cites [455] Sud S, Friedrich JO, Taccone P et al (2010) Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med 36(4):585–599 source
Not checked in the free run.
- cites [456] Guérin C, Reignier J, Richard JC et al (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368(23):2159–2168 source
Not checked in the free run.
May combine two claims.
PremisecitationA patient-level meta-analysis showed no benefit of higher PEEP in all patients with ARDS; however, patients with moderate or severe ARDS (PaO2/FiO2 ≤ 200 mmHg) had decreased mortality with the use of higher PEEP, whereas those with mild ARDS did not.
“A patient-level meta-analysis showed no benefit of higher PEEP in all patients with ARDS; however, patients with moderate or severe ARDS (PaO2/FiO2 ≤ 200 mmHg) had decreased mortality with the use of higher PEEP, whereas those with mild ARDS did not [443].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [443] Briel M, Meade M, Mercat A et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303(9):865–873 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe overall balance of effects for restrictive versus liberal transfusion is uncertain and does not favour either strategy.
“The overall balance of effects is uncertain and does not favour either the intervention or comparator.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenPolymyxin B haemoperfusion is expensive, resource intensive, potentially reduces health equity, and is infeasible in low-income economies.
“Polymyxin B haemoperfusion is expensive, resource intensive, potentially reduces health equity, and is infeasible in low-income economies.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationIn APROCCHSS, the dose of vasopressor was ≥ 0.25 μg/kg/min or ≥ 1 mg/h of norepinephrine or epinephrine, or any other vasopressor for at least 6 h to maintain a MAP ≥ 65 mmHg.
“In APROCCHSS [478] the dose of vasopressor was ≥ 0.25 µg/kg/min or ≥ 1 mg/h of norepinephrine or epinephrine, or any other vasopressor for at least 6 h to maintain a MAP ≥ 65 mmHg.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [478] Annane D, Renault A, Brun-Buisson C et al (2018) Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med 378(9):809–818 source
Not checked in the free run.
May combine two claims.
PremisecitationThe three trials used different inclusion criteria: in ADRENAL, eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.
“The three trials [354, 478, 479] also used different inclusion criteria: in ADRENAL [479] eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [479] Venkatesh B, Finfer S, Cohen J et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797–808 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRandomised trials of this technique have been previously summarised in a systematic review and meta-analysis.
“Randomised trials of this technique have been previously summarised in a systematic review and meta-analysis [482].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [482] Zhou F, Peng Z, Murugan R et al (2013) Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 41(9):2209–2220 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenIn clinical practice, patient selection is important and usually discussed prior to initiation of ECMO at an ECMO centre.
“In clinical practice, patient selection is important and usually discussed prior to initiation of ECMO at an ECMO centre.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
Interpretationnone givenCost and equity are substantial issues; and registry data will be very important to document longer-term outcomes in these patients outside of the clinical trial context.
“Cost and equity are substantial issues; and registry data will be very important to document longer-term outcomes in these patients outside of the clinical trial context.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe evidence for the use of VV-ECMO in sepsis-induced ARDS is limited, with two RCTs completed in the last 10 years to assess the potential efficacy of VV ECMO for severe ARDS.
“The evidence for the use of VV-ECMO in sepsis-induced ARDS is limited, with two RCTs completed in the last 10 years to assess the potential efficacy of VV ECMO for severe ARDS [476, 477].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [476] Combes A, Hajage D, Capellier G et al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378(21):1965–1975 source
Not checked in the free run.
- cites [477] Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe previous guidelines made no recommendation regarding the use of blood purification techniques.
“The previous guidelines made no recommendation regarding the use of blood purification techniques [12, 13].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45(3):486–552 source
Not checked in the free run.
- cites [13] Rhodes A, Evans LE, Alhazzani W et al (2017) surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe updated literature search for guideline identified one new relevant RCT.
“The updated literature search for guideline identified one new relevant RCT [481].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [481] Dellinger RP, Bagshaw SM, Antonelli M et al (2018) Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES Randomized Clinical Trial. JAMA 320(14):1455–1463 source
Not checked in the free run.
May combine two claims.
Study design and conductcitationIn one trial, all intervention participants were treated at one centre, which may have inflated the effect size because the centre specialised in ECMO management.
“In one trial, all intervention participants were treated at one centre, which may have inflated the effect size because the centre specialised in ECMO management [477].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [477] Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the TRISS trial, a transfusion threshold of 70 g/L versus 90 g/L in 1000 septic shock patients after ICU admission resulted in similar 90-day mortality, ischaemic events, and use of life support, with fewer transfusions in the lower-threshold group.
“The results showed similar 90-day mortality, ischaemic events, and use of life support in the two treatment groups with fewer transfusions in the lower-threshold group.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [484] Hébert PC, Wells G, Blajchman MA et al (1999) a multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340(6):409–417 source
Not checked in the free run.
- cites [485] Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391 source
Not checked in the free run.
May combine two claims.
PremisecitationThe optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses.
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [354] Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518 source
Not checked in the free run.
- cites [479] Venkatesh B, Finfer S, Cohen J et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797–808 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe dose of hydrocortisone is typically 200 mg/day.
“The dose of hydrocortisone is typically 200 mg/day.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenIntravenous immunoglobulin is relatively expensive, possibly not cost-effective, and may reduce health equity.
“Intravenous immunoglobulin is also relatively expensive, possibly not cost-effective and may reduce health equity.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationnone givenA restrictive transfusion strategy was determined likely beneficial with regards to resources required, cost effectiveness, and health equity considerations.
“However, a restrictive strategy was determined likely beneficial with regards to resources required, cost effectiveness, and health equity considerations.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationStress ulcers develop in the gastrointestinal tract of critically ill patients and can be associated with significant morbidity and mortality.
“Stress ulcers develop in the gastrointestinal (GI) tract of critically ill patients and can be associated with significant morbidity and mortality [493].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [493] Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330(6):377–381 source
Not checked in the free run.
May combine two claims.
PremisereasoningSubstantial uncertainty as to any beneficial effect exists and the frequency of undesirable effects is reported in few trials.
“Substantial uncertainty as to any beneficial effect exists and the frequency of undesirable effects is reported in few trials.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe quality of evidence for IVIG and IVIGM is low, with many included studies at high risk of bias due to single-centre design, small sample size, undefined randomisation, allocation and blinding, different dosing regimens and durations, different controls, and few reporting adverse events.
“however the quality of evidence is low with many of the included studies at high risks of bias including single-centre trials with small sample size, undefined randomisation, allocation and blinding procedures, different dosing regimens and durations of treatment, different controls and few studies reported adverse events.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe most recent and largest RCT did not demonstrate any effect of pantoprazole versus placebo on 90-day mortality or a composite outcome of clinically important events.
“However, it was noted that the most recent (and largest) RCT did not demonstrate any effect of pantoprazole versus placebo on 90-day mortality and a composite outcome of clinically important events [494].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [494] Krag M, Marker S, Perner A et al (2018) Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 379(23):2199–2208 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the TRICOP trial, at 28 days, mortality was 45% in the liberal group versus 56% in the restrictive group (HR 0.74; 95% CI 0.53-1.04; p = 0.08), with no differences in ICU and hospital length of stay.
“At 28 days after randomisation, the mortality rate in the liberal group was 45% 67 patients versus 56% 84 patients in the restrictive group (HR 0.74; 95% CI 0.53–1.04; p = 0.08) with no differences in ICU and hospital length of stay.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [487] Bergamin FS, Almeida JP, Landoni G et al (2017) Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 45(5):766–773 source
Not checked in the free run.
May combine two claims.
PremisecitationIn the ADRENAL study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS hydrocortisone was administered for seven days; in VANISH 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [479] Venkatesh B, Finfer S, Cohen J et al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378(9):797–808 source
Not checked in the free run.
- cites [478] Annane D, Renault A, Brun-Buisson C et al (2018) Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med 378(9):809–818 source
Not checked in the free run.
- cites [354] Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518 source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenWhile no adverse effects were observed, the quality of evidence for these outcomes was low.
“While no adverse effects were observed, the quality of evidence for these outcomes was low.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe STARRT-AKI trial randomised 3000 participants and demonstrated no difference in mortality between accelerated and standard RRT strategies.
“The trial, which randomised 3000 participants, demonstrated no difference in mortality in those allocated to an accelerated strategy of RRT compared to those allocated to a “standard” strategy.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [508] Investigators S-A, Canadian Critical Care Trials G, Australian et al (2020) Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med 383(3):240–251 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe resources required for continuous and intermittent RRT vary.
“It was acknowledged that the resources required for the interventions vary.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenIn some patients with sepsis and septic shock, pharmacologic prophylaxis may be contraindicated.
“It is acknowledged that in some patents with sepsis and septic shock pharmacologic prophylaxis may be contraindicated.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVitamin C is known to have anti-inflammatory properties.
“Vitamin C is known to have anti-inflammatory properties [520].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [520] Kuhn SO, Meissner K, Mayes LM et al (2018) Vitamin C in sepsis. Curr Opin Anaesthesiol 31(1):55–60 source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenIn low- and middle-income economies, the specialised equipment, expertise, and personnel required for continuous modalities may not be available.
“In low- and middle-income economies, the specialised equipment, expertise and personal required for continuous modalities may not be available.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningLMWH may have greater consumer acceptance as it requires only one subcutaneous injection daily.
“Further, LMWH may have greater consumer acceptance as it requires only one subcutaneous injection daily.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe judgment favouring stress ulcer prophylaxis is driven by a modest reduction in gastrointestinal haemorrhage, for which there is moderate quality of evidence.
“This is driven by a modest reduction in gastrointestinal haemorrhage for which there is moderate quality of evidence (Supplementary Appendix 5).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn 2017, a single centre before and after study reported shorter duration of vasopressor therapy and lower mortality following administration of high dose vitamin C, hydrocortisone, and thiamine to patients with sepsis and septic shock.
“In 2017, a single centre before and after study reported shorter duration of vasopressor therapy and lower mortality following the administration of combination of high dose vitamin C, hydrocortisone, and thiamine to patients with sepsis and septic shock [521].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [521] Marik PE, Khangoora V, Rivera R et al (2017) Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 151(6):1229–1238 source
Not checked in the free run.
May combine two claims.
Interpretationnone givenThe cost of pharmacologic VTE prophylaxis is not large, and it is likely feasible in countries with low- and middle-income economies.
“The cost of intervention is not large, and it is likely feasible in countries with low- and middle-income economies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn a single centre study, targeting blood glucose to 80-110 mg/dL reduced ICU mortality, but this finding was not reproduced in subsequent multi-centre RCTs.
“In a single centre study, targeting blood glucose to 80-110 mg/dL reduced ICU mortality [513], however this finding was not reproduced in subsequent multi-centre RCTs [514, 515].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [513] van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367 source
Not checked in the free run.
- cites [514] Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139 source
Not checked in the free run.
- cites [515] Preiser JC, Devos P, Ruiz-Santana S et al (2009) A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35(10):1738–1748 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationThe American Diabetes Association recommends initiating insulin therapy for persistent hyperglycemia > 180 mg/dL and targeting a glucose range of 140-180 mg/dL.
“The American Diabetes Association, in its most recent recommendations for glycemic control of critically ill patients, recommended the initiation of insulin therapy for persistent hyperglycemia > 180 mg/dL and thereafter a target glucose range of 140–180 mg/dL [512].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [512] Diabetes Care in the Hospital (2018) Standards of Medical Care in Diabetes—2018. Diabetes Care 41(Supplement 1):S144–S151
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPrior research has suggested both benefit and harm for early versus delayed initiation of RRT.
“Prior research has suggested benefit [505] or harm [506] for “early” versus “delayed” initiation of RRT.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [505] Zarbock A, Kellum JA, Schmidt C et al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA 315(20):2190–2199 source
Not checked in the free run.
- cites [506] Gaudry S, Hajage D, Schortgen F et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133 source
Not checked in the free run.
May combine two claims.
Study design and conductcitationThe certainty of evidence for mortality, renal recovery, and CVAD infection was at least moderate and was only downgraded for imprecision.
“The certainty of evidence for the key outcomes of mortality, renal recovery and CVAD infection was a least moderate and was only downgraded for imprecision (Supplementary Appendix 5).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningThese patients may benefit from mechanical VTE prophylaxis.
“These patients may benefit from mechanical VTE prophylaxis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe incidence of DVT acquired in the ICU may be as high as 10%, and the incidence of acquired PE may be 2-4%.
“The incidence of DVT acquired in the ICU may be as high as 10% [497], the incidence of acquired PE may be 2–4% [498, 499].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [497] Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33(7):1565–1571 source
Not checked in the free run.
- cites [498] Alhazzani W, Lim W, Jaeschke RZ et al (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41(9):2088–2098 source
Not checked in the free run.
- cites [499] Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e195S-e226S source
Not checked in the free run.
The quote only partly states this claim.
Study design and conductcitationThe overall quality of evidence for glucose control was rated moderate.
“The overall quality of evidence was rated as moderate (Supplementary Appendix 5).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHyperglycemia (> 180 mg/dL), hypoglycemia, and increased glycemic variability are associated with increased mortality in critically ill patients.
“Hyperglycemia (> 180 mg/dL), hypoglycemia and increased glycemic variability are associated with increased mortality in critically ill patients [509–511].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [509] Badawi O, Waite MD, Fuhrman SA et al (2012) Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 40(12):3180–3188 source
Not checked in the free run.
- cites [510] Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36(11):3008–3013 source
Not checked in the free run.
- cites [511] Siegelaar SE, Hermanides J, Oudemans-van Straaten HM et al (2010) Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care 14(6):R224 source
Not checked in the free run.
Classified as probably not a substantial claim.
Interpretationnone givenThere are resource implications and costs associated with the use of mechanical VTE prophylaxis.
“However, there are resource implications and costs associated with the use of mechanical VTE prophylaxis.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe PREVENT study was downgraded during quality assessment for imprecision; for mortality, quality was moderate, and for other outcomes it was further downgraded for risk of bias.
“The study was downgraded during the quality assessment for imprecision. For the outcome of mortality, the quality was assessed as moderate; for other outcomes it was further downgraded for risk of bias.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenAny difference in resources required between LMWH and UFH was considered negligible, and LMWH administration was feasible and applicable in countries with low- and middle-income economies.
“Any difference in resources required between the two interventions was considered to be negligible, and LMWH administration was feasible and applicable in countries with low- and middle-income economies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenStress ulcer prophylaxis is relatively inexpensive, requires limited resources, and is applicable to countries with low-income economies.
“Stress ulcer prophylaxis is relatively inexpensive, requires limited resources and is applicable to countries with low-income economies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn the PREVENT study, no difference in mortality (RR 0.98; 95% CI 0.84-1.13) or rates of DVT and PE were observed between combination mechanical and pharmacological prophylaxis and pharmacological prophylaxis alone.
“No difference in mortality (RR 0.98 95% CI 0.84–1.13), or the rates of DVT and PE were observed.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [500] Arabi YM, Al-Hameed F, Burns KEA et al (2019) Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 380(14):1305–1315 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThere is broad consensus that the current healthcare system is likely falling short of optimal care during the recovery period for sepsis survivors.
“There is broad consensus that the current healthcare system is likely falling short of what optimal care during the recovery period might look like for this patient population.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningGiven the variety of triggers used in these studies and the lack of superiority of any single trigger, no recommendation can be made for specific criteria to initiate a goals of care discussion.
“Given the variety of triggers used in these studies and the lack of superiority of any single trigger, no recommendation can be made for specific criteria to initiate a goals of care discussion.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationA discussion of goals of care and prognosis is essential to determine which treatments are acceptable and which are not desired.
“A discussion of goals of care and prognosis is essential to determine which treatments are acceptable and those interventions that are not desired [536].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [536] Ely EW (2017) The ABCDEF Bundle: science and philosophy of how ICU liberation serves patients and families. Crit Care Med 45(2):321–330 source
Not checked in the free run.
May combine two claims.
PremisecitationThe previous guidance was based on two small, blinded crossover RCTs that compared equimolar saline vs sodium bicarbonate in patients with lactic acidosis and failed to reveal any difference in haemodynamic variables or vasopressor requirements.
“The previous guidance was based on two small, blinded crossover RCTs that compared equimolar saline vs sodium bicarbonate in patients with lactic acidosis and failed to reveal any difference in haemodynamic variables or vasopressor requirements [526, 527].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [526] Cooper DJ, Walley KR, Wiggs BR et al (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112(7):492–498 source
Not checked in the free run.
- cites [527] Mathieu D, Neviere R, Billard V et al (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19(11):1352–1356 source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningDespite lack of evidence, the panel recognised that discussion of prognosis and exploration of goals of care with patients and/or family is a necessary precondition to determine patient treatment preferences and provide value-concordant care.
“Despite lack of evidence, the panel recognised that discussion of prognosis and exploration of goals of care with patients and/or family is a necessary precondition to determine patient treatment preferences and providing value-concordant care.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenSome patients may accept any and all treatment for their condition, but others may consider limitations depending on prognosis, invasiveness of interventions, and predicted quality of life.
“Some patients may accept any and all treatment for their condition, but others may consider limitations depending on prognosis, invasiveness of interventions, and predicted quality of life (QoL).”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenPatients with sepsis or septic shock are at high risk of multi-organ failure, long-term functional sequelae, and death.
“Patients with sepsis or septic shock are at high risk of multi-organ failure, long-term functional sequelae, and death.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenPatients who survive a protracted period of ICU care for sepsis typically face a long and complicated road to recovery.
“Patients who survive a protracted period of ICU care for sepsis typically face a long and complicated road to recovery.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAdvance care planning in patients with life-limiting illness may reduce use of life-sustaining treatments, may increase use of hospice and palliative care, and may improve concordance between treatment and patient values.
“While advance care planning in patients with life-limiting illness may reduce use of life-sustaining treatments, it may also increase use of hospice and palliative care, and improve concordance between treatment and patient values [537].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [537] Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A (2014) The effects of advance care planning on end-of-life care: a systematic review. Palliat Med 28(8):1000–1025 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenThe intervention of vitamin C requires limited resources and is feasible in low- and middle-income economies.
“The intervention itself requires limited resources and is feasible in low- and middle-income economies.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationnone givenThe relevance of advance care planning for future health needs to goals of care discussions at the time of a critical illness is unclear.
“The relevance of advance care planning for future health needs to goals of care discussions at the time of a critical illness is unclear.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTransitions of care are prone to communication errors, which have been identified as a barrier to timely detection and management of sepsis.
“Transitions of care are prone to communication errors, which have been identified as a barrier to the timely detection and management of sepsis [567].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [567] Matthaeus-Kraemer CT, Thomas-Rueddel DO, Schwarzkopf D et al (2016) Crossing the handover chasm: Clinicians’ perceptions of barriers to the early detection and timely management of severe sepsis and septic shock. J Crit Care 36:85–91 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningScreening for economic and social support may help reduce inequities.
“Screening for economic and social support may help reduce these inequities.”
Quote in the paperNot a substantial claim- Rests on an assumption: Non-medical social needs and modifiable factors such as economic and social support largely influence health outcomes.
- Rests on an assumption: Long-term health requires survivors to have the resources to recover and thrive.
Classified as probably not a substantial claim.
InterpretationreasoningIt is unlikely that many research studies would be conducted on screening because locally available social needs and supports vary.
“Furthermore, it is unlikely that many research studies would be conducted, since locally available social needs and supports vary.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTransfer from ICU to general floor and hospital discharge are vulnerable periods with high frequency of medication errors and information loss.
“Transfer from ICU to general floor and discharge from the hospital are both vulnerable periods for patients, with high frequency of medication errors and information loss [596–602].”
Quote in the paperSubstantial claim0 of 7 sources checked- cites [596] Bell CM, Brener SS, Gunraj N et al (2011) Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 306:840–847 source
Not checked in the free run.
- cites [597] Fabes J, Seligman W, Barrett C et al (2017) Does the implementation of a novel intensive care discharge risk score and nurse-led inpatient review tool improve outcome? A prospective cohort study in two intensive care units in the UK. BMJ Open 7(12):e018322 source
Not checked in the free run.
- cites [598] Mekonnen AB, McLachlan AJ, Brien JA (2016) Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis. J Clin Pharm Ther 41(2):128–144 source
Not checked in the free run.
- cites [599] Morandi A, Vasilevskis E, Pandharipande PP et al (2013) Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc 61:1128–1134 source
Not checked in the free run.
- cites [600] Scales DC, Fischer HD, Li P et al (2016) Unintentional continuation of medications intended for acute illness after hospital discharge: A population-based cohort study. J Gen Intern Med 31:196–202 source
Not checked in the free run.
- cites [601] Stelfox HT, Bastos J, Niven DJ et al (2016) Critical care transition programs and the risk of readmission or death after discharge from ICU. Intensive Care Med 42(3):401–410 source
Not checked in the free run.
- cites [602] Tomichek JE, Stollings JL, Pandharipande PP et al (2016) Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care 20:378 source
Not checked in the free run.
May combine two claims.
PremisecitationPeer support groups have been used to enhance recovery from illness with long-lasting disability but have only recently been used in critical care and sepsis.
“Peer support groups have been used to enhance recovery from illness when survivors have long-lasting disability but have only recently been used in critical care and sepsis [549–551].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [549] Clark E, MacCrosain A, Ward NS et al (2020) The key features and role of peer support within group self-management interventions for stroke? A systematic review. Disabil Rehabil 42(3):307–316 source
Not checked in the free run.
- cites [550] Govindan S, Iwashyna TJ, Watson SR et al (2014) Issues of survivorship are rarely addressed during intensive care unit stays. Baseline results from a statewide quality improvement collaborative. Ann Am Thorac Soc 11(4):587–591 source
Not checked in the free run.
- cites [551] Wobma R, Nijland RH, Ket JC et al (2016) Evidence for peer support in rehabilitation for individuals with acquired brain injury: a systematic review. J Rehabil Med 48(10):837–840 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningLessons learned in post-critical care clinics could be adapted to other, more-scalable interventions such as telehealth.
“Lessons learned in post-critical care clinics could be adapted to other, more-scalable interventions such as telehealth.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationnone givenFollow-up with a provider after hospital discharge is one step in the recovery process.
“Follow-up with a provider after hospital discharge is one-step in the recovery process.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningIn centers where cognitive therapy is used, it could reasonably be continued as it is likely acceptable and feasible, but there is insufficient evidence to change practice in centers without such therapy.
“In centers where cognitive therapy is used, it could reasonably be continued as it is likely acceptable and feasible, but there is insufficient evidence to change practice in centers without such therapy.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Early identification and appropriate management in the initial hours after sepsis onset improve outcomes.
“Early identification and appropriate management in the initial hours after the development of sepsis improve outcomes.”
The paper relies on this without support.
Timely, effective fluid resuscitation is crucial for stabilisation of sepsis-induced tissue hypoperfusion in sepsis and septic shock.
“Timely, effective fluid resuscitation is crucial for the stabilisation of sepsis-induced tissue hypoperfusion in sepsis and septic shock.”
The paper relies on this without support.
Most patients require continued fluid administration following initial resuscitation.
“Most patients require continued fluid administration following initial resuscitation.”
The paper relies on this without support.
Fluid administration beyond initial resuscitation must be balanced against risk of fluid accumulation and potential harm, including prolonged ventilation, progression of acute kidney injury, and increased mortality.
“Such administration needs to be balanced with the risk of fluid accumulation and potential harm associated with fluid overload, in particular, prolonged ventilation, progression of acute kidney injury (AKI) and increased mortality.”
The paper relies on this without support.
Heart rate, central venous pressure, and systolic blood pressure alone are poor indicators of fluid status.
“Heart rate, central venous pressure (CVP) and systolic blood pressure alone are poor indicators of fluid status.”
The paper relies on this without support.
Dynamic measures have better diagnostic accuracy at predicting fluid responsiveness than static techniques.
“Dynamic measures have demonstrated better diagnostic accuracy at predicting fluid responsiveness compared with static techniques.”
The paper relies on this without support.
Most data on fluid resuscitation arise from high-income settings, and evidence is scarce in resource-limited settings to guide optimal titration and safety endpoints.
“Most data arise from high income settings and a paucity of evidence exists in resource-limited settings to guide optimal titration of fluid resuscitation as well as the appropriate safety end- points.”
The paper relies on this without support.
MAP is a key determinant of mean systemic filling pressure, which is the major driver of venous return and cardiac output.
“MAP is a key determinant of mean systemic filling pressure, which in turn, is the major driver of venous return and CO.”
The paper relies on this without support.
Increasing MAP usually results in increased tissue blood flow and augments the supply side of tissue perfusion.
“Increasing MAP therefore usually results in increased tissue blood flow and augments the supply side of tissue perfusion.”
The paper relies on this without support.
The outcome of critically ill patients depends on timely application of critical care interventions in an appropriate environment.
“The outcome of critically ill patients depends on timely application of critical care interventions in an appropriate environment.”
The paper relies on this without support.
The availability and turn-around time for laboratory testing, rapid infectious diagnostic, imaging, etc. varies widely by regions and settings.
“The availability and turn-around time for laboratory testing, rapid infectious diagnostic, imaging, etc. varies widely by regions and settings.”
The paper relies on this without support.
The risk of Candida sepsis or septic shock in immunosuppressed populations other than febrile neutropenia is highly disease- and therapy-specific.
“The risk of Candida sepsis or septic shock for other immunosuppressed populations is highly disease- and therapy-specific.”
The paper relies on this without support.
Effective therapies are lacking for most zoonotic viruses that can manifest with clinical signs of sepsis.
“Unfortunately, effective therapies are lacking for most of these viruses.”
The paper relies on this without support.
Procalcitonin testing may not be available in all countries and healthcare settings, including LMICs.
“Procalcitonin testing may not be available in all countries and healthcare settings, including LMICs.”
The paper relies on this without support.
The direct costs of antibiotics can increase with routine use of multiple agents, particularly in resource-limited settings.
“The overall quality of evidence was very low, and the direct costs of antibiotics can increase with the routine use of multiple agents for treatment. This may specifically have an impact in resource-limited settings.”
The paper relies on this without support.
Treatment with empiric antifungals may be associated with increased costs.
“The overall quality of evidence was low, and treatment with empiric antifungals may be associated with increased costs.”
The paper relies on this without support.
Clinical experience indicates that without adequate source control, many severe presentations will not stabilise or improve despite rapid resuscitation and appropriate antimicrobials.
“Clinical experience suggests that without adequate source control, many severe presentations will not stabilise or improve despite rapid resuscitation and provision of appropriate antimicrobials.”
The paper relies on this without support.
Crystalloids are inexpensive and widely available.
“Crystalloids have the advantage of being inexpensive and widely available.”
The paper relies on this without support.
Albumin is more costly than crystalloids.
“it is more costly and there is no clear benefit with its routine use.”
The paper relies on this without support.
Norepinephrine is more potent than dopamine as a vasoconstrictor.
“Norepinephrine is more potent than dopamine as a vasoconstrictor.”
The paper relies on this without support.
Dopamine's beta-1 adrenergic receptor activity can lead to dose-limiting arrhythmias.
“its β-1 adrenergic receptor activity can lead to dose-limiting arrhythmias.”
The paper relies on this without support.
Availability of and experience with norepinephrine may vary.
“The panel also recognised that availability of, and experience with, norepinephrine may vary.”
The paper relies on this without support.
The results of clinical trials conducted in general critically ill or ARDS populations are applicable to patients with sepsis-induced ARDS.
“Of note, the studies that guide the recommendations in this section enrolled patients using criteria from the American-European Consensus Criteria Definition for Acute Lung Injury and ARDS [422].”
The paper relies on this without support.
The 2012 Berlin definition of ARDS does not materially alter the applicability of trial results that used the older American-European Consensus Criteria.
“For the current document, we used the 2012 Berlin definition and the terms mild, moderate, and severe ARDS (PaO2/FiO2 ≤ 300, ≤ 200, and ≤ 100 mm Hg, respectively) [423].”
The paper relies on this without support.
Non-medical social needs and modifiable factors such as economic and social support largely influence health outcomes.
“Non-medical social needs and potentially modifiable factors such as economic and social support largely influence health outcomes.”
The paper relies on this without support.
Long-term health requires survivors to have the resources to recover and thrive.
“While survival from sepsis is improving, long-term health requires survivors to have the resources to recover and thrive.”
The paper relies on this without support.
Socioeconomic screening is considered part of standard clinical practice.
“Although socioeconomic screening is considered part of standard clinical practice, all clinical teams in many settings may not do it.”
The paper relies on this without support.
Shared decision making is less routinely used in post-ICU and hospital discharge planning than in other aspects of acute patient care.
“This patient-centered approach may be less routinely used in post-ICU and hospital discharge planning than in other aspects of acute patient care.”
The paper relies on this without support.
Medication reconciliation is broadly recognised to be important during patient transitions.
“Medication reconciliation is broadly recognised to be important during patient transitions.”
The paper relies on this without support.
Individuals who receive referral to peer support have the choice to participate or not.
“As individuals who receive referral to peer support have the choice to participate or not (based on personal preference, timing, location, functional status, and resources required) a weak recommendation provides an opportunity to access support for sepsis survivors who otherwise may not know where to turn [552].”
The paper relies on this without support.
Many sepsis interventions and tests are time-dependent, and communication failures may increase the chances of critical medical errors.
“While it is unclear whether structured handoffs impact important patient outcomes, many sepsis interventions and tests are time-dependent and communication failures may increase the chances of critical medical errors.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Early and effective inhibition or killing of pathogens is essential for the prevention and treatment of sepsis.
“Early and effective inhibition or killing of pathogens is essential for the prevention and treatment of sepsis.12”
From Identification of heptapeptides targeting a lethal bacterial strain in septic mice through an integrative approach (2022) · cites this paper as [12]
The Infection rationale (page not provided) says early, appropriate antimicrobials reduce mortality in patients with sepsis, supporting the treatment portion. It does not establish that inhibiting or killing pathogens prevents sepsis; its recommendations concern patients with suspected or established sepsis. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Vitamin C vasopressor result is described in the opposite direction
MinorThe text calls the result reduced vasopressor use, but a larger proportion of vitamin C recipients than controls remained on vasopressors at the stated time point.
“One study reported reduced vasopressor use at 168 h [523].”
“Of the patients alive at 7 days, 22% (16/72) administered vitamin C remained on vasopressor therapy compared to 10% (6/59) of controls.”
Fluid-pressure estimate falls outside its confidence interval
MinorThe reported mean difference is negative, but both stated confidence-interval endpoints are positive. The point estimate cannot lie within that interval.
“MD −2.3 cm H2O”
“95% CI 3.02–1.05”
Review date conflicts with its cited reference
MinorThe rationale dates the cited systematic review to 2015, while reference 450 lists it as published in 2012.
“A 2015 systematic review and meta-analysis found a reduction in the risk of a composite endpoint of ARDS or pneumonia during the hospital stay in the low tidal volume ventilation group compared to the high tidal volume ventilation group (RR 0.72; 95% CI 0.52–0.98) [450].”
“450. Serpa Neto A Cardoso SO Manetta JA Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis JAMA 2012”
Negative confidence limit is incompatible with a risk ratio
MinorThe result labels its effect measure a risk ratio, but gives a confidence interval extending below zero; a risk ratio cannot be negative.
“days on mechanical ventilation (RR = 0.00;”
“95% CI −1.02 to 1.02”
Digital-ischaemia percentage rounds incorrectly
MinorThirty-three of 260 patients is 12.69%, which rounds to 13%, not the reported 12%.
Reported 12 · recomputed 12.692308
“33 of 260 (12%) patients experienced digital ischaemia after receiving terlipressin”
VTE trial control group is described two different ways
MinorThe trial is first described as comparing combined mechanical and drug prophylaxis with drug prophylaxis alone. The later description instead says its comparison group received mechanical prophylaxis alone, changing the comparison used to support the recommendation.
“Our literature search identified one new RCT that compared the combination of mechanical and pharmacological prophylaxis to pharmacological prophylaxis alone [500].”
“The PREVENT study randomised 2003 critically ill patients to intermittent pneumatic calf compression alone or in combination with pharmacological prophylaxis [500].”
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250 · see citing works
Self-citationGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941 · see citing works
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · see citing works
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977 · see citing works
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694 · see citing works
Self-citationGRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · see citing works
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,282 · see citing works
Self-citationBernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746 · see citing works
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621 · see citing works
Self-citationKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · see citing works
Self-citation2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E. H., Angus, D. C., Cook, D., Cohen, J., Opal, S. M., Vincent, J., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,976 · see citing works
Self-citationA Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187 · see citing works
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · see citing works
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609 · see citing works
Self-citationPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works
Prone positioning in severe acute respiratory distress syndrome.
Guérin, C., Reignier, J., Richard, J.-C., Beuret, P., Gacouin, A., Boulain, T., Mercier, E., Badet, M., Mercat, A., Baudin, O., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214103 · Cited by 4,040 · see citing works
Seymour, C. W., Liu, V. X., Iwashyna, T. J., Brunkhorst, F. M., Rea, T. D., Scherag, A., Rubenfeld, G., Kahn, J. M., Shankar-Hari, M., Singer, M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0288 · Cited by 3,939 · see citing works
Self-citationMultistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931 · see citing works
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892 · see citing works
Self-citationMetlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657 · see citing works
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.
Amato, M. B. P., Barbas, C. S. V., Medeiros, D. M., Magaldi, R. B., Schettino, G. P., Lorenzi-Filho, G., Kairalla, R. A., Deheinzelin, D., Munoz, C., Oliveira, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802053380602 · Cited by 3,654 · see citing works
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652 · see citing works
Self-citationMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638 · see citing works
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548 · see citing works
Self-citationFreifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463 · see citing works
Peek, G. J., Mugford, M., Tiruvoipati, R., Wilson, A., Allen, E., Thalanany, M. M., Hibbert, C. L., Truesdale, A., Clemens, F., Cooper, N., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61069-2 · Cited by 3,395 · see citing works
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,012 · see citing works
Self-citationIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · see citing works
Self-citationDriving pressure and survival in the acute respiratory distress syndrome.
Amato, M. B. P., Meade, M. O., Slutsky, A. S., Brochard, L., Costa, E. L. V., Schoenfeld, D. A., Stewart, T. E., Briel, M., Talmor, D., Mercat, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1410639 · Cited by 2,801 · see citing works
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693 · see citing works
Needham, D. M., Davidson, J., Cohen, H., Hopkins, R. O., Weinert, C., Wunsch, H., Zawistowski, C., Bemis-Dougherty, A., Berney, S. C., Bienvenu, O. J., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232da75 · Cited by 2,639 · see citing works
Long-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582 · see citing works
Self-citation(2004) · New England Journal of Medicine · doi:10.1056/nejmoa032193 · Cited by 2,565 · see citing works
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
Shankar‐Hari, M., Phillips, G. S., Levy, M. L., Seymour, C. W., Liu, V. X., Deutschman, C. S., Angus, D. C., Rubenfeld, G. D., Singer, M., & for the Sepsis Definitions Task Force (2016) · JAMA · doi:10.1001/jama.2016.0289 · Cited by 2,440 · see citing works
Self-citationNeuromuscular Blockers in Early Acute Respiratory Distress Syndrome
Papazian, L., Forel, J.-M., Gacouin, A., Penot-Ragon, C., Perrin, G., Loundou, A., Jaber, S., Arnal, J.-M., Perez, D., Seghboyan, J.-M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005372 · Cited by 2,432 · see citing works
A randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414 · see citing works
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
Combes, A., Hajage, D., Capellier, G., Demoule, A., Lavoué, S., Guervilly, C., Da Silva, D., Zafrani, L., Tirot, P., Veber, B., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800385 · Cited by 2,380 · see citing works
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
Frat, J.-P., Thille, A. W., Mercat, A., Girault, C., Ragot, S., Perbet, S., Prat, G., Boulain, T., Morawiec, E., Cottereau, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503326 · Cited by 2,342 · see citing works
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225 · see citing works
Self-citationAlhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105 · see citing works
Self-citationKripalani, S., LeFevre, F., Phillips, C. O., Williams, M. V., Basaviah, P., & Baker, D. W. (2007) · JAMA · doi:10.1001/jama.297.8.831 · Cited by 2,103 · see citing works
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · see citing works
Self-citationGRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911 · see citing works
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884 · see citing works
Self-citationRybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795 · see citing works
Trial of early, goal-directed resuscitation for septic shock.
Mouncey, P. R., Osborn, T. M., Power, G. S., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Jahan, R., Harvey, S. E., Bell, D., Bion, J. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500896 · Cited by 1,604 · see citing works
Self-citationSolomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O’Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,571 · see citing works
Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570 · see citing works
Lung recruitment in patients with the acute respiratory distress syndrome.
Gattinoni, L., Caironi, P., Cressoni, M., Chiumello, D., Ranieri, V. M., Quintel, M., Russo, S., Patroniti, N., Cornejo, R., & Bugedo, G. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052052 · Cited by 1,548 · see citing works
Boyd, J. H., Forbes, J., Nakada, T.-A., Walley, K. R., & Russell, J. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181feeb15 · Cited by 1,517 · see citing works
The effects of advance care planning on end-of-life care: A systematic review
Brinkman-Stoppelenburg, A., Rietjens, J. A., & van der Heide, A. (2014) · Palliative Medicine · doi:10.1177/0269216314526272 · Cited by 1,480 · see citing works
Briel, M., Meade, M., Mercat, A., Brower, R. G., Talmor, D., Walter, S. D., Slutsky, A. S., Pullenayegum, E., Zhou, Q., Cook, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.218 · Cited by 1,467 · see citing works
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456 · see citing works
The surviving sepsis campaign bundle: 2018 update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5085-0 · Cited by 1,445 · see citing works
Self-citationImmunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Hotchkiss, R. S., Monneret, G., & Payen, D. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70001-x · Cited by 1,445 · see citing works
Balanced crystalloids versus saline in critically ill adults.
Semler, M. W., Self, W. H., Wanderer, J. P., Ehrenfeld, J. M., Wang, L., Byrne, D. W., Stollings, J. L., Kumar, A. B., Hughes, C. G., Hernandez, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1711584 · Cited by 1,433 · see citing works
Self-citationAndrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416 · see citing works
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376 · see citing works
Meade, M. O., Cook, D. J., Guyatt, G. H., Slutsky, A. S., Arabi, Y. M., Cooper, D. J., Davies, A. R., Hand, L. E., Zhou, Q., Thabane, L., et al. (2008) · JAMA · doi:10.1001/jama.299.6.637 · Cited by 1,370 · see citing works
Self-citationMercat, A., Richard, J.-C. M., Vielle, B., Jaber, S., Osman, D., Diehl, J.-L., Lefrant, J.-Y., Prat, G., Richecoeur, J., Nieszkowska, A., et al. (2008) · JAMA · doi:10.1001/jama.299.6.646 · Cited by 1,344 · see citing works
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315 · see citing works
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · see citing works
A communication strategy and brochure for relatives of patients dying in the ICU.
Lautrette, A., Darmon, M., Megarbane, B., Joly, L. M., Chevret, S., Adrie, C., Barnoud, D., Bleichner, G., Bruel, C., Choukroun, G., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063446 · Cited by 1,279 · see citing works
Effect of prone positioning on the survival of patients with acute respiratory failure.
Gattinoni, L., Tognoni, G., Pesenti, A., Taccone, P., Mascheroni, D., Labarta, V., Malacrida, R., Di Giulio, P., Fumagalli, R., Pelosi, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010043 · Cited by 1,271 · see citing works
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,268 · see citing works
Self-citationInitiation strategies for renal-replacement therapy in the intensive care unit.
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603017 · Cited by 1,243 · see citing works
High versus low blood-pressure target in patients with septic shock.
Asfar, P., Meziani, F., Hamel, J.-F., Grelon, F., Megarbane, B., Anguel, N., Mira, J.-P., Dequin, P.-F., Gergaud, S., Weiss, N., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312173 · Cited by 1,239 · see citing works
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198 · see citing works
Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193 · see citing works
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183 · see citing works
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · see citing works
Mechanical ventilation guided by esophageal pressure in acute lung injury.
Talmor, D., Sarge, T., Malhotra, A., O'Donnell, C. R., Ritz, R., Lisbon, A., Novack, V., & Loring, S. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708638 · Cited by 1,149 · see citing works
Zarbock, A., Kellum, J. A., Schmidt, C., Van Aken, H., Wempe, C., Pavenstädt, H., Boanta, A., Gerß, J., & Meersch, M. (2016) · JAMA · doi:10.1001/jama.2016.5828 · Cited by 1,143 · see citing works
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096 · see citing works
Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K.-M., Koulenti, D., Martin, C., Montravers, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu027 · Cited by 1,090 · see citing works
Self-citationEnhancing Recovery From Sepsis: A Review
Prescott, H. C., & Angus, D. C. (2018) · JAMA · doi:10.1001/jama.2017.17687 · Cited by 1,059 · see citing works
Self-citationRoberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046 · see citing works
Self-citationAdjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037 · see citing works
Self-citationHernandez, A. F. (2010) · JAMA · doi:10.1001/jama.2010.533 · Cited by 1,032 · see citing works
Chalfin, D. B., Trzeciak, S., Likourezos, A., Baumann, B. M., & Dellinger, R. P. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000266585.74905.5a · Cited by 1,022 · see citing works
Self-citationWriting Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators, Cavalcanti, A. B., Suzumura, É. A., Laranjeira, L. N., Paisani, D. D. M., Damiani, L. P., Guimarães, H. P., Romano, E. R., Regenga, M. D. M., Taniguchi, L. N. T., et al. (2017) · JAMA · doi:10.1001/jama.2017.14171 · Cited by 1,018 · see citing works
Self-citationAntonelli, M., Conti, G., Rocco, M., Bufi, M., De Blasi, R. A., Vivino, G., Gasparetto, A., & Meduri, G. U. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390703 · Cited by 1,014 · see citing works
Self-citationPrevalence and outcomes of infection among patients in intensive care units in 2017.
Vincent, J.-L., Sakr, Y., Singer, M., Martin-Loeches, I., Machado, F. R., Marshall, J. C., Finfer, S., Pelosi, P., Brazzi, L., Aditianingsih, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.2717 · Cited by 1,011 · see citing works
Self-citationRisk Factors for Gastrointestinal Bleeding in Critically Ill Patients
Cook, D. J., Fuller, H. D., Guyatt, G. H., Marshall, J. C., Leasa, D., Hall, R., Winton, T. L., Rutledge, F., Todd, T., Roy, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402103300601 · Cited by 1,010 · see citing works
The timing of early antibiotics and hospital mortality in sepsis.
Liu, V. X., Fielding-Singh, V., Greene, J. D., Baker, J. M., Iwashyna, T. J., Bhattacharya, J., & Escobar, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1848oc · Cited by 1,006 · see citing works
Self-citationVasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990 · see citing works
Fleischmann-Struzek, C., Mellhammar, L., Rose, N., Cassini, A., Rudd, K. E., Schlattmann, P., Allegranzi, B., & Reinhart, K. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06151-x · Cited by 982 · see citing works
Gaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., Shofer, F. S., & Goyal, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4824 · Cited by 970 · see citing works
Horn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · see citing works
Hernández, G., Ospina-Tascón, G. A., Damiani, L. P., Estenssoro, E., Dubin, A., Hurtado, J., Friedman, G., Castro, R., Alegría, L., Teboul, J.-L., et al. (2019) · JAMA · doi:10.1001/jama.2019.0071 · Cited by 946 · see citing works
Self-citationHydrocortisone plus fludrocortisone for adults with septic shock.
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705716 · Cited by 939 · see citing works
Angiotensin II for the Treatment of Vasodilatory Shock
Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704154 · Cited by 916 · see citing works
Self-citationPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911 · see citing works
NECROTIZING FASCIITIS: CLINICAL PRESENTATION, MICROBIOLOGY, AND DETERMINANTS OF MORTALITY
WONG, C.-H., CHANG, H.-C., PASUPATHY, S., KHIN, L.-W., TAN, J.-L., & LOW, C.-O. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200308000-00005 · Cited by 909 · see citing works
Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock
Holst, L. B., Haase, N., Wetterslev, J., Wernerman, J., Guttormsen, A. B., Karlsson, S., Johansson, P. I., Åneman, A., Vang, M. L., Winding, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406617 · Cited by 899 · see citing works
Self-citationHydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887 · see citing works
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome
The National Heart, L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901686 · Cited by 886 · see citing works
Levy, M. M., Dellinger, R. P., Townsend, S. R., Linde-Zwirble, W. T., Marshall, J. C., Bion, J., Schorr, C., Artigas, A., Ramsay, G., Beale, R., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1738-3 · Cited by 868 · see citing works
Self-citationScheer, B., Perel, A., & Pfeiffer, U. J. (2002) · Critical Care · doi:10.1186/cc1489 · Cited by 855 · see citing works
Serpa Neto, A., Cardoso, S. O., Manetta, J. A., Pereira, V. G. M., Espósito, D. C., Pasqualucci, M. D. O. P., Damasceno, M. C. T., & Schultz, M. J. (2012) · JAMA · doi:10.1001/jama.2012.13730 · Cited by 843 · see citing works
Fowler, A. A., Truwit, J. D., Hite, R. D., Morris, P. E., DeWilde, C., Priday, A., Fisher, B., Thacker, L. R., Natarajan, R., Brophy, D. F., et al. (2019) · JAMA · doi:10.1001/jama.2019.11825 · Cited by 836 · see citing works
Self-citationGRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
Guyatt, G. H., Oxman, A. D., Santesso, N., Helfand, M., Vist, G., Kunz, R., Brozek, J., Norris, S., Meerpohl, J., Djulbegovic, B., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.012 · Cited by 836 · see citing works
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00053-0 · Cited by 836 · see citing works
BROCHARD, L., ROUDOT-THORAVAL, F., ROUPIE, E., DELCLAUX, C., CHASTRE, J., FERNANDEZ-MONDÉJAR, E., CLÉMENTI, E., MANCEBO, J., FACTOR, P., MATAMIS, D., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9801044 · Cited by 800 · see citing works
Association of adverse events with antibiotic use in hospitalized patients.
Tamma, P. D., Avdic, E., Li, D. X., Dzintars, K., & Cosgrove, S. E. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1938 · Cited by 800 · see citing works
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · see citing works
Chu, D. K., Kim, L. H.-Y., Young, P. J., Zamiri, N., Almenawer, S. A., Jaeschke, R., Szczeklik, W., Schünemann, H. J., Neary, J. D., & Alhazzani, W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30479-3 · Cited by 778 · see citing works
Self-citationTiming of renal-replacement therapy in patients with acute kidney injury and sepsis.
Barbar, S. D., Clere-Jehl, R., Bourredjem, A., Hernu, R., Montini, F., Bruyère, R., Lebert, C., Bohé, J., Badie, J., Eraldi, J.-P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803213 · Cited by 777 · see citing works
Timing of initiation of renal-replacement therapy in acute kidney injury.
The STARRT-AKI Investigators (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2000741 · Cited by 771 · see citing works
Chowdhury, A. H., Cox, E. F., Francis, S. T., & Lobo, D. N. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318256be72 · Cited by 764 · see citing works
Formal guidelines: Management of acute respiratory distress syndrome.
Papazian, L., Aubron, C., Brochard, L., Chiche, J.-D., Combes, A., Dreyfuss, D., Forel, J.-M., Guérin, C., Jaber, S., Mekontso-Dessap, A., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0540-9 · Cited by 761 · see citing works
Trial of short-course antimicrobial therapy for intraabdominal infection.
Sawyer, R. G., Claridge, J. A., Nathens, A. B., Rotstein, O. D., Duane, T. M., Evans, H. L., Cook, C. H., O’Neill, P. J., Mazuski, J. E., Askari, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411162 · Cited by 747 · see citing works
Wald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742 · see citing works
Glycemic variability: A strong independent predictor of mortality in critically ill patients.
Krinsley, J. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b38d2 · Cited by 729 · see citing works
Young, P., Bailey, M., Beasley, R., Henderson, S., Mackle, D., McArthur, C., McGuinness, S., Mehrtens, J., Myburgh, J., Psirides, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.12334 · Cited by 728 · see citing works
Gordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.10485 · Cited by 728 · see citing works
Self-citationGirardis, M., Busani, S., Damiani, E., Donati, A., Rinaldi, L., Marudi, A., Morelli, A., Antonelli, M., & Singer, M. (2016) · JAMA · doi:10.1001/jama.2016.11993 · Cited by 723 · see citing works
Self-citationMaziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698 · see citing works
Interventions for increasing the use of shared decision making by healthcare professionals
Légaré, F., Adekpedjou, R., Stacey, D., Turcotte, S., Kryworuchko, J., Graham, I. D., Lyddiatt, A., Politi, M. C., Thomson, R., Elwyn, G., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006732.pub4 · Cited by 698 · see citing works
The Surviving Sepsis Campaign Bundle: 2018 Update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003119 · Cited by 679 · see citing works
Self-citationBellani, G., Laffey, J. G., Pham, T., Madotto, F., Fan, E., Brochard, L., Esteban, A., Gattinoni, L., Bumbasirevic, V., Piquilloud, L., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201606-1306oc · Cited by 667 · see citing works
Self-citationBlumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661 · see citing works
Schneiderman, L. J., Gilmer, T., Teetzel, H. D., Dugan, D. O., Blustein, J., Cranford, R., Briggs, K. B., Komatsu, G. I., Goodman-Crews, P., Cohn, F., et al. (2003) · JAMA · doi:10.1001/jama.290.9.1166 · Cited by 661 · see citing works
Schünemann, H. J., Wiercioch, W., Brożek, J., Etxeandia‐Ikobaltzeta, I., Mustafa, R. A., Manja, V., Brignardello‐Petersen, R., Neumann, I., Falavigna, M., Alhazzani, W. A., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.09.009 · Cited by 652 · see citing works
Self-citationMuthuri, S. G., Venkatesan, S., Myles, P. R., Leonardi-Bee, J., Al Khuwaitir, T. S. A., Al Mamun, A., Anovadiya, A. P., Azziz-Baumgartner, E., Báez, C., Bassetti, M., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70041-4 · Cited by 644 · see citing works
Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure
Mauri, T., Turrini, C., Eronia, N., Grasselli, G., Volta, C. A., Bellani, G., & Pesenti, A. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201605-0916oc · Cited by 641 · see citing works
Weiss, S. L., Peters, M. J., Alhazzani, W. A., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 638 · see citing works
Self-citationAmato, M. B., Barbas, C. S., Medeiros, D. M., Schettino, G. D. P., Lorenzi Filho, G., Kairalla, R. A., Deheinzelin, D., Morais, C., Fernandes, E. D. O., & Takagaki, T. Y. (1995) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.152.6.8520744 · Cited by 625 · see citing works
Physiology of Vasopressin Relevant to Management of Septic Shock
Holmes, C. L., Patel, B. M., Russell, J. A., & Walley, K. R. (2001) · Chest · doi:10.1378/chest.120.3.989 · Cited by 620 · see citing works
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605 · see citing works
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604 · see citing works
Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis
Munshi, L., Del Sorbo, L., Adhikari, N. K. J., Hodgson, C. L., Wunsch, H., Meade, M. O., Uleryk, E., Mancebo, J., Pesenti, A., Ranieri, V. M., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201704-343ot · Cited by 601 · see citing works
Self-citationEarly, Goal-Directed Therapy for Septic Shock — A Patient-Level Meta-Analysis
The PRISM Investigators (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701380 · Cited by 600 · see citing works
Reignier, J., Boisramé-Helms, J., Brisard, L., Lascarrou, J.-B., Ait Hssain, A., Anguel, N., Argaud, L., Asehnoune, K., Asfar, P., Bellec, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32146-3 · Cited by 595 · see citing works
Effects of perfusion pressure on tissue perfusion in septic shock.
LeDoux, D., Astiz, M. E., Carpati, C. M., & Rackow, E. C. (2000) · Critical Care Medicine · doi:10.1097/00003246-200008000-00007 · Cited by 586 · see citing works
Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.
Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914433 · Cited by 577 · see citing works
Brower, R. G., Shanholtz, C. B., Fessler, H. E., Shade, D. M., White, P., Wiener, C. M., Teeter, J. G., Dodd-o, J. M., Almog, Y., & Piantadosi, S. (1999) · Critical Care Medicine · doi:10.1097/00003246-199908000-00015 · Cited by 575 · see citing works
Sud, S., Friedrich, J. O., Taccone, P., Polli, F., Adhikari, N. K. J., Latini, R., Pesenti, A., Guérin, C., Mancebo, J., Curley, M. A. Q., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1748-1 · Cited by 563 · see citing works
Guilhaumou, R., Benaboud, S., Bennis, Y., Dahyot-Fizelier, C., Dailly, E., Gandia, P., Goutelle, S., Lefeuvre, S., Mongardon, N., Roger, C., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2378-9 · Cited by 543 · see citing works
A randomized trial of a family-support intervention in intensive care units
White, D. B., Angus, D. C., Shields, A.-M., Buddadhumaruk, P., Pidro, C., Paner, C., Chaitin, E., Chang, C.-C. H., Pike, F., Weissfeld, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802637 · Cited by 524 · see citing works
Self-citationThe ABCDEF Bundle: Science and Philosophy of How ICU Liberation Serves Patients and Families
Ely, E. W. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002175 · Cited by 514 · see citing works
Conservative Oxygen Therapy during Mechanical Ventilation in the ICU
The ICU-ROX Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1903297 · Cited by 511 · see citing works
Tidal Volume Reduction in Patients with Acute Lung Injury When Plateau Pressures Are Not High
Hager, D. N., Krishnan, J. A., Hayden, D. L., & Brower, R. G. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-048cp · Cited by 509 · see citing works
Dellinger, R. P., Bagshaw, S. M., Antonelli, M., Foster, D. M., Klein, D. J., Marshall, J. C., Palevsky, P. M., Weisberg, L. S., Schorr, C. A., Trzeciak, S., et al. (2018) · JAMA · doi:10.1001/jama.2018.14618 · Cited by 502 · see citing works
Self-citationCuthbertson, B. H., Rattray, J., Campbell, M. K., Gager, M., Roughton, S., Smith, A., Hull, A., Breeman, S., Norrie, J., Jenkinson, D., et al. (2009) · BMJ · doi:10.1136/bmj.b3723 · Cited by 488 · see citing works
Mechanism by Which the Prone Position Improves Oxygenation in Acute Lung Injury
Lamm, W. J., Graham, M. M., & Albert, R. K. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.150.1.8025748 · Cited by 486 · see citing works
Septic shock attributed to Candida infection: Importance of empiric therapy and source control.
Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis305 · Cited by 477 · see citing works
Self-citationBeitler, J. R., Sarge, T., Banner-Goodspeed, V. M., Gong, M. N., Cook, D., Novack, V., Loring, S. H., Talmor, D., & for the EPVent-2 Study Group (2019) · JAMA · doi:10.1001/jama.2019.0555 · Cited by 469 · see citing works
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
Ulldemolins, M., Roberts, J. A., Rello, J., Paterson, D. L., & Lipman, J. (2011) · Clinical Pharmacokinetics · doi:10.2165/11539220-000000000-00000 · Cited by 469 · see citing works
Self-citationLiberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome
Barrot, L., Asfar, P., Mauny, F., Winiszewski, H., Montini, F., Badie, J., Quenot, J.-P., Pili-Floury, S., Bouhemad, B., Louis, G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916431 · Cited by 467 · see citing works
Fujii, T., Luethi, N., Young, P. J., Frei, D. R., Eastwood, G. M., French, C. J., Deane, A. M., Shehabi, Y., Hajjar, L. A., Oliveira, G., et al. (2020) · JAMA · doi:10.1001/jama.2019.22176 · Cited by 466 · see citing works
Self-citationFukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F., & Marr, K. A. (2003) · Blood · doi:10.1182/blood-2003-02-0456 · Cited by 465 · see citing works
McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.009 · Cited by 464 · see citing works
Cardoso, L. T., Grion, C. M., Matsuo, T., Anami, E. H., Kauss, I. A., Seko, L., & Bonametti, A. M. (2011) · Critical Care · doi:10.1186/cc9975 · Cited by 461 · see citing works
The endothelial glycocalyx: a review of the vascular barrier
Alphonsus, C. S., & Rodseth, R. N. (2014) · Anaesthesia · doi:10.1111/anae.12661 · Cited by 460 · see citing works
Cooper, D. J., Walley, K. R., Wiggs, B. R., & Russell, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-492 · Cited by 452 · see citing works
Rehabilitation after critical illness: A randomized, controlled trial.
Jones, C., Skirrow, P., Griffiths, R. D., Humphris, G. H., Ingleby, S., Eddleston, J., Waldmann, C., & Gager, M. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000089938.56725.33 · Cited by 446 · see citing works
Yahav, D., Franceschini, E., Koppel, F., Turjeman, A., Babich, T., Bitterman, R., Neuberger, A., Ghanem-Zoubi, N., Santoro, A., Eliakim-Raz, N., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1054 · Cited by 433 · see citing works
Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.
Ferrer, R., Artigas, A., Suarez, D., Palencia, E., Levy, M. M., Arenzana, A., Pérez, X. L., & Sirvent, J.-M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1912oc · Cited by 433 · see citing works
Self-citationCook, D., Crowther, M., Meade, M., Rabbat, C., Griffith, L., Schiff, D., Geerts, W., & Guyatt, G. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000171207.95319.b2 · Cited by 430 · see citing works
Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6211 · Cited by 426 · see citing works
Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization
Fan, D., Coughlin, L. A., Neubauer, M. M., Kim, J., Kim, M. S., Zhan, X., Simms-Waldrip, T. R., Xie, Y., Hooper, L. V., & Koh, A. Y. (2015) · Nature Medicine · doi:10.1038/nm.3871 · Cited by 426 · see citing works
Eichacker, P. Q., Gerstenberger, E. P., Banks, S. M., Cui, X., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-956oc · Cited by 423 · see citing works
Lactate and shock state: The metabolic view.
Levy, B. (2006) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000235208.77450.15 · Cited by 422 · see citing works
Andrews, B., Semler, M. W., Muchemwa, L., Kelly, P., Lakhi, S., Heimburger, D. C., Mabula, C., Bwalya, M., & Bernard, G. R. (2017) · JAMA · doi:10.1001/jama.2017.10913 · Cited by 418 · see citing works
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy874 · Cited by 418 · see citing works
Machado, F. R., Cavalcanti, A. B., Bozza, F. A., Ferreira, E. M., Angotti Carrara, F. S., Sousa, J. L., Caixeta, N., Salomao, R., Angus, D. C., Pontes Azevedo, L. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30322-5 · Cited by 416 · see citing works
Self-citationWaters, J. H., Gottlieb, A., Schoenwald, P., Popovich, M. J., Sprung, J., & Nelson, D. R. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200110000-00004 · Cited by 410 · see citing works
Jaber, S., Paugam, C., Futier, E., Lefrant, J.-Y., Lasocki, S., Lescot, T., Pottecher, J., Demoule, A., Ferrandière, M., Asehnoune, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31080-8 · Cited by 410 · see citing works
Antibiotics in critically ill patients: A systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira, J., & Póvoa, P. (2011) · Critical Care · doi:10.1186/cc10441 · Cited by 408 · see citing works
Griffiths, J., Hatch, R. A., Bishop, J., Morgan, K., Jenkinson, C., Cuthbertson, B. H., & Brett, S. J. (2013) · Critical Care · doi:10.1186/cc12745 · Cited by 400 · see citing works
Forel, J.-M., Roch, A., Marin, V., Michelet, P., Demory, D., Blache, J.-L., Perrin, G., Gainnier, M., Bongrand, P., & Papazian, L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239435.87433.0d · Cited by 400 · see citing works
Munshi, L., Walkey, A., Goligher, E., Pham, T., Uleryk, E. M., & Fan, E. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30452-1 · Cited by 398 · see citing works
Rhee, C., Kadri, S. S., Dekker, J. P., Danner, R. L., Chen, H.-C., Fram, D., Zhang, F., Wang, R., Klompas, M., & Program, F. T. C. P. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2899 · Cited by 397 · see citing works
Self-citationA Multicenter Evaluation of Tests for Diagnosis of Histoplasmosis
Hage, C. A., Ribes, J. A., Wengenack, N. L., Baddour, L. M., Assi, M., McKinsey, D. S., Hammoud, K., Alapat, D., Babady, N. E., Parker, M., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir435 · Cited by 393 · see citing works
Kett, D. H., Azoulay, E., Echeverria, P. M., & Vincent, J.-L. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c1ca · Cited by 389 · see citing works
Shimabukuro, D. W., Barton, C. W., Feldman, M. D., Mataraso, S. J., & Das, R. (2017) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000234 · Cited by 382 · see citing works
Branch-Elliman, W., O’Brien, W., Strymish, J., Itani, K., Wyatt, C., & Gupta, K. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.0569 · Cited by 381 · see citing works
Managing ICU surge during the COVID-19 crisis: Rapid guidelines.
Aziz, S., Arabi, Y. M., Alhazzani, W., Evans, L., Citerio, G., Fischkoff, K., Salluh, J., Meyfroidt, G., Alshamsi, F., Oczkowski, S., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06092-5 · Cited by 380 · see citing works
Self-citationRoberts, J. A., Abdul-Aziz, M.-H., Davis, J. S., Dulhunty, J. M., Cotta, M. O., Myburgh, J., Bellomo, R., & Lipman, J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201601-0024oc · Cited by 379 · see citing works
Self-citationLaffey, J. G., Bellani, G., Pham, T., Fan, E., Madotto, F., Bajwa, E. K., Brochard, L., Clarkson, K., Esteban, A., Gattinoni, L., et al. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4571-5 · Cited by 378 · see citing works
The CLASSIC Trial Group, Hjortrup, P. B., The Scandinavian Critical Care Trials Group, Haase, N., Bundgaard, H., Thomsen, S. L., Winding, R., Pettilä, V., Aaen, A., Lodahl, D., et al. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4500-7 · Cited by 376 · see citing works
Self-citationPuskarich, M. A., Trzeciak, S., Shapiro, N. I., Arnold, R. C., Horton, J. M., Studnek, J. R., Kline, J. A., & Jones, A. E. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e87ab · Cited by 376 · see citing works
Self-citationWilliams, E. L., Hildebrand, K. L., McCormick, S. A., et al. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199905000-00006 · Cited by 376 · see citing works
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis
Gordon, A. C., Perkins, G. D., Singer, M., McAuley, D. F., Orme, R. M. L., Santhakumaran, S., Mason, A. J., Cross, M., Al-Beidh, F., Best-Lane, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609409 · Cited by 372 · see citing works
Medication reconciliation: a practical tool to reduce the risk of medication errors
Pronovost, P., Weast, B., Schwarz, M., Wyskiel, R. M., Prow, D., Milanovich, S. N., Berenholtz, S., Dorman, T., & Lipsett, P. (2003) · Journal of Critical Care · doi:10.1016/j.jcrc.2003.10.001 · Cited by 371 · see citing works
De Backer, D., Creteur, J., Silva, E., & Vincent, J.-L. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063045.77339.b6 · Cited by 371 · see citing works
Continuous versus intermittent renal replacement therapy: A meta-analysis.
A. Kellum, J., C. Angus, D., P. Johnson, J., Leblanc, M., Griffin, M., Ramakrishnan, N., & T. Linde-Zwirble, W. (2002) · Intensive Care Medicine · doi:10.1007/s00134-001-1159-4 · Cited by 369 · see citing works
A comparison of epinephrine and norepinephrine in critically ill patients
Myburgh, J. A., Higgins, A., Jovanovska, A., Lipman, J., Ramakrishnan, N., Santamaria, J., & the CAT Study investigators (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1219-0 · Cited by 368 · see citing works
Azoulay, E., Pochard, F., Chevret, S., Jourdain, M., Bornstain, C., Wernet, A., Cattaneo, I., Annane, D., Brun, F., Bollaert, P.-E., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.200108-006oc · Cited by 368 · see citing works
Invasive aspergillosis in the intensive care unit
Meersseman, W., Lagrou, K., Maertens, J., & Wijngaerden, E. V. (2007) · Clinical Infectious Diseases · doi:10.1086/518852 · Cited by 366 · see citing works
Marik, P. E., Linde-Zwirble, W. T., Bittner, E. A., Sahatjian, J., & Hansell, D. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4675-y · Cited by 362 · see citing works
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356 · see citing works
Lamontagne, F., Richards-Belle, A., Thomas, K., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Camsooksai, J., Darnell, R., Gordon, A. C., Henry, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.0930 · Cited by 354 · see citing works
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
Mengoli, C., Cruciani, M., Barnes, R. A., Loeffler, J., & Donnelly, J. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70019-2 · Cited by 354 · see citing works
Carson, S. S., Cox, C. E., Wallenstein, S., Hanson, L. C., Danis, M., Tulsky, J. A., Chai, E., & Nelson, J. E. (2016) · JAMA · doi:10.1001/jama.2016.8474 · Cited by 352 · see citing works
Epidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- Liu G, An Y, Yi X et al (2017) Early lactate levels for prediction of mortality in patients with sepsis or septic shock: a meta-analysis. Int J Exp Med 10:37–47
- Vincent J (2019) Arterial, central venous, and pulmonary artery catheters. In: JE P (ed) Critical care medicine: principles and diagnosis and management in the adult, 5th edn. Elsevier, Philadelphia, pp 40–49
- Belenguer-Muncharaz A, Cubedo-Bort M, Blasco-Asensio D et al (2017) Non-invasive ventilation versus invasive mechanical ventilation in patients with hypoxemic acute respiratory failure in an Intensive Care Unit. A randomized controlled study. Minerva Pneumologica 56:1–10
- Force ADT, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533
- Cavalcanti AB, Suzumura ÉA, Laranjeira LN et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318(14):1335–1345 · DOI · Paper page
- Diabetes Care in the Hospital (2018) Standards of Medical Care in Diabetes—2018. Diabetes Care 41(Supplement 1):S144–S151
Cited by
Sorted by citations
Restriction of Intravenous Fluid in ICU Patients with Septic Shock
Meyhoff, T. S., Hjortrup, P. B., Wetterslev, J., Sivapalan, P., Laake, J. H., Cronhjort, M., Jakob, S. M., Cecconi, M., Nalos, M., Ostermann, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202707 · Cited by 427 · see citing works
Self-citationHow can assessing hemodynamics help to assess volume status?
De Backer, D., Aissaoui, N., Cecconi, M., Chew, M. S., Denault, A., Hajjar, L., Hernandez, G., Messina, A., Myatra, S. N., Ostermann, M., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06808-9 · Cited by 199 · see citing works
Self-citationQian, E. T., Casey, J. D., Wright, A., Wang, L., Shotwell, M. S., Siemann, J. K., Dear, M. L., Stollings, J. L., Lloyd, B. D., Marvi, T. K., et al. (2023) · JAMA · doi:10.1001/jama.2023.20583 · Cited by 150 · see citing works
Self-citationDark, P., Hossain, A., McAuley, D. F., Brealey, D., Carlson, G., Clayton, J. C., Felton, T. W., Ghuman, B. K., Gordon, A. C., Hellyer, T. P., et al. (2025) · JAMA · doi:10.1001/jama.2024.26458 · Cited by 114 · see citing works
Self-citationZhang, S., Yu, J., Xu, X., Yin, C., Lu, Y., Yao, B., Tory, M., Padilla, L. M., Caterino, J., Zhang, P., et al. (2024) · Proceedings of the CHI Conference on Human Factors in Computing Systems · doi:10.1145/3613904.3642343 · Cited by 99 · see citing works
Lou, X., Xue, J., Shao, R., Yang, Y., Ning, D., Mo, C., Wang, F., & Chen, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063543 · Cited by 87 · see citing works
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117 · see citing works
Self-citationSepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice
Fang, H., Wang, Y., Deng, J., Zhang, H., Wu, Q., He, L., Xu, J., Shao, X., Ouyang, X., He, Z., et al. (2022) · mSystems · doi:10.1128/msystems.01399-21 · Cited by 87 · see citing works
Hu, C., Li, L., Li, Y., Wang, F., Hu, B., & Peng, Z. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00671-3 · Cited by 63 · see citing works
Blood lactate concentration in COVID-19: a systematic literature review
Carpenè, G., Onorato, D., Nocini, R., Fortunato, G., Rizk, J. G., Henry, B. M., & Lippi, G. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-1115 · Cited by 68 · see citing works
Zhou, S., Li, Y., Hong, Y., Zhong, Z., & Zhao, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175616 · Cited by 45 · see citing works
Grillo-Ardila, C. F., Tibavizco-Palacios, D., Triana, L. C., Rugeles, S. J., Vallejo-Ortega, M. T., Calderón-Franco, C. H., & Ramírez-Mosquera, J. J. (2024) · Nutrients · doi:10.3390/nu16111560 · Cited by 35 · see citing works
Kam, K. Q., Chen, T., Kadri, S. S., Lawandi, A., Yek, C., Walker, M., Warner, S., Fram, D., Chen, H.-C., Shappell, C. N., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciae591 · Cited by 29 · see citing works
Self-citation21st Century critical care medicine: an overview
Padte, S., Samala Venkata, V., Mehta, P., Tawfeeq, S., Kashyap, R., & Surani, S. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i1.90176 · Cited by 26 · see citing works
Gut microbiota and sepsis and sepsis-related death: a Mendelian randomization investigation
Shang, W., Zhang, S., Qian, H., Huang, S., Li, H., Liu, J., & Chen, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1266230 · Cited by 23 · see citing works
Tian, Y., Wang, L., Fan, X., Zhang, H., Dong, Z., & Tao, T. (2023) · PLOS ONE · doi:10.1371/journal.pone.0279964 · Cited by 21 · see citing works
Multicenter Prospective Validation of an Updated Proprietary Sepsis Prediction Model
Wong, A., Currey, D., Schwinne, M., Park-Egan, B., Meyer, S., Gutting, A., Cao, J., Khan, S., Dantes, R., Pan, T., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.0181 · Cited by 21 · see citing works
Ke, X., Zhang, F., Huang, G., & Wang, A. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/4820464 · Cited by 16 · see citing works
Pan, K., Li, R., Li, Y., Ding, X., Li, X., & Lv, Q. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae410 · Cited by 16 · see citing works
Zhang, X., Li, S., Luo, H., He, S., Yang, H., Li, L., Tian, T., Han, Q., Ye, J., Huang, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01035-6 · Cited by 14 · see citing works
Alu, F. F., & Oluwadare, S. (2026) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2026.1737532 · Cited by 13 · see citing works
Antibiotic De-escalation in adults hospitalized for community-onset Sepsis
Gupta, A. B., Heath, M., Walzl, E., Ratz, D., Munroe, E., Vaughn, V. M., Horowitz, J. K., Czilok, T., Petty, L. A., Gandhi, T. N., et al. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.6919 · Cited by 14 · see citing works
Self-citationXu, K., Huang, Q., Lyu, Y., Wang, S., Lu, Y., & Qian, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117200 · Cited by 11 · see citing works
Fixler, A., Oliaro, B., Frieden, M., Girardo, C., Winterbottom, F. A., Fort, L. B., & Hill, J. (2023) · Ochsner Journal · doi:10.31486/toj.22.0098 · Cited by 11 · see citing works
Optimal antibiotic use in the intensive care unit
Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025) · Critical Care · doi:10.1186/s13054-025-05653-8 · Cited by 11 · see citing works
Philippon, A.-L., Lebal, S., Cancella de Abreu, M., Gerlier, C., Mirò, O., Simon, T., & Freund, Y. (2025) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000001212 · Cited by 10 · see citing works
Liu, X., Liu, Y., Su, X., Jiang, L., Tang, G., & Wang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112263 · Cited by 7 · see citing works
Acute management of sepsis beyond 24 hours
Premachandra, A., & Heming, N. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0044-1787991 · Cited by 2 · see citing works
- Authors
- Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., Schorr, C., Simpson, S., Wiersinga, W. J., Alshamsi, F., Angus, D. C., Arabi, Y., Azevedo, L., Beale, R., Beilman, G., Belley-Cote, E., Burry, L., Cecconi, M., Centofanti, J., Coz Yataco, A., De Waele, J., Dellinger, R. P., Doi, K., Du, B., Estenssoro, E., Ferrer, R., Gomersall, C., Hodgson, C., Møller, M. H., Iwashyna, T., Jacob, S., Kleinpell, R., Klompas, M., Koh, Y., Kumar, A., Kwizera, A., Lobo, S., Masur, H., McGloughlin, S., Mehta, S., Mehta, Y., Mer, M., Nunnally, M., Oczkowski, S., Osborn, T., Papathanassoglou, E., Perner, A., Puskarich, M., Roberts, J., Schweickert, W., Seckel, M., Sevransky, J., Sprung, C. L., Welte, T., Zimmerman, J., & Levy, M.
- Affiliations
- University of Washington (US)
- St George's, University of London (GB)
- McMaster University (CA)
- Agostino Gemelli University Polyclinic (IT)
- Emory University (US)
- Western Health (AU)
- Hospital São Paulo (BR)
- Ottawa Hospital (CA)
- Guy's Hospital (GB)
- University of Michigan (US)
- Cooper Norcross Health (US)
- University of Kansas Medical Center (US)
- Amsterdam University Medical Centers (NL)
- United Arab Emirates University (AE)
- University of Pittsburgh (US)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Universidade de São Paulo (BR)
- University of Minnesota (US)
- Mount Sinai Hospital (CA)
- Humanitas University (IT)
- The University of Tokyo (JP)
- Peking Union Medical College Hospital (CN)
- Vall d'Hebron Institut de Recerca (ES)
- Prince of Wales Hospital (CN)
- Monash University (AU)
- Copenhagen University Hospital (DK)
- Michigan Medicine (US)
- Liverpool School of Tropical Medicine (GB)
- Vanderbilt University (US)
- Brigham and Women's Hospital (US)
- Asan Medical Center (KR)
- University of Manitoba (CA)
- Makerere University (UG)
- Faculdade de Medicina de São José do Rio Preto (BR)
- National Institutes of Health (US)
- Alfred Health (AU)
- Medanta The Medicity (IN)
- University of the Witwatersrand (ZA)
- New York University (US)
- Washington University in St. Louis (US)
- University of Alberta (CA)
- Rigshospitalet (DK)
- The University of Queensland (AU)
- University of Pennsylvania (US)
- Hebrew University of Jerusalem (IL)
- Medizinische Hochschule Hannover (DE)
- Brown University (US)
- Corresponding author
- Evans, Laura
- ORCID
- Evans, Laura
- Rhodes, Andrew
- Alhazzani, Waleed
- Antonelli, Massimo
- Coopersmith, Craig M.
- French, Craig
- Machado, Flávia R.
- Mcintyre, Lauralyn
- Ostermann, Marlies
- Prescott, Hallie C.
- Schorr, Christa
- Simpson, Steven
- Wiersinga, W. Joost
- Alshamsi, Fayez
- Angus, Derek C.
- Arabi, Yaseen
- Azevedo, Luciano
- Beilman, Gregory
- Burry, Lisa
- Cecconi, Maurizio
- Centofanti, John
- Doi, Kent
- Du, Bin
- Estenssoro, Elisa
- Ferrer, Ricard
- Gomersall, Charles
- Hodgson, Carol
- Møller, Morten Hylander
- Iwashyna, Theodore
- Jacob, Shevin
- Kleinpell, Ruth
- Klompas, Michael
- Koh, Younsuck
- Kumar, Anand
- Kwizera, Arthur
- Lobo, Suzana
- Masur, Henry
- Mehta, Sangeeta
- Mehta, Yatin
- Mer, Mervyn
- Nunnally, Mark
- Oczkowski, Simon
- Osborn, Tiffany
- Papathanassoglou, Elizabeth
- Perner, Anders
- Puskarich, Michael
- Roberts, Jason
- Schweickert, William
- Seckel, Maureen
- Sprung, Charles L.
- Welte, Tobias
- Levy, Mitchell
- Venue
- Intensive Care Medicine
- Published
- 2021-10-02
- Volume
- 47
- Issue
- 11
- Pages
- 1181-1247
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- PMC
- PMC8486643
- OpenAlex
- W3202964273
- Cited by
- 5,082
- References
- 645
- Citations by year
- 2026: 903 · 2025: 1227 · 2024: 1203 · 2023: 1080 · 2022: 614 · 2021: 44 · 2020: 5 · 2012: 1
- FWCI
- 532.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, cc-by)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- American Thoracic Society
- Society for Academic Emergency Medicine
- European Respiratory Society
- American Association of Critical-Care Nurses
- National Institute for Health and Care Research (17/63/42)
- Intensive Care Society
- European Society of Clinical Microbiology and Infectious Diseases
- European Society of Intensive Care Medicine
- Topics
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Abdominal Surgery and Complications
- Health Sciences › Medicine › Pharmacology › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- sepsis, septic shock, Surviving Sepsis Campaign, sepsis screening, early sepsis treatment, fluid resuscitation, vasoactive drugs, antimicrobial therapy, mechanical ventilation, goals of care, long-term outcomes, adults
- MeSH terms
- Critical Care, Humans, Shock, Septic, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-01.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-01.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review